Triumph Financial (TFIN) 10-Q 20 Oct 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Oct. 17, 2020
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	001-36722
Entity Registrant Name	TRIUMPH BANCORP, INC.
Entity Incorporation, State or Country Code	TX
Entity Tax Identification Number	20-0477066
Entity Address, Address Line One	12700 Park Central Drive, Suite 1700
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75251
City Area Code	214
Local Phone Number	365-6900
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		24,851,581
Amendment Flag	false
Entity Central Index Key	0001539638
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.01 per share
Trading Symbol	TBK
Security Exchange Name	NASDAQ
Depositary Shares
Document Information [Line Items]
Title of 12(b) Security	Depositary Shares Each Representing a 1/40th Interest in a Share of 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock
Trading Symbol	TBKCP
Security Exchange Name	NASDAQ

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
ASSETS
Cash and due from banks	$ 54,740	$ 67,747
Interest bearing deposits with other banks	233,538	130,133
Total cash and cash equivalents	288,278	197,880
Securities - equity investments	6,040	5,437
Securities - available for sale	242,802	248,820
Securities - held to maturity, net of allowance for credit losses of $1,961 and $0, respectively, fair value of $5,473 and $6,907, respectively	6,096	8,417
Loans held for sale	36,716	2,735
Loans, net of allowance for credit losses of $90,995 and $29,092, respectively	4,761,916	4,165,420
Federal Home Loan Bank and other restricted stock, at cost	18,464	19,860
Premises and equipment, net	105,455	96,595
Other real estate owned, net	1,704	3,009
Goodwill	163,263	158,743
Intangible assets, net	28,778	31,543
Bank-owned life insurance	41,440	40,954
Deferred tax assets, net	7,716	3,812
Other assets	128,119	77,072
Total assets	5,836,787	5,060,297
Deposits
Noninterest bearing	1,315,900	809,696
Interest bearing	2,932,201	2,980,210
Total deposits	4,248,101	3,789,906
Customer repurchase agreements	14,192	2,033
Advances from Federal Home Loan Banks	435,000	430,000
Paycheck Protection Program Liquidity Facility	223,713	0
Subordinated notes	87,455	87,327
Junior subordinated debentures	39,944	39,566
Other liabilities	94,540	74,875
Total liabilities	5,142,945	4,423,707
Commitments and contingencies - See Note 9 and Note 10
Stockholders' equity - See Note 13
Preferred stock	45,000	0
Common stock, 24,851,601 and 24,964,961 shares outstanding, respectively	279	272
Additional paid-in-capital	488,094	473,251
Treasury stock, at cost	(102,942)	(67,069)
Retained earnings	258,254	229,030
Accumulated other comprehensive income (loss)	5,157	1,106
Total stockholders’ equity	693,842	636,590
Total liabilities and stockholders' equity	$ 5,836,787	$ 5,060,297

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Securities - Held to maturity, Allowance for credit losses	$ 1,961		$ 0
Securities - Held to maturity, Fair value	5,473		6,907
Allowance for credit losses	$ 90,995	$ 54,613	$ 29,092	$ 31,895	$ 29,416	$ 27,571
Common stock, outstanding (in shares)	24,851,601		24,964,961

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Interest and dividend income:
Loans, including fees	$ 48,774	$ 50,249	$ 147,491	$ 143,253
Factored receivables, including fees	31,468	25,570	76,861	75,684
Securities	1,927	2,784	6,710	8,095
FHLB and other restricted stock	122	209	474	547
Cash deposits	73	603	640	2,403
Total interest income	82,364	79,415	232,176	229,982
Interest expense:
Deposits	5,834	11,036	23,095	29,264
Subordinated notes	1,348	840	4,016	2,518
Junior subordinated debentures	462	719	1,662	2,223
Other borrowings	341	2,055	2,273	6,482
Total interest expense	7,985	14,650	31,046	40,487
Net interest income (expense)	74,379	64,765	201,130	189,495
Credit loss expense (benefit)	(258)	2,865	33,649	7,560
Net interest income after credit loss expense	74,637	61,900	167,481	181,935
Noninterest income:
Net OREO gains (losses) and valuation adjustments	(41)	(56)	(399)	301
Net gains (losses) on sale or call of securities	3,109	19	3,210	22
Insurance commissions	990	1,247	2,905	3,127
Gain on sale of subsidiary or division	0	0	9,758	0
Other	1,472	956	8,670	3,525
Total noninterest income	10,493	7,742	37,999	22,903
Noninterest expense:
Salaries and employee benefits	31,651	28,717	93,177	83,276
Occupancy, furniture and equipment	5,574	4,505	15,720	13,529
FDIC insurance and other regulatory assessments	360	(2)	1,170	600
Professional fees	3,265	1,969	7,023	5,384
Amortization of intangible assets	2,141	2,228	6,265	6,977
Advertising and promotion	1,105	1,379	3,548	4,779
Communications and technology	5,569	5,382	16,514	15,244
Other	5,632	7,975	19,359	21,634
Total noninterest expense	55,297	52,153	162,776	151,423
Net income before income tax expense	29,833	17,489	42,704	53,415
Income tax expense	6,929	3,172	10,810	11,580
Net income	22,904	14,317	31,894	41,835
Dividends on preferred stock	(899)	0	(899)	0
Net income to common stockholders	$ 22,005	$ 14,317	$ 30,995	$ 41,835
Earnings per common share
Basic (in dollars per share)	$ 0.89	$ 0.56	$ 1.28	$ 1.60
Diluted (in dollars per share)	$ 0.89	$ 0.56	$ 1.27	$ 1.59
Service charges on deposits
Noninterest income:
Revenue	$ 1,470	$ 1,937	$ 3,631	$ 5,243
Card income
Noninterest income:
Revenue	2,091	2,015	5,832	5,930
Fee income
Noninterest income:
Revenue	$ 1,402	$ 1,624	$ 4,392	$ 4,755

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 22,904	$ 14,317	$ 31,894	$ 41,835
Unrealized gains (losses) on securities:
Unrealized holding gains (losses) arising during the period	2,443	(40)	8,589	3,361
Tax effect	(637)	9	(2,144)	(777)
Unrealized holding gains (losses) arising during the period, net of taxes	1,806	(31)	6,445	2,584
Reclassification of amount realized through sale or call of securities	(3,109)	(19)	(3,210)	(22)
Tax effect	761	4	805	5
Reclassification of amount realized through sale or call of securities, net of taxes	(2,348)	(15)	(2,405)	(17)
Change in unrealized gains (losses) on securities, net of tax	(542)	(46)	4,040	2,567
Unrealized gains (losses) on derivative financial instruments:
Unrealized holding gains (losses) arising during the period	357	0	32	0
Tax effect	(88)		(9)
Unrealized holding gains (losses) arising during the period, net of taxes	269	0	23	0
Reclassification of amount of gains (losses) recognized into income	(16)	0	(16)	0
Tax effect	4	0	4	0
Reclassification of amount of gains (losses) recognized into income, net of taxes	(12)	0	(12)	0
Change in unrealized gains (losses) on derivative financial instruments	257	0	11	0
Total other comprehensive income (loss)	(285)	(46)	4,051	2,567
Comprehensive income	$ 22,619	$ 14,271	$ 35,945	$ 44,402

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Preferred Stock	Preferred StockPreferred Stock	Common Stock	Common StockCommon Stock	Additional Paid-in- Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balance (in shares) at Dec. 31, 2018				26,949,936			104,063
Beginning Balance at Dec. 31, 2018	$ 636,607			$ 271		$ 469,341	$ (2,288)	$ 170,486	$ (1,203)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock awards (in shares)				8,063
Stock based compensation	911					911
Forfeiture of restricted stock awards (in shares)				(1,276)			1,276
Forfeiture of restricted stock awards						40	$ (40)
Purchase of treasury stock (in shares)				(247,312)			247,312
Purchase of treasury stock	(7,553)						$ (7,553)
Net income (loss)	14,788							14,788
Other comprehensive income (loss)	1,463								1,463
Ending Balance (in shares) at Mar. 31, 2019				26,709,411			352,651
Ending Balance at Mar. 31, 2019	646,216			$ 271		470,292	$ (9,881)	185,274	260
Beginning Balance (in shares) at Dec. 31, 2018				26,949,936			104,063
Beginning Balance at Dec. 31, 2018	636,607			$ 271		469,341	$ (2,288)	170,486	(1,203)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	41,835
Other comprehensive income (loss)	2,567
Ending Balance (in shares) at Sep. 30, 2019				25,357,985			1,805,448
Ending Balance at Sep. 30, 2019	633,693			$ 272		472,368	$ (52,632)	212,321	1,364
Beginning Balance (in shares) at Mar. 31, 2019				26,709,411			352,651
Beginning Balance at Mar. 31, 2019	646,216			$ 271		470,292	$ (9,881)	185,274	260
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock awards (in shares)				85,503
Stock based compensation	825					825
Forfeiture of restricted stock awards (in shares)				(920)			920
Forfeiture of restricted stock awards						28	$ (28)
Stock option exercises, net (in shares)				368
Purchase of treasury stock (in shares)				(596,054)			596,054
Purchase of treasury stock	(17,559)						$ (17,559)
Net income (loss)	12,730							12,730
Other comprehensive income (loss)	1,150								1,150
Ending Balance (in shares) at Jun. 30, 2019				26,198,308			949,625
Ending Balance at Jun. 30, 2019	643,362			$ 271		471,145	$ (27,468)	198,004	1,410
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock awards (in shares)				10,847
Issuance of restricted stock awards				$ 1		(1)
Stock based compensation	1,058					1,058
Forfeiture of restricted stock awards (in shares)				(5,730)			5,730
Forfeiture of restricted stock awards						166	$ (166)
Stock option exercises, net (in shares)				4,653
Purchase of treasury stock (in shares)				(850,093)			850,093
Purchase of treasury stock	(24,998)						$ (24,998)
Net income (loss)	14,317							14,317
Other comprehensive income (loss)	(46)								(46)
Ending Balance (in shares) at Sep. 30, 2019				25,357,985			1,805,448
Ending Balance at Sep. 30, 2019	633,693			$ 272		472,368	$ (52,632)	212,321	1,364
Beginning Balance (in shares) at Dec. 31, 2019				24,964,961			2,198,681
Beginning Balance at Dec. 31, 2019	636,590			$ 271		473,251	$ (67,068)	229,030	1,106
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Impact of adoption of ASU 2016-13 | ASU 2016-13	(1,771)							(1,771)
Issuance of restricted stock awards (in shares)				8,079
Issuance of restricted stock awards				$ 1		(1)
Stock based compensation	1,168					1,168
Forfeiture of restricted stock awards (in shares)				(601)			601
Forfeiture of restricted stock awards						23	$ (23)
Purchase of treasury stock (in shares)				(871,319)			871,319
Purchase of treasury stock	(35,586)						$ (35,586)
Net income (loss)	(4,450)							(4,450)
Other comprehensive income (loss)	(6,604)								(6,604)
Ending Balance (in shares) at Mar. 31, 2020				24,101,120			3,070,601
Ending Balance at Mar. 31, 2020	589,347			$ 272		474,441	$ (102,677)	222,809	(5,498)
Beginning Balance (in shares) at Dec. 31, 2019				24,964,961			2,198,681
Beginning Balance at Dec. 31, 2019	636,590			$ 271		473,251	$ (67,068)	229,030	1,106
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	31,894
Other comprehensive income (loss)	4,051
Ending Balance (in shares) at Sep. 30, 2020				24,851,601			3,081,070
Ending Balance at Sep. 30, 2020	693,842	$ 45,000		$ 279		488,094	$ (102,942)	258,254	5,157
Beginning Balance (in shares) at Mar. 31, 2020				24,101,120			3,070,601
Beginning Balance at Mar. 31, 2020	589,347			$ 272		474,441	$ (102,677)	222,809	(5,498)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock awards (in shares)				110,035
Issuance of restricted stock awards				$ 1		(1)
Issuance of stock	42,364		$ 45,000			(2,636)
Stock based compensation	966					966
Forfeiture of restricted stock awards (in shares)				(1,033)			1,033
Forfeiture of restricted stock awards						25	$ (25)
Purchase of treasury stock (in shares)				(7,436)			7,436
Purchase of treasury stock	(186)						$ (186)
Net income (loss)	13,440							13,440
Other comprehensive income (loss)	10,940								10,940
Ending Balance (in shares) at Jun. 30, 2020				24,202,686			3,079,070
Ending Balance at Jun. 30, 2020	656,871	45,000		$ 273		472,795	$ (102,888)	236,249	5,442
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock awards (in shares)				20,303
Issuance of restricted stock awards				$ (1)		1
Issuance of stock (in shares)					630,268
Issuance of stock	13,942				$ 7	13,935
Stock based compensation	1,309					1,309
Forfeiture of restricted stock awards (in shares)				(2,000)			2,000
Forfeiture of restricted stock awards						54	$ (54)
Stock option exercises, net (in shares)				344
Preferred stock dividends	(899)							(899)
Net income (loss)	22,904							22,904
Other comprehensive income (loss)	(285)								(285)
Ending Balance (in shares) at Sep. 30, 2020				24,851,601			3,081,070
Ending Balance at Sep. 30, 2020	$ 693,842	$ 45,000		$ 279		$ 488,094	$ (102,942)	$ 258,254	$ 5,157

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income	$ 31,894	$ 41,835
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	7,378	6,020
Net accretion on loans	(8,377)	(4,013)
Amortization of subordinated notes issuance costs	128	81
Amortization of junior subordinated debentures	378	360
Net amortization on securities	(104)	234
Amortization of intangible assets	6,265	6,977
Deferred taxes	(3,320)	1,693
Credit Loss Expense	33,649	7,560
Stock based compensation	3,443	2,794
Net (gains) losses on sale or call of debt securities	(3,210)	(22)
Net (gains) losses on equity securities	(603)	(499)
Net OREO (gains) losses and valuation adjustments	399	(301)
Gain on sale of subsidiary or division	(9,758)	0
Origination of loans held for sale	(45,220)	(21,017)
Purchases of loans held for sale	(33,811)	(24,733)
Proceeds from sale of loans originated for sale	71,782	42,753
Net gains on sale of loans	(2,323)	(409)
Net (gains) losses on transfer of loans to loans held for sale	466	(229)
Net change in operating leases	92	145
(Increase) decrease in other assets	(4,206)	(6,759)
Increase (decrease) in other liabilities	15,387	4,017
Net cash provided by (used in) operating activities	60,329	56,487
Cash flows from investing activities:
Purchases of securities available for sale	(128,970)	(80,459)
Proceeds from sales of securities available for sale	65,184	40,617
Proceeds from maturities, calls, and pay downs of securities available for sale	78,276	75,777
Proceeds from maturities, calls, and pay downs of securities held to maturity	581	668
Purchases of loans held for investment	(277,333)	(26,714)
Proceeds from sale of loans	145,513	25,653
Net change in loans	(524,820)	(603,694)
Purchases of premises and equipment, net	(16,283)	(9,740)
Net proceeds from sale of OREO	1,918	2,513
(Purchases) redemptions of FHLB and other restricted stock, net	1,396	(8,017)
Net cash (paid for) received in acquisitions	(108,375)	0
Proceeds from sale of subsidiary or division, net	93,835	0
Net cash provided by (used in) investing activities	(669,078)	(583,396)
Cash flows from financing activities:
Net increase (decrease) in deposits	452,582	247,484
Increase (decrease) in customer repurchase agreements	12,159	9,639
Increase (decrease) in Federal Home Loan Bank advances	5,000	200,000
Proceeds from Paycheck Protection Program Liquidity Facility borrowings	231,370	0
Repayment of Paycheck Protection Program Liquidity Facility borrowings	(7,657)	0
Issuance of preferred stock, net of issuance costs	42,364	0
Preferred dividends	(899)	0
Purchase of treasury stock	(35,772)	(50,110)
Net cash provided by (used in) financing activities	699,147	407,013
Net increase (decrease) in cash and cash equivalents	90,398	(119,896)
Cash and cash equivalents at beginning of period	197,880	234,939
Cash and cash equivalents at end of period	288,278	115,043
Supplemental cash flow information:
Interest paid	33,868	37,336
Income taxes paid, net	4,572	12,797
Cash paid for operating lease liabilities	3,183	3,138
Supplemental noncash disclosures:
Loans transferred to OREO	1,012	3,001
Loans held for investment transferred to loans held for sale	172,565	27,411
Assets transferred to assets held for sale	84,077	0
Lease liabilities arising from obtaining right-of-use assets	$ 1,777	$ 2,179

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations Triumph Bancorp, Inc. (collectively with its subsidiaries, “Triumph”, or the “Company” as applicable) is a financial holding company headquartered in Dallas, Texas. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries Triumph CRA Holdings, LLC (“TCRA”), TBK Bank, SSB (“TBK Bank”), TBK Bank’s wholly owned subsidiary Advance Business Capital LLC, which currently operates under the d/b/a of Triumph Business Capital (“TBC”), and TBK Bank’s wholly owned subsidiary Triumph Insurance Group, Inc. (“TIG”). On June 30, 2020, the Company sold the assets of Triumph Premium Finance (“TPF”) and exited its premium finance line of business. TPF operated within the Company’s TBK Bank subsidiary. See Note 2 – Business Combinations and Divestitures for details of the TPF sale and its impact on our consolidated financial statements. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”) for interim financial information and in accordance with guidance provided by the Securities and Exchange Commission (“SEC”). Accordingly, the condensed financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal and recurring adjustments considered necessary for a fair presentation. Transactions between the subsidiaries have been eliminated. These condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. The Company has three reportable segments consisting of Banking, Factoring, and Corporate. The Company’s Chief Executive Officer uses segment results to make operating and strategic decisions. Risks and Uncertainties The outbreak of COVID-19 has adversely impacted a broad range of industries in which the Company’s customers operate and could impair their ability to fulfill their financial obligations to the Company. The Company’s business is dependent upon the willingness and ability of its employees and customers to conduct banking and other financial transactions. If the global response to contain COVID-19 escalates further or is unsuccessful, the Company could experience further material adverse effects on its business, financial condition, results of operations and cash flows. While it is not possible to know the full universe or extent that the impact of COVID-19, and resulting measures to curtail its spread, will have on the Company’s operations, the Company is disclosing potentially material items of which it is aware. Financial position and results of operations In keeping with guidance from regulators, the Company continues to actively work with COVID-19 affected customers. During the second quarter of 2020 we waived fees from a variety of sources, such as, but not limited to, insufficient funds and overdraft fees, ATM fees, account maintenance fees, etc. These reductions in fees were temporary and expired on June 1, 2020 resulting in a decrease in service charges on deposits fee income for the nine months ended September 30, 2020 compared to the same period during 2019. Should the pandemic and the global response escalate further, it is possible that the Company could reduce such fees in future periods; however, at this time, the Company is unable to project the materiality of such an impact on the results of operations in future periods. The Company’s interest income could be reduced due to COVID-19. In keeping with guidance from regulators, the Company continues to work with COVID-19 affected borrowers to defer their payments, interest, and fees. While interest and fees continue to accrue to income, through normal GAAP accounting, should eventual credit losses on these deferred payments emerge, the related loans would be placed on nonaccrual status and interest income and fees accrued would be reversed. In such a scenario, interest income in future periods could be negatively impacted. As of September 30, 2020 the Company has recognized $695,000 of accrued interest income and fees on outstanding deferrals made to COVID-19 affected borrowers. At this time, the Company is unable to project the materiality of such an impact on future deferrals to COVID-19 affected borrowers, but recognizes the breadth of the economic impact may affect its borrowers’ ability to repay in future periods. Capital and liquidity Our reported and regulatory capital ratios could be adversely impacted by further credit loss expense. We rely on cash on hand as well as dividends from our subsidiary bank to service our debt. If our capital deteriorates such that our subsidiary bank is unable to pay dividends to us for an extended period of time, we may not be able to service our debt. We maintain access to multiple sources of liquidity. Wholesale funding markets have remained open to us, but rates for short term funding have recently been volatile. If funding costs are elevated for an extended period of time, it could have an adverse effect on our net interest margin. If an extended recession caused large numbers of our deposit customers to withdraw their funds, we might become more reliant on volatile or more expensive sources of funding. Asset valuation COVID-19 could cause a decline in the Company’s stock price or the occurrence of what management would deem to be a triggering event that could, under certain circumstances, cause us to perform a goodwill impairment test and result in an impairment charge being recorded for that period. In the event that the Company concludes that all or a portion of its goodwill is impaired, a non-cash charge for the amount of such impairment would be recorded to earnings. Such a charge would have no impact on tangible capital or regulatory capital. It is possible that the lingering effects of COVID-19 could cause the occurrence of what management would deem to be a triggering event that could, under certain circumstances, cause us to perform an intangible asset impairment test and result in an impairment charge being recorded for that period. In the event that the Company concludes that all or a portion of its intangible assets are impaired, a non-cash charge for the amount of such impairment would be recorded to earnings. Such a charge would have no impact on tangible capital or regulatory capital. Lending operations and accommodations to borrowers In keeping with regulatory guidance to work with borrowers during this unprecedented situation and as outlined in the Section 4013 of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) , the Company is executing a payment deferral program for its commercial lending clients that are adversely affected by the pandemic. Depending on the demonstrated need of the client, the Company is deferring either the full loan payment or the principal component of the loan payment for 60 or 90 days. As of September 30, 2020, the Company’s balance sheet reflected 77 of these deferrals on outstanding loan balances of $102,987,000. In accordance with the CARES Act and March 2020 interagency guidance, these short term deferrals are not considered troubled debt restructurings. It is possible that these deferrals could be extended further under the CARES Act; however, the volume of these future potential extensions is unknown. It is also possible that in spite of our best efforts to assist our borrowers and achieve full collection of our investment, these deferred loans could result in future charge-offs with additional credit loss expense charged to earnings; however, the amount of any future charge-offs on deferred loans is unknown. With the passage of the Paycheck Protection Program (“PPP”), administered by the Small Business Administration (“SBA”), the Company has actively participated in assisting its customers with applications for resources through the program. PPP loans have two-year and five-year terms and earn interest at a 1% coupon. The Company believes that the majority of these loans will ultimately be forgiven by the SBA in accordance with the terms of the program. As of September 30, 2020, the Company carried 2,080 PPP loans representing a book value of $223,000,000. The Company has received approximately $7,700,000 in total fees from the SBA, $2,600,000 of which were recognized in interest income and fees during the nine months ended September 30, 2020. The remaining fees will be amortized and recognized over the remaining lives of the loans. It is the Company’s understanding that loans funded through the PPP program are fully guaranteed by the U.S. government. Should those circumstances change, the Company could be required to establish an allowance for credit loss through additional credit loss expense charged to earnings. Credit The Company is working with customers directly affected by COVID-19. The Company is prepared to offer short-term assistance in accordance with regulator guidelines. As a result of the current economic environment caused by the COVID-19 virus, the Company is engaging in more frequent communication with borrowers to better understand their situation and the challenges faced, allowing it to respond proactively as needs and issues arise. Should economic conditions worsen, the Company could experience further increases in its required allowance for credit losses (“ACL”) and record additional credit loss expense. It is possible that the Company’s asset quality measures could worsen at future measurement periods if the effects of COVID-19 are prolonged. Held to Maturity Securities At September 30, 2020, we held $8,057,000 in subordinated notes of three CLO securities managed by our former subsidiary. These securities are the junior-most in securitization capital structures, and are subject to suspension of distributions if the credit of the underlying loan portfolios deteriorates materially. During the nine months ended September 30, 2020, pandemic-related downgrades and default activity caused overcollateralization triggers to be tripped on two of the three CLO investments which had a material impact on expected cash flows used to calculate the ACL. The required ACL on these balances was $1,961,000 September 30, 2020 resulting in $1,835,000 of credit loss expense recognized during the nine months ended September 30, 2020. Ultimately, the realized cash flows on CLO securities such as these will be driven by a variety of factors, including credit performance of the underlying loan portfolio, adjustments to the portfolio by the asset manager, and the timing of a potential call. Thus, we may not receive the full amount of cash distributions we expect to receive, which would cause us to record additional allowance for credit losses with a corresponding charge to credit loss expense through earnings. As of September 30, 2020, the Company’s held to maturity securities were classified as nonaccrual. Transportation The Company’s transportation businesses may be affected by COVID-19 and the volatility in oil prices. The global supply disruption from China and Mexico, in combination with the U.S. supply chain challenges due to business disruptions and an overall decrease in consumer demand could have a material impact on freight volumes in the U.S., which could impact our factoring and transportation lending operations in future periods; however, the ultimate impact is unknown. Debt Securities The Company determines the classification of debt securities at the time of purchase. Debt securities that management has the positive intent and ability to hold to maturity are classified as held to maturity and recorded at amortized cost. Trading securities are recorded at fair value with changes in fair value included in earnings. Debt securities not classified as held to maturity or trading are classified as available for sale and recorded at fair value, with unrealized gains and losses excluded from earnings and reported in other comprehensive income (loss), net of tax. Gains and losses on the sale of securities are recorded on the trade date and are determined using the specific-identification method. Amortization of premiums and discounts are recognized in interest income over the period to maturity using the interest method, except for premiums on callable debt securities, which are amortized to their earliest call date. The Company has made a policy election to exclude accrued interest from the amortized cost basis of debt securities and report accrued interest separately in other assets in the consolidated balance sheets. A debt security is placed on nonaccrual status at the time any principal or interest payments become more than 90 days delinquent or if full collection of interest or principal becomes uncertain. Accrued interest for a security placed on nonaccrual is reversed against interest income. There was no accrued interest related to debt securities reversed against interest income for the three and nine months ended September 30, 2020 and 2019. Allowance for Credit Losses – Available for Sale Securities For available for sale debt securities in an unrealized loss position, the Company evaluates the securities to determine whether the decline in the fair value below the amortized cost basis (impairment) is due to credit-related factors or noncredit-related factors. Any impairment that is not credit related is recognized in other comprehensive income, net of applicable taxes. Credit-related impairment is recognized as an allowance for credit losses (“ACL”) on the balance sheet, limited to the amount by which the amortized cost basis exceeds the fair value, with a corresponding adjustment to earnings. Both the ACL and the adjustment to net income may be reversed if conditions change. However, if the Company intends to sell an impaired available for sale debt security or more likely than not will be required to sell such a security before recovering its amortized cost basis, the entire impairment amount must be recognized in earnings with a corresponding adjustment to the security’s amortized cost basis. Because the security’s amortized cost basis is adjusted to fair value, there is no ACL in this situation. In evaluating available for sale debt securities in unrealized loss positions for impairment and the criteria regarding its intent or requirement to sell such securities, the Company considers the extent to which fair value is less than amortized cost, whether the securities are issued by the federal government or its agencies, whether downgrades by bond rating agencies have occurred, and the results of reviews of the issuers’ financial condition, among other factors. Changes in the allowance for credit losses are recorded as provision for (or reversal of) credit loss expense. Losses are charged against the ACL when management believes the uncollectability of an available for sale debt security is confirmed or when either of the criteria regarding intent or requirement to sell is met. Accrued interest receivable is excluded from the estimate of credit losses. Allowance for Credit Losses – Held to Maturity Securities The allowance for credit losses on held to maturity securities is estimated on a collective basis by major security type. At September 30, 2020 and December 31, 2019, the Company’s held to maturity securities consisted of investments in the subordinated notes of collateralized loan obligation (“CLO”) funds. Expected credit losses for these securities are estimated using a discounted cash flow methodology which considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Accrued interest receivable is excluded from the estimate of credit losses. Loans Loans that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are reported at their amortized cost basis, which is the unpaid principal balance outstanding, net of unearned income, deferred loan fees and costs, premiums and discounts associated with acquisition date fair value adjustments on acquired loans, and any direct principal charge-offs. The Company has made a policy election to exclude accrued interest from the amortized cost basis of loans and report accrued interest separately from the related loan balance in other assets on consolidated balance sheets. Interest income is accrued on the unpaid principal balance. Loan origination fees, net of certain direct origination costs, are deferred and recognized in interest income over the remaining life of the loan without anticipating prepayments. Loans are considered past due or delinquent when the contractual principal or interest due in accordance with the terms of the loan agreement or any portion thereof remains unpaid after the due date of the scheduled payment. Loans are classified as nonaccrual when, in the opinion of management, collection of principal or interest is doubtful. The accrual of interest income on loans is typically discontinued at the time the loan is 90 days delinquent unless the loan is well-secured and in process of collection, or if full collection of interest or principal becomes uncertain. Consumer loans are typically charged off no later than 120 days past due. All interest accrued but not received for a loan placed on nonaccrual is reversed against interest income. Interest received on such loans is accounted for on the cash-basis or cost recovery method, until qualifying for return to accrual. Under the cost-recovery method, interest income is not recognized until the loan balance is reduced to zero. Under the cash basis method, interest income is recorded when the payment is received in cash. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured. Factored Receivables The Company purchases invoices from its factoring clients in schedules or batches. To a much lesser extent, the Company will also make short-term advances to its clients on transportation contracts for upcoming loads. Cash is advanced to the client to the extent of the applicable advance rate, less fees, as set forth in the individual factoring agreements. The face value of the invoices purchased or amount advanced is recorded by the Company as factored receivables, and the unadvanced portions of the invoices purchased, less fees, are considered client reserves. The client reserves are held to settle any payment disputes or collection shortfalls, may be used to pay clients’ obligations to various third parties as directed by the client, are periodically released to or withdrawn by clients, and are reported as deposits in the consolidated balance sheets. Unearned factoring fees and unearned net origination fees are deferred and recognized over the weighted average collection period for each client. Subsequent factoring fees are recognized in interest income as incurred by the client and deducted from the clients’ reserve balances. Other factoring-related fees, which include wire transfer fees, carrier payment fees, fuel advance fees, and other similar fees, are reported by the Company as non-interest income as incurred by the client. Acquired Loans Acquired loans are recorded at fair value at the date of acquisition based on a discounted cash flow methodology that considers various factors including the type of loan and related collateral, classification status, fixed or variable interest rate, term of loan and whether or not the loan was amortizing, and a discount rate reflecting the Company’s assessment of risk inherent in the cash flow estimates. Certain larger purchased loans are individually evaluated while certain purchased loans are grouped together according to similar risk characteristics and are treated in the aggregate when applying various valuation techniques. These cash flow evaluations are inherently subjective as they require material estimates, all of which may be susceptible to significant change. Prior to January 1, 2020, loans acquired in a business combination that had evidence of deterioration of credit quality since origination and for which it was probable, at acquisition, that the Company would be unable to collect all contractually required payments receivable were considered purchased credit impaired (“PCI”). PCI loans were individually evaluated and recorded at fair value at the date of acquisition with no initial valuation allowance based on a discounted cash flow methodology that considered various factors including the type of loan and related collateral, classification status, fixed or variable interest rate, term of loan and whether or not the loan was amortizing, and a discount rate reflecting the Company’s assessment of risk inherent in the cash flow estimates. The difference between the undiscounted cash flows expected at acquisition and the investment in the loan, or the “accretable yield,” was recognized as interest income on a level-yield method over the life of the loan. Contractually required payments for interest and principal that exceed the undiscounted cash flows expected at acquisition, or the “nonaccretable difference,” were not recognized on the balance sheet and did not result in any yield adjustments, loss accruals or valuation allowances. Increases in expected cash flows, including prepayments, subsequent to the initial investment were recognized prospectively through adjustment of the yield on the loan over its remaining life. Decreases in expected cash flows were recognized as impairment. Valuation allowances on PCI loans reflected only losses incurred after the acquisition (meaning the present value of all cash flows expected at acquisition that ultimately were not to be received). Subsequent to January 1, 2020, loans acquired in a business combination that have experienced more-than-insignificant deterioration in credit quality since origination are considered purchased credit deteriorated (“PCD”) loans. At the acquisition date, an estimate of expected credit losses is made for groups of PCD loans with similar risk characteristics and individual PCD loans without similar risk characteristics. This initial allowance for credit losses is allocated to individual PCD loans and added to the purchase price or acquisition date fair values to establish the initial amortized cost basis of the PCD loans. As the initial allowance for credit losses is added to the purchase price, there is no credit loss expense recognized upon acquisition of a PCD loan. Any difference between the unpaid principal balance of PCD loans and the amortized cost basis is considered to relate to noncredit factors and results in a discount or premium. Discounts and premiums are recognized through interest income on a level-yield method over the life of the loans. All loans considered to be PCI prior to January 1, 2020 were converted to PCD on that date. For acquired loans not deemed purchased credit deteriorated at acquisition, the differences between the initial fair value and the unpaid principal balance are recognized as interest income on a level-yield basis over the lives of the related loans. At the acquisition date, an initial allowance for expected credit losses is estimated and recorded as credit loss expense. The subsequent measurement of expected credit losses for all acquired loans is the same as the subsequent measurement of expected credit losses for originated loans. Allowance for Credit Losses – Loans Under the current expected credit loss model, the allowance for credit losses on loans is a valuation allowance estimated at each balance sheet date in accordance with US GAAP that is deducted from the loans’ amortized cost basis to present the net amount expected to be collected on the loans. The Company estimates the ACL on loans based on the underlying assets’ amortized cost basis, which is the amount at which the financing receivable is originated or acquired, adjusted for applicable accretion or amortization of premium, discount, and net deferred fees or costs, collection of cash, and charge-offs. In the event that collection of principal becomes uncertain, the Company has policies in place to reverse accrued interest in a timely manner. Therefore, the Company has made a policy election to exclude accrued interest from the measurement of ACL. Expected credit losses are reflected in the allowance for credit losses through a charge to credit loss expense. When the Company deems all or a portion of a financial asset to be uncollectible the appropriate amount is written off and the ACL is reduced by the same amount. The Company applies judgment to determine when a financial asset is deemed uncollectible; however, generally speaking, an asset will be considered uncollectible no later than when all efforts at collection have been exhausted. Subsequent recoveries, if any, are credited to the ACL when received. The Company measures expected credit losses of financial assets on a collective (pool) basis, when the financial assets share similar risk characteristics. Depending on the nature of the pool of financial assets with similar risk characteristics, the Company uses a discounted cash flow (“DCF”) method or a loss-rate method to estimate expected credit losses. The Company’s methodologies for estimating the ACL consider available relevant information about the collectability of cash flows, including information about past events, current conditions, and reasonable and supportable forecasts. The methodologies apply historical loss information, adjusted for asset-specific characteristics, economic conditions at the measurement date, and forecasts about future economic conditions expected to exist through the contractual lives of the financial assets that are reasonable and supportable, to the identified pools of financial assets with similar risk characteristics for which the historical loss experience was observed. The Company’s methodologies revert back to historical loss information on a straight line basis over eight quarters when it can no longer develop reasonable and supportable forecasts. The Company has identified the following pools of financial assets with similar risk characteristics for measuring expected credit losses: Commercial Real Estate — This category of loans consists of the following loan types: Non-farm Non-residential — This category includes real estate loans for a variety of commercial property types and purposes, including owner occupied commercial real estate loans primarily secured by commercial office or industrial buildings, warehouses or retail buildings where the owner of the building occupies the property. Repayment terms vary considerably, interest rates are fixed or variable, and are structured for full, partial, or no amortization of principal. This category also includes investment real estate loans that are primarily secured by office and industrial buildings, warehouses, small retail shopping centers and various special purpose properties. Generally, these types of loans are thought to involve a greater degree of credit risk than owner occupied commercial real estate as they are more sensitive to adverse economic conditions. Multi-family residential — Investment real estate loans are primarily secured by non-owner occupied apartment or multifamily residential buildings. Generally, these types of loans are thought to involve a greater degree of credit risk than owner occupied commercial real estate as they are more sensitive to adverse economic conditions. Construction, land development, land —This category of loans consists of loans to finance the ground up construction, improvement and/or carrying for sale after the completion of construction of owner occupied and non-owner occupied residential and commercial properties, and loans secured by raw or improved land. The repayment of construction loans is generally dependent upon the successful completion of the improvements by the builder for the end user, or sale of the property to a third party. Repayment of land secured loans are dependent upon the successful development and sale of the property, the sale of the land as is, or the outside cash flow of the owners to support the retirement of the debt. 1-4 family residential — This category of loans includes both first and junior liens on residential real estate. Home equity revolving lines of credit and home equity term loans are included in this group of loans. Farmland — These loans are principally loans to purchase farmland. Commercial — Commercial loans are loans for commercial, corporate and business purposes. The Company’s commercial business loan portfolio is comprised of loans for a variety of purposes and across a variety of industries. These loans include general commercial and industrial loans, loans to purchase capital equipment, agriculture operating loans and other business loans for working capital and operational purposes. Commercial loans are generally secured by accounts receivable, inventory and other business assets. A portion of the commercial loan portfolio consists of specialty commercial finance products as follows: Equipment — Equipment finance loans are commercial loans primarily secured by new or used revenue producing, essential-use equipment from major manufacturers that is movable, may be used in more than one type of business, and generally has broad resale markets. Core markets include transportation, construction, and waste. Loan terms do not exceed the economic life of the equipment and typically are 60 months or less . Asset-based Lending — These loans are originated to borrowers to support general working capital needs. The asset-based loan structure involves advances of loan proceeds against a borrowing base which typically consists of accounts receivable, identified readily marketable inventory, or other collateral of the borrower. The maximum amount a customer may borrow at any time is fixed as a percentage of the borrowing base outstanding. A portion of the commercial loan portfolio also consists of the following national lending product: Liquid Credit — Broadly syndicated leveraged loans secured by a variety of collateral types. Factored Receivables — The Company operates as a factor by purchasing accounts receivable from its clients, then collecting the receivable from the account debtor. The Company’s smaller factoring relationships are typically structured as “non-recourse” relationships ( i.e. , the Company retains the credit risk associated with the ability of the account debtor on a purchased invoice to ultimately make payment) and the Company’s larger factoring relationships are typically structured as “recourse” relationships ( i.e. , the Company’s client agrees to repurchase any invoices for which payment is not ultimately received from the account debtor). Advances initially made to the client to acquire the receivables are typically at a discount to the invoice value. The discount balance is held in client reserves, net of the Company’s compensation. The client reserves are held to settle any payment disputes or collection shortfalls, may be used to pay clients’ obligations to various third parties as directed by the client, are periodically released to or withdrawn by clients, and are reported as deposits. Consumer — Loans used for personal use, typically on an unsecured basis, and client overdrafts. Mortgage Warehouse — Mortgage Warehouse facilities are provided to unaffiliated mortgage origination companies and are collateralized by 1-4 family residential loans. The originator closes new mortgage loans with the intent to sell these loans to third party investors for a profit. The Company provides funding to the mortgage companies for the period between the origination and their sale of the loan. The Company has a policy that requires that it separately validate that each residential mortgage loan was underwritten con

Business Combinations and Dives

Business Combinations and Divestitures	9 Months Ended
	Sep. 30, 2020
Business Combinations [Abstract]
Business Combinations and Divestitures	BUSINESS COMBINATIONS AND DIVESTITURES Transportation Financial Solutions On July 8, 2020, the Company, through its wholly-owned subsidiary Advance Business Capital LLC (“ABC”), acquired the transportation factoring assets (the “TFS Acquisition”) of Transport Financial Solutions (“TFS”), a wholly owned subsidiary of Covenant Logistics Group, Inc. ("CVLG"), in exchange for cash consideration of $108,375,000, 630,268 shares of the Company’s common stock valued at approximately $13,942,000, and contingent consideration of up to approximately $9,900,000 to be paid in cash following the twelve-month period ending July 31, 2021. Subsequent to the closing of the TFS Acquisition, the Company identified that approximately $62,200,000 of the assets acquired at closing were advances against future payments to be made to three large clients (and their affiliated entities) of TFS pursuant to long-term contractual arrangements between the obligor on such contracts and such clients (and their affiliated entities) for services that had not yet been performed. On September 23, 2020, the Company and ABC entered into an Account Management Agreement, Amendment to Purchase Agreement and Mutual Release (the “Agreement”) with CVLG and Covenant Transport Solutions, LLC, a wholly owned subsidiary of CVLG ( “CTS” and, together with CVLG, "Covenant"). Pursuant to the Agreement, the parties agreed to certain amendments to that certain Accounts Receivable Purchase Agreement (the “ARPA”), dated as of July 8, 2020, by and among ABC, as buyer, CTS, as seller, and the Company, as buyer indirect parent. Such amendments include: • Return of the portion of the purchase price paid under the ARPA consisting of 630,268 shares of Company common stock, which will be accomplished through the sale of such shares by Covenant pursuant to the terms of the Agreement and the surrender of the cash proceeds of such sale (net of brokerage or underwriting fees and commissions) to the Company; • Elimination of the up to $9,900,000 in earn-out consideration potentially payable to CTS under the ARPA; and • Modification of the indemnity provisions under the ARPA to eliminate the existing indemnifications for breaches of representations and warranties and to replace such with a newly established indemnification by Covenant in the event ABC incurs losses related to the $62,200,000 in over-formula advances made to specified clients identified in the Agreement (the “Over-Formula Advance Portfolio”). Under the terms of the new indemnification arrangement, Covenant will be responsible for and will indemnify ABC for 100% of the first $30,000,000 of any losses incurred by ABC related to the Over-Formula Advance Portfolio, and for 50% of the next $30,000,000 of any losses incurred by ABC, for total indemnification by Covenant of $45,000,000. Covenant’s indemnification obligations under the Agreement are secured by a pledge of equipment collateral by Covenant with an estimated net orderly liquidation value of $60,000,000 (the “Equipment Collateral”). The Company’s wholly-owned bank subsidiary, TBK Bank, SSB, has provided Covenant with a $45,000,000 line of credit, also secured by the Equipment Collateral, the proceeds of which may be drawn to satisfy Covenant’s indemnification obligations under the Agreement. Pursuant to the Agreement, Triumph and Covenant have agreed to certain terms related to the management of the Over-Formula Advance Portfolio, and the terms by which Covenant may provide assistance to maximize recovery on the Over-Formula Advance Portfolio. Pursuant to the Agreement, the Company and Covenant have provided mutual releases to each other related to any and all claims related to the transactions contemplated by the ARPA or the Over-Formula Advance Portfolio. Also in connection the Agreement, Covenant agreed to dismiss, with prejudice, the declaratory judgment action filed in the 95th Judicial District Court of Dallas County, Texas (removed to the United States District Court, Northern District of Texas), related to the ARPA and the transactions contemplated thereby. The measurement period for this transaction remains open and the Company has determined that there is a clear and direct link between the Agreement and the ARPA. Therefore, the terms of the Agreement have been incorporated into the Company's purchase accounting which has resulted in the elimination of the contingent consideration component of the ARPA, the recognition of cash due from Covenant as part of the consideration for the transaction, and an indemnification asset to reflect the modification of Covenant's indemnification obligations. A summary of the estimated fair values of assets acquired, liabilities assumed, consideration transferred, and the resulting goodwill is as follows: (Dollars in thousands) Assets acquired: Factored receivables $107,524 Allowance for credit losses (37,415) Factored receivables, net of ACL 70,109 Intangible assets 3,500 Indemnification asset 31,218 Deferred income taxes 1,387 106,214 Liabilities assumed: Deposits 5,613 5,613 Fair value of net assets acquired $100,601 Consideration: Cash paid $108,375 Stock consideration 13,942 Cash due from seller subsequent to liquidation of stock consideration (17,196) Total consideration $105,121 Goodwill $4,520 The acquired assets were allocated to the Company’s Factoring segment. The Company has recognized goodwill of $4,520,000, which was calculated as the excess of the fair value of consideration exchanged as compared to the fair value of identifiable net assets acquired and was allocated to the Company’s Factoring segment. The goodwill in this acquisition resulted from expected synergies and expansion in the factoring market. The goodwill will not be deducted for tax purposes. Consideration included cash due from Covenant subsequent to liquidation of the stock consideration with an acquisition date fair value of $17,196,000. The fair value of cash due from Covenant was based on the Company's stock price on the date of the Agreement, less an estimate of broker commissions and discounts. Final consideration payout will be determined by the price at which the Company's stock is sold less broker commissions and discounts. The Company has elected the fair value option and the fair value of the associated asset will be remeasured each reporting period with changes in fair value recorded in noninterest income in the consolidated statements of income. The fair value of the consideration was $19,248,000 at September 30, 2020. During the three months ended September 30, 2020, the Company recognized $2.0 million of other noninterest income related to the change in fair value of the consideration during that period. The intangible assets recognized include a customer relationship intangible asset with an acquisition date fair value of $3,500,000 which will be amortized utilizing an accelerated method over its eight year estimated useful life. The indemnification asset was measured separately from the related covered portfolio. It is not contractually embedded in the covered portfolio nor is it transferable with the covered portfolio should the Company choose to dispose of the portfolio or a portion of the portfolio. The indemnification asset was initially recorded in other assets in the Consolidated Balance Sheets at the time of the TFS Acquisition at a fair value of $31,218,000, measured as the present value of the estimated cash payments expected to be received from Covenant for probable losses on the covered Over-Formula Advance Portfolio. These cash flows were discounted at a rate to reflect the uncertainty of the timing and receipt of the payments from Covenant . The amount ultimately collected for this asset will be dependent upon the performance of the underlying covered portfolio, the passage of time, and Covenant's willingness and ability to make necessary payments. The terms of the Agreement are such that indemnification has no expiration date and the Company will continue to carry the indemnification asset until ultimate resolution of the covered portfolio. The indemnification asset is reviewed quarterly and changes to the asset are recorded as adjustments to other noninterest income or expense, as appropriate, within the Consolidated Statements of Income. The Company's estimate of probable losses on the covered portfolio did not change between the acquisition date and September 30, 2020 and therefore, no activity related to the indemnification asset was recorded during the three and nine months ended September 30, 2020. The contractually required payments and the fair value at acquisition of factored receivables purchased for which there was not, at acquisition, evidence of more than insignificant deterioration of credit quality since origination (non-PCD loans) totaled $45,228,000 and $44,962,000, respectively. Management determined that the $62,200,000 in Over-Formula Advances obtained through the TFS Acquisition had experienced more than insignificant credit deterioration since origination and thus, deemed those Over-Formula Advances to be purchased credit deteriorated ("PCD"). Other, less significant factored receivables were also considered to be PCD. The following table presents information at the acquisition date for factored receivables purchased for which there was, at acquisition, evidence of more than insignificant deterioration of credit quality since origination: (Dollars in thousands) Purchase price of loans at acquisition $25,148 Allowance for credit losses at acquisition 37,415 Non-credit discount/(premium) at acquisition 941 Par value of acquired loans at acquisition $63,504 Revenue and earnings of TFS since the acquisition date have not been disclosed as the acquired company was merged into the Company and separate financial information is not readily available. The initial accounting for the acquisition has not been completed because the fair values of the assets acquired and liabilities assumed have not yet been finalized. Expenses related to the acquisition, including professional fees and other transaction costs, totaling $827,000 were recorded in noninterest expense in the consolidated statements of income during the three months ended September 30, 2020. Triumph Premium Finance On April 20, 2020, the Company entered into an agreement to sell the assets (the “Disposal Group”) of Triumph Premium Finance (“TPF”) and exit its premium finance line of business. The decision to sell TPF was made during the three months ended March 31, 2020, and at March 31, 2020, the carrying amount of the Disposal Group was transferred to assets held for sale. The sale closed on June 30, 2020. A summary of the carrying amount of the assets in the Disposal Group and the gain on sale is as follows: (Dollars in thousands) Carrying amount of assets in the disposal group: Loans $ 84,504 Premises and equipment, net 45 Other assets 11 84,560 Carrying amount of liabilities in the disposal group: Other liabilities 479 Total carrying amount $ 84,081 Total consideration received 94,531 Gain on sale of division 10,450 Transaction costs 692 Gain on sale of division, net of transaction costs $ 9,758 The Disposal Group was included in the Banking segment, and the loans in the Disposal Group were previously included in the commercial loan portfolio.

Securities

Securities	9 Months Ended
	Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]
Securities	SECURITIES Equity Securities with Readily Determinable Fair Values The Company held equity securities with fair values of $6,040,000 and $5,437,000 at September 30, 2020 and December 31, 2019, respectively. The gross realized and unrealized losses recognized on equity securities with readily determinable fair values in noninterest income in the Company’s consolidated statements of income were as follows: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Unrealized gains (losses) on equity securities still held at the reporting date $ (371) $ 64 $ 603 $ 499 Realized gains (losses) on equity securities sold during the period — — — — $ (371) $ 64 $ 603 $ 499 Debt Securities Debt securities have been classified in the financial statements as available for sale or held to maturity. The following table summarizes the amortized cost, fair value, and allowance for credit losses of debt securities and the corresponding amounts of gross unrealized gains and losses of available for sale securities recognized in accumulated other comprehensive income (loss) and gross unrecognized gains and losses of held to maturity securities: (Dollars in thousands) Amortized Gross Gross Allowance Fair September 30, 2020 Available for sale securities: U.S. Government agency obligations $ 18,227 $ 221 $ — $ — $ 18,448 Mortgage-backed securities, residential 28,604 1,189 (3) — 29,790 Asset-backed securities 7,173 — (82) — 7,091 State and municipal 42,034 1,328 — — 43,362 CLO securities 113,795 4,058 (362) — 117,491 Corporate bonds 22,615 319 (7) — 22,927 SBA pooled securities 3,536 162 (5) — 3,693 Total available for sale securities $ 235,984 $ 7,277 $ (459) $ — $ 242,802 (Dollars in thousands) Amortized Gross Gross Fair September 30, 2020 Held to maturity securities: CLO securities $ 8,057 $ — $ (2,584) $ 5,473 Allowance for credit losses (1,961) Total held to maturity securities, net of ACL $ 6,096 (Dollars in thousands) Amortized Gross Gross Fair December 31, 2019 Available for sale securities: U.S. Government agency obligations $ 39,679 $ 115 $ (34) $ 39,760 Mortgage-backed securities, residential 37,324 728 (36) 38,016 Asset-backed securities 8,039 — (80) 7,959 State and municipal 31,746 327 (8) 32,065 CLO Securities 75,592 39 (358) 75,273 Corporate bonds 50,889 695 (1) 51,583 SBA pooled securities 4,112 53 (1) 4,164 Total available for sale securities $ 247,381 $ 1,957 $ (518) $ 248,820 (Dollars in thousands) Amortized Gross Gross Fair December 31, 2019 Held to maturity securities: CLO securities $ 8,417 $ — $ (1,510) $ 6,907 The amortized cost and estimated fair value of securities at September 30, 2020, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Available for Sale Securities Held to Maturity Securities (Dollars in thousands) Amortized Fair Amortized Fair Due in one year or less $ 38,449 $ 38,799 $ — $ — Due from one year to five years 19,799 20,264 — — Due from five years to ten years 24,878 26,456 8,057 5,473 Due after ten years 113,545 116,709 — — 196,671 202,228 8,057 5,473 Mortgage-backed securities, residential 28,604 29,790 — — Asset-backed securities 7,173 7,091 — — SBA pooled securities 3,536 3,693 — — $ 235,984 $ 242,802 $ 8,057 $ 5,473 Proceeds from sales of debt securities and the associated gross gains and losses as well as net gains and losses from calls of debt securities are as follows: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Proceeds $ 65,184 $ — $ 65,184 $ 40,617 Gross gains 3,217 — 3,217 133 Gross losses (140) — (140) (130) Net gains and losses from calls of securities 32 19 133 19 Debt securities with a carrying amount of approximately $83,013,000 and $48,237,000 at September 30, 2020 and December 31, 2019, respectively, were pledged to secure public deposits, customer repurchase agreements, and for other purposes required or permitted by law. Accrued interest on available for sale securities totaled $1,316,000 and $1,685,000 at September 30, 2020 and December 31, 2019, respectively, and was included in other assets in the consolidated balance sheets. The following table summarizes available for sale debt securities in an unrealized loss position for which an allowance for credit losses has not been recorded, aggregated by investment category and length of time that individual securities have been in a continuous loss position: Less than 12 Months 12 Months or More Total (Dollars in thousands) Fair Unrealized Fair Unrealized Fair Unrealized September 30, 2020 Available for sale securities: U.S. Government agency obligations $ — $ — $ — $ — $ — $ — Mortgage-backed securities, residential 127 (1) 288 (2) 415 (3) Asset-backed securities 150 (1) 6,941 (81) 7,091 (82) State and municipal — — — — — — CLO securities 16,591 (144) 34,739 (218) 51,330 (362) Corporate bonds 996 (7) 150 0 1,146 (7) SBA pooled securities 726 (5) 32 0 758 (5) $ 18,590 $ (158) $ 42,150 $ (301) $ 60,740 $ (459) Less than 12 Months 12 Months or More Total (Dollars in thousands) Fair Unrealized Fair Unrealized Fair Unrealized December 31, 2019 Available for sale securities: U.S. Government agency obligations $ — $ — $ 12,331 $ (34) $ 12,331 $ (34) Mortgage-backed securities, residential 3,549 (29) 777 (7) 4,326 (36) Asset-backed securities 2,986 (36) 4,973 (44) 7,959 (80) State and municipal 562 — 3,426 (8) 3,988 (8) CLO Securities 58,160 (358) — — 58,160 (358) Corporate bonds — — 149 (1) 149 (1) SBA pooled securities 354 — 9 (1) 363 (1) $ 65,611 $ (423) $ 21,665 $ (95) $ 87,276 $ (518) Management evaluates available for sale debt securities in unrealized loss positions to determine whether the impairment is due to credit-related factors or noncredit-related factors. Consideration is given to (1)the extent to which the fair value is less than cost, (2)the financial condition and near-term prospects of the issuer, and (3)the intent and ability of the Company to retain its investment in the security for a period of time sufficient to allow for any anticipated recovery in fair value. At September 30, 2020, the Company had 45 available for sale debt securities in an unrealized loss position without an allowance for credit losses. Management does not have the intent to sell any of these securities and believes that it is more likely than not that the Company will not have to sell any such securities before a recovery of cost. The fair value is expected to recover as the securities approach their maturity date or repricing date or if market yields for such investments decline. Accordingly, as of September 30, 2020, management believes that the unrealized losses detailed in the previous table are due to noncredit-related factors, including changes in interest rates and other market conditions, and therefore no losses have been recognized in the Company’s consolidated statements of income. The following table presents the activity in the allowance for credit losses for held to maturity debt securities: (Dollars in thousands) Three Months Ended Nine Months Ended Held to Maturity CLO Securities Allowance for credit losses: Beginning balance $ 1,855 $ — Impact of adopting ASC 326 — 126 Credit loss expense 106 1,835 Allowance for credit losses ending balance $ 1,961 $ 1,961

Loans and Allowance for Credit

Loans and Allowance for Credit Losses	9 Months Ended
	Sep. 30, 2020
Loans and Leases Receivable Disclosure [Abstract]
Loans and Allowance for Credit Losses	LOANS AND ALLOWANCE FOR CREDIT LOSSES Loans Held for Sale The following table presents loans held for sale: (Dollars in thousands) September 30, 2020 December 31, 2019 Commercial real estate $ 19,919 $ — 1-4 family residential 11,644 2,735 Commercial 5,153 — Total loans held for sale $ 36,716 $ 2,735 Commercial real estate loans held for sale totaling $19,919,000 were on nonaccrual status and risk graded as classified at September 30, 2020. Loans Held for Investment Loans The following table presents the amortized cost and unpaid principal balance of loans held for investment: September 30, 2020 December 31, 2019 (Dollars in thousands) Amortized Unpaid Difference Amortized Unpaid Difference Commercial real estate $ 762,531 $ 766,471 $ (3,940) $ 1,046,961 $ 1,051,684 $ (4,723) Construction, land development, land 244,512 244,966 (454) 160,569 162,335 (1,766) 1-4 family residential 164,785 165,442 (657) 179,425 180,340 (915) Farmland 110,966 111,870 (904) 154,975 156,995 (2,020) Commercial 1,536,903 1,554,805 (17,902) 1,342,683 1,346,444 (3,761) Factored receivables 1,016,337 1,017,805 (1,468) 619,986 621,697 (1,711) Consumer 17,106 17,139 (33) 21,925 21,994 (69) Mortgage warehouse 999,771 999,771 — 667,988 667,988 — Total loans held for investment 4,852,911 $ 4,878,269 $ (25,358) 4,194,512 $ 4,209,477 $ (14,965) Allowance for credit losses (90,995) (29,092) $ 4,761,916 $ 4,165,420 The difference between the amortized cost and the unpaid principal is primarily (1) premiums and discounts associated with acquired loans totaling $20,121,000 and $13,573,000 at September 30, 2020 and December 31, 2019, respectively, and (2) net deferred origination and factoring fees totaling $5,237,000 and $1,392,000 at September 30, 2020 and December 31, 2019, respectively. Accrued interest on loans, which is excluded from the amortized cost of loans held for investment, totaled $18,933,000 and $18,553,000 at September 30, 2020 and December 31, 2019, respectively, and was included in other assets in the consolidated balance sheets. At September 30, 2020 and December 31, 2019, the Company had $110,510,000 and $66,754,000, respectively, of customer reserves associated with factored receivables. These amounts represent customer reserves held to settle any payment disputes or collection shortfalls, may be used to pay customers’ obligations to various third parties as directed by the customer, are periodically released to or withdrawn by customers, and are reported as deposits in the consolidated balance sheets. At September 30, 2020 the balance of the Over-Formula Advance Portfolio included in factored receivables was $62.2 million. Loans with carrying amounts of $2,185,499,000 and $1,301,851,000 at September 30, 2020 and December 31, 2019, respectively, were pledged to secure Federal Home Loan Bank borrowing capacity and, beginning in 2020, to secure Paycheck Protection Program Liquidity Facility borrowings and Federal Reserve Bank discount window borrowing capacity. During the three and nine months ended September 30, 2020, loans with carrying amounts of $56,934,000 and $172,565,000, respectively, were transferred from loans held for investment to loans held for sale at fair value concurrently with management’s change in intent and decision to sell the loans. During the three and nine months ended September 30, 2020, loans transferred to held for sale were sold resulting in proceeds of $58,313,000 and $145,513,000, respectively. The Company recorded net losses on transfers and sales of loans of $515,000 and $466,000 for the three and nine months ended September 30, 2020, respectively. Net gains and losses on transfers and sales of loans are recorded as other noninterest income in the consolidated statements of income. During the three and nine months ended September 30, 2019, loans with a carrying amount of $21,180,000 and $27,411,000, respectively, were transferred from loans held for investment to loans held for sale at fair value concurrently with management’s change in intent and decision to sell the loans. During the three and nine months ended September 30, 2019, loans transferred to held for sale were sold resulting in proceeds of $19,322,000 and $25,653,000, respectively, and net gains on transfers and sales of loans of $129,000 and $229,000, respectively, which were recorded as other noninterest income in the consolidated statements of income. Allowance for Credit Losses The Company’s estimate of the ACL reflects losses expected over the remaining contractual life of the assets. The contractual term does not consider extensions, renewals or modifications unless the Company has identified an expected troubled debt restructuring. The activity in the allowance for credit losses (“ACL”) related to loans held for investment is as follows: (Dollars in thousands) Beginning Impact of Initial ACL on Loans Purchased Credit Loss Charge-offs Recoveries Reclassification Ending Three months ended September 30, 2020 Commercial real estate $ 15,539 $ — $ — $ (2,440) $ — $ 53 $ — $ 13,152 Construction, land development, land 5,917 — — (319) — 2 — 5,600 1-4 family residential 2,027 — — (56) (6) 7 — 1,972 Farmland 958 — — (95) — — — 863 Commercial 23,283 — — (657) (528) 615 — 22,713 Factored receivables 5,244 — 37,415 3,059 (773) 40 — 44,985 Consumer 768 — — 29 (118) 31 — 710 Mortgage warehouse 877 — — 123 — — — 1,000 $ 54,613 $ — $ 37,415 $ (356) $ (1,425) $ 748 $ — $ 90,995 (Dollars in thousands) Beginning Credit Loss Charge-offs Recoveries Ending Three months ended September 30, 2019 Commercial real estate $ 5,677 $ 147 $ (26) $ — $ 5,798 Construction, land development, land 1,035 47 — 2 1,084 1-4 family residential 409 4 — 4 417 Farmland 590 349 — — 939 Commercial 13,899 1,195 (557) 234 14,771 Factored receivables 6,861 851 (210) 215 7,717 Consumer 563 66 (85) 37 581 Mortgage warehouse 382 206 — — 588 $ 29,416 $ 2,865 $ (878) $ 492 $ 31,895 (Dollars in thousands) Beginning Impact of Initial ACL on Loans Purchased Credit Loss Charge-offs Recoveries Reclassification Ending Nine Months Ended September 30, 2020 Commercial real estate $ 5,353 $ 1,372 $ — $ 6,366 $ — $ 61 $ — $ 13,152 Construction, land development, land 1,382 (187) — 4,400 — 5 — 5,600 1-4 family residential 308 513 — 1,138 (27) 40 — 1,972 Farmland 670 437 — (324) — 80 — 863 Commercial 12,566 (184) — 11,004 (1,173) 949 (449) 22,713 Factored receivables 7,657 (1,630) 37,415 4,475 (3,027) 95 — 44,985 Consumer 488 (52) — 583 (410) 101 — 710 Mortgage warehouse 668 — — 332 — — — 1,000 $ 29,092 $ 269 $ 37,415 $ 27,974 $ (4,637) $ 1,331 $ (449) $ 90,995 (Dollars in thousands) Beginning Credit Loss Charge-offs Recoveries Ending Nine months ended September 30, 2019 Commercial real estate $ 4,493 $ 1,343 $ (39) $ 1 $ 5,798 Construction, land development, land 1,134 (63) (78) 91 1,084 1-4 family residential 317 86 (43) 57 417 Farmland 535 404 — — 939 Commercial 12,865 3,252 (1,671) 325 14,771 Factored receivables 7,299 1,839 (1,682) 261 7,717 Consumer 615 424 (594) 136 581 Mortgage warehouse 313 275 — — 588 $ 27,571 $ 7,560 $ (4,107) $ 871 $ 31,895 The ACL as of September 30, 2020 was estimated using the current expected credit loss model. Management determined that the $62,200,000 in Over-Formula Advances obtained through the TFS Acquisition had experienced more than insignificant credit deterioration since origination and thus deemed those Over-Formula Advances to be purchased credit deteriorated ("PCD"). This resulted in recording a $37,400,000 ACL on the Over-Formula Advance Portfolio through purchase accounting during the three months ended September 30, 2020. There was no impact to credit loss expense resulting from the PCD determination. The Company's expectation of loss on the Over-Formula Advance Portfolio did not change between the acquisition date and September 30, 2020 and thus, the PCD ACL was held constant at September 30, 2020. The primary reason for the increase in required ACL during the three months ended September 30, 2020 is related to the $37,400,000 PCD ACL. There was relatively little change to the loss drivers that the Company forecasts to calculate expected losses during the three months ended September 30, 2020. The primary reasons for the increase in required ACL during the nine months ended September 30, 2020 are the PCD ACL increase discussed previously and significant projected deterioration of the loss drivers that the Company forecasts to calculate expected losses and, to a much lesser extent, changes in qualitative loss factors during the period. The Company uses the discounted cash flow (DCF) method to estimate ACL for the commercial real estate, construction, land development, land, 1-4 family residential, commercial (excluding liquid credit), and consumer loan pools. For all loan pools utilizing the DCF method, the Company utilizes and forecasts national unemployment as a loss driver. The Company also utilizes and forecasts either one-year percentage change in national retail sales (commercial real estate – non multifamily, commercial general, commercial agriculture, commercial asset-based lending, commercial equipment finance, consumer), one-year percentage change in the national home price index (1-4 family residential and construction, land development, land), or one-year percentage change in national gross domestic product (commercial real estate – multifamily) as a second loss driver depending on the nature of the underlying loan pool and how well that loss driver correlates to expected future losses. Consistent forecasts of the loss drivers are used across the loan segments. For all DCF models at September 30, 2020, the Company has determined that four quarters represents a reasonable and supportable forecast period and reverts back to a historical loss rate over eight quarters on a straight-line basis. The Company leverages economic projections from a reputable and independent third party to inform its loss driver forecasts over the four-quarter forecast period. Other internal and external indicators of economic forecasts are also considered by the Company when developing the forecast metrics. At September 30, 2020, as compared to January 1, 2020, the Company forecasted a significant increase in national unemployment, significant decrease in one-year percentage change in national retail sales, significant decrease in one-year percentage change in the national home price index, and a significant decrease in one-year percentage change in national gross domestic product for the first forecasted quarter. The Company projected little to no improvement in the loss drivers over the first three quarters with these loss drivers remaining significantly worse compared to recent historical trends over the past several years. Some improvement is expected in the fourth projected quarter. At September 30, 2020, as compared to June 30, 2020, Company forecasts over the reasonable and supportable forecast period were somewhat comparable. The Company uses a loss-rate method to estimate expected credit losses for the farmland, liquid credit, premium finance, factored receivable, and mortgage warehouse loan pools. For each of these loan segments, the Company applies an expected loss ratio based on internal and peer historical losses adjusted as appropriate for qualitative factors. Qualitative loss factors are based on the Company's judgment of company, market, industry or business specific data, changes in underlying loan composition of specific portfolios, trends relating to credit quality, delinquency, non-performing and adversely rated loans, and reasonable and supportable forecasts of economic conditions. Loss factors used to calculate the required ACL on pools that use the loss-rate method reflect the forecasted economic conditions described above. For the nine months ended September 30, 2020, the TFS Acquisition created the need for an additional $37,400,000 of PCD ACL previously discussed. The projected economic impact of COVID-19 on the Company’s loss drivers and assumptions over the reasonable and supportable forecast period created the need for $23,300,000 of additional ACL. The increase in required ACL was also driven by net charge-offs of $3,300,000 (which carried reserves of $1,600,000 at the time of charge-off), and net new specific allowances recorded on individual loans of $5,700,000. The increase was offset by contraction and changes in mix in the underlying portfolio. For the three months ended September 30, 2020, the TFS Acquisition created the need for an additional $37,400,000 of PCD ACL previously discussed. The changes in projected loss drivers and assumptions over the reasonable and supportable forecast period increased the ACL by $600,000. The increase in required ACL was also driven by net charge-offs of $700,000 (which carried reserves of $800,000 at the time of charge-off), and net new specific allowances recorded on individual loans of $800,000. Changes in loan volume and changes in mix in the underlying portfolio also increased the reserve. The following table presents the amortized cost basis of collateral dependent loans, which are individually evaluated to determine expected credit losses, and the related ACL allocated to these loans: (Dollars in thousands) Real Estate Accounts Equipment Other Total ACL September 30, 2020 Commercial real estate $ 14,198 $ — $ — $ 366 $ 14,564 $ 1,668 Construction, land development, land 2,112 — — — 2,112 271 1-4 family residential 1,962 — — 181 2,143 24 Farmland 1,914 — 148 572 2,634 — Commercial 2,875 4,893 7,034 4,124 18,926 4,563 Factored receivables — 73,875 — — 73,875 40,072 Consumer — — — 322 322 29 Mortgage warehouse — — — — — — Total $ 23,061 $ 78,768 $ 7,182 $ 5,565 $ 114,576 $ 46,627 At September 30, 2020 the balance of the Over-Formula Advance Portfolio included in factored receivables was $62,200,000 and carried an ACL allocation of $37,400,000 The following table presents loans individually and collectively evaluated for impairment, as well as purchased credit impaired (“PCI”) loans, and their respective allowance for credit loss allocations as of December 31, 2019, as determined in accordance with ASC 310 prior to the adoption of ASU 2016-13: (Dollars in thousands) Loan Evaluation ALLL Allocations December 31, 2019 Individually Collectively PCI Total loans Individually Collectively PCI Total ALLL Commercial real estate $ 7,455 $ 1,030,439 $ 9,067 $ 1,046,961 $ 344 $ 5,009 $ — $ 5,353 Construction, land development, land 2,138 155,985 2,446 160,569 271 1,111 — 1,382 1-4 family residential 1,728 177,189 508 179,425 33 275 — 308 Farmland 6,638 148,233 104 154,975 — 670 — 670 Commercial 15,618 1,326,515 550 1,342,683 1,278 11,284 4 12,566 Factored receivables 15,947 604,039 — 619,986 3,178 4,479 — 7,657 Consumer 327 21,598 — 21,925 9 479 — 488 Mortgage warehouse — 667,988 — 667,988 — 668 — 668 $ 49,851 $ 4,131,986 $ 12,675 $ 4,194,512 $ 5,113 $ 23,975 $ 4 $ 29,092 The following table presents information pertaining to impaired loans as of December 31, 2019, as determined in accordance with ASC 310 prior to the adoption of ASU 2016-13: Impaired Loans and Purchased Credit Impaired Loans (Dollars in thousands) Recorded Unpaid Related Recorded Unpaid December 31, 2019 Commercial real estate $ 878 $ 907 $ 344 $ 6,577 $ 6,643 Construction, land development, land 935 935 271 1,203 1,305 1-4 family residential 35 22 33 1,693 1,799 Farmland — — — 6,638 6,819 Commercial 6,032 6,053 1,278 9,586 9,751 Factored receivables 15,940 15,940 3,178 7 7 Consumer 17 16 9 310 311 Mortgage warehouse — — — — — PCI 71 55 4 — — $ 23,908 $ 23,928 $ 5,117 $ 26,014 $ 26,635 The following table presents average impaired loans, as determined in accordance with ASC 310 prior to the adoption of ASU 2016-13, and interest recognized on such loans, for the three and nine months ended September 30, 2019: Three Months Ended Nine Months Ended Average Interest Average Interest (Dollars in thousands) Commercial real estate $ 7,500 $ 180 $ 7,675 $ 180 Construction, land development, land 1,087 5 624 5 1-4 family residential 2,353 13 2,326 15 Farmland 6,737 31 7,186 75 Commercial 15,222 321 16,397 373 Factored receivables 10,453 — 9,455 — Consumer 458 5 411 5 Mortgage warehouse — — — — PCI 71 — 71 — $ 43,881 $ 555 $ 44,145 $ 653 Past Due and Nonaccrual Loans The following tables present an aging of contractually past due loans: (Dollars in thousands) Past Due Past Due Past Due 90 Total Current Total Past Due 90 September 30, 2020 Commercial real estate $ 1,714 $ 6,993 $ 2,666 $ 11,373 $ 751,158 $ 762,531 $ 1,287 Construction, land development, land 608 894 1,184 2,686 241,826 244,512 — 1-4 family residential 1,049 849 1,061 2,959 161,826 164,785 143 Farmland 400 — 284 684 110,282 110,966 — Commercial 5,954 1,548 6,319 13,821 1,523,082 1,536,903 276 Factored receivables 68,522 7,247 8,638 84,407 931,930 1,016,337 8,638 Consumer 442 83 141 666 16,440 17,106 — Mortgage warehouse — — — — 999,771 999,771 — Total $ 78,689 $ 17,614 $ 20,293 $ 116,596 $ 4,736,315 $ 4,852,911 $ 10,344 (Dollars in thousands) Past Due Past Due Past Due 90 Total Current Total Past Due 90 December 31, 2019 Commercial real estate $ 1,752 $ 1,328 $ 1,759 $ 4,839 $ 1,042,122 $ 1,046,961 $ — Construction, land development, land 1,785 842 361 2,988 157,581 160,569 — 1-4 family residential 1,396 723 554 2,673 176,752 179,425 286 Farmland 52 132 2,376 2,560 152,415 154,975 — Commercial 4,444 4,154 9,555 18,153 1,324,530 1,342,683 808 Factored receivables 29,118 7,182 4,226 40,526 579,460 619,986 4,226 Consumer 508 429 183 1,120 20,805 21,925 49 Mortgage warehouse — — — — 667,988 667,988 — Total $ 39,055 $ 14,790 $ 19,014 $ 72,859 $ 4,121,653 $ 4,194,512 $ 5,369 At September 30, 2020, total past due Over-Formula Advances recorded in factored receivables was $38,500,000. This balance was past due 30-59 Days. Aging of the Over-Formula Advances is based upon the service month on which the advances were made by TFS prior to acquisition. The following table presents the amortized cost basis of loans on nonaccrual status and the amortized cost basis of loans on nonaccrual status for which there was no related allowance for credit losses: September 30, 2020 December 31, 2019 (Dollars in thousands) Nonaccrual Nonaccrual Nonaccrual Nonaccrual Commercial real estate $ 12,235 $ 4,700 $ 7,501 $ 6,623 Construction, land development, land 2,089 1,180 3,922 2,987 1-4 family residential 1,761 1,640 1,730 1,694 Farmland 2,452 2,452 6,494 6,494 Commercial 19,462 5,210 16,080 9,977 Factored receivables — — — — Consumer 322 247 327 310 Mortgage warehouse — — — — $ 38,321 $ 15,429 $ 36,054 $ 28,085 The following table presents accrued interest on nonaccrual loans reversed through interest income: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Commercial real estate $ 371 $ 13 $ 435 $ 32 Construction, land development, land 1 — 1 9 1-4 family residential 21 — 31 12 Farmland 36 26 36 27 Commercial 37 13 76 50 Factored receivables — — — — Consumer — 2 2 3 Mortgage warehouse — — — — $ 466 $ 54 $ 581 $ 133 There was no interest earned on nonaccrual loans during the three and nine months ended September 30, 2020 and 2019. The following table presents information regarding nonperforming loans: (Dollars in thousands) September 30, 2020 December 31, 2019 Nonaccrual loans (1) $ 38,321 $ 36,054 Factored receivables greater than 90 days past due 8,638 4,226 Other nonperforming factored receivables (2) 10,029 — Troubled debt restructurings accruing interest 3 333 $ 56,991 $ 40,613 (1) Includes troubled debt restructurings of $15,743,000 and $4,888,000 at September 30, 2020 and December 31, 2019, respectively. (2) Other nonperforming factored receivables represent the portion of the Over-Formula Advance Portfolio that is not covered by Covenant's indemnification. This amount is also considered Classified from a risk rating perspective. Credit Quality Information The Company categorizes loans into risk categories based on relevant information about the ability of borrowers to service their debt, including: current collateral and financial information, historical payment experience, credit documentation, public information, and current economic trends, among other factors. The Company analyzes loans individually by classifying the loans as to credit risk on a regular basis. Large groups of smaller balance homogeneous loans, such as consumer loans, are analyzed primarily based on payment status. The Company uses the following definitions for risk ratings: Pass – Pass rated loans have low to average risk and are not otherwise classified. Classified – Classified loans are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans so classified have a well-defined weakness or weaknesses that jeopardize the repayment of the debt. They are characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Certain classified loans have the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions and values, highly questionable and improbable. PCI (Prior to the Adoption of ASU 2016-13) – At acquisition, PCI loans had the characteristics of classified loans and it was probable, at acquisition, that all contractually required principal and interest payments would not be collected. The Company evaluates these loans on a projected cash flow basis with this evaluation performed quarterly. Management considers the guidance in ASC 310-20 when determining whether a modification, extension, or renewal of loan constitutes a current period origination. Generally, current period renewals of credit are re-underwritten at the point of renewal and considered current period originations for purposes of the table below. As of September 30, 2020 and December 31, 2019, based on the most recent analysis performed, the risk category of loans is as follows: Revolving Revolving Total (Dollars in thousands) Year of Origination September 30, 2020 2020 2019 2018 2017 2016 Prior Commercial real estate Pass $ 374,993 $ 85,458 $ 95,818 $ 92,112 $ 35,576 $ 53,189 $ 7,124 $ 908 $ 745,178 Classified 13,918 437 182 636 852 1,328 — — 17,353 Total commercial real estate $ 388,911 $ 85,895 $ 96,000 $ 92,748 $ 36,428 $ 54,517 $ 7,124 $ 908 $ 762,531 Construction, land development, land Pass $ 141,940 $ 29,654 $ 55,887 $ 12,362 $ 268 $ 1,776 $ 13 $ 500 $ 242,400 Classified 905 838 — — — 369 — — 2,112 Total construction, land development, land $ 142,845 $ 30,492 $ 55,887 $ 12,362 $ 268 $ 2,145 $ 13 $ 500 $ 244,512 1-4 family residential Pass $ 35,959 $ 12,614 $ 15,172 $ 13,316 $ 11,773 $ 30,076 $ 38,669 $ 5,320 $ 162,899 Classified 570 76 16 — 359 758 107 — 1,886 Total 1-4 family residential $ 36,529 $ 12,690 $ 15,188 $ 13,316 $ 12,132 $ 30,834 $ 38,776 $ 5,320 $ 164,785 Farmland Pass $ 19,870 $ 17,100 $ 16,458 $ 15,168 $ 13,829 $ 21,150 $ 2,130 $ 486 $ 106,191 Classified 1,207 417 1,672 145 — 560 774 — 4,775 Total farmland $ 21,077 $ 17,517 $ 18,130 $ 15,313 $ 13,829 $ 21,710 $ 2,904 $ 486 $ 110,966 Commercial Pass $ 848,660 $ 135,269 $ 48,573 $ 41,531 $ 6,013 $ 5,548 $ 405,676 $ 11,396 $ 1,502,666 Classified 7,186 7,357 4,725 1,445 731 348 12,445 — 34,237 Total commercial $ 855,846 $ 142,626 $ 53,298 $ 42,976 $ 6,744 $ 5,896 $ 418,121 $ 11,396 $ 1,536,903 Factored receivables Pass $ 995,046 $ — $ — $ — $ — $ — $ — $ — $ 995,046 Classified 21,291 — — — — — — — 21,291 Total factored receivables $ 1,016,337 $ — $ — $ — $ — $ — $ — $ — $ 1,016,337 Consumer Pass $ 3,820 $ 2,617 $ 1,614 $ 4,694 $ 3,088 $ 875 $ 73 $ — $ 16,781 Classified — 18 7 94 162 44 — — 325 Total consumer $ 3,820 $ 2,635 $ 1,621 $ 4,788 $ 3,250 $ 919 $ 73 $ — $ 17,106 Mortgage warehouse Pass $ — $ — $ — $ — $ — $ — $ 999,771 $ — $ 999,771 Classified — — — — — — — — — Total mortgage warehouse $ — $ — $ — $ — $ — $ — $ 999,771 $ — $ 999,771 Total loans Pass $ 2,420,288 $ 282,712 $ 233,522 $ 179,183 $ 70,547 $ 112,614 $ 1,453,456 $ 18,610 $ 4,770,932 Classified 45,077 9,143 6,602 2,320 2,104 3,407 13,326 — 81,979 Total loans $ 2,465,365 $ 291,855 $ 240,124 $ 181,503 $ 72,651 $ 116,021 $ 1,466,782 $ 18,610 $ 4,852,911 (Dollars in thousands) December 31, 2019 Pass Classified PCI Total Commercial real estate $ 1,030,358 $ 7,536 $ 9,067 $ 1,046,961 Construction, land development, land 155,985 2,138 2,446 160,569 1-4 family residential 177,177 1,740 508 179,425 Farmland 144,777 10,094 104 154,975 Commercial 1,313,042 29,091 550 1,342,683 Factored receivables 604,774 15,212 — 619,986 Consumer 21,594 331 — 21,925 Mortgage warehouse 667,988 — — 667,988 $ 4,115,695 $ 66,142 $ 12,675 $ 4,194,512 Troubled Debt Restructurings and Loan Modifications The Company had troubled debt restructurings with an amortized cost of $18,326,000 and $5,221,000 as of September 30, 2020 and December 31, 2019, respectively. The Company had allocated $2,030,000 and $718,000 of allowance for those loans at September 30, 2020 and December 31, 2019, respectively, and had not committed to lend additional amounts. The following table presents the pre- and post-modification recorded investment of loans modified as troubled debt restructurings during the three and nine months ended September 30, 2020 and 2019. The Company did not grant principal reductions on any restructured loans. (Dollars in thousands) Extended Payment AB Note Interest Rate Total Number of Nine months ended September 30, 2020 Commercial real estate $ — $ 246 $ — $ — $ 246 2 Construction, land development, land 8 — — — 8 1 Farmland 3,486 — — — 3,486 1 Commercial 4,714 9,296 — — 14,010 19 $ 8,208 $ 9,542 $ — $ — $ 17,750 23 Three months ended September 30, 2020 Commercial 123 3,503 — — 3,626 14 $ 123 $ 3,503 $ — $ — $ 3,626 14 Nine months ended September 30, 2019 Commercial real estate $ — $ — $ 4,597 $ — $ 4,597 1 Commercial 1,649 84 — 593 2,326 6 $ 1,649 $ 84 $ 4,597 $ 593 $ 6,923 7 Three months ended September 30, 2019 Commercial real estate $ — $ — $ — $ — $ — — Commercial 554 — — — 554 1 $ 554 $ — $ — $ — $ 554 1 During the nine months ended September 30, 2020, the Company had two loans modified as troubled debt restructurings with a recorded investment of $18,000 for which there were payment defaults within twelve months following the modification. During the nine months ended September 30, 2019, the Company had two loans modified as troubled debt restructurings with a recorded investment of $240,000 for which there were payment defaults within twelve months following the modification. Default is determined at 90 or more days past due, charge-off, or foreclosure. During the three and nine months ended September 30, 2020, the Company modified $12,625,000 and $617,976,000, respectively, in loans for borrowers impacted by the COVID-19 pandemic. These modifications primarily consisted of short-term payment deferrals generally no more than six months in duration to assist customers. As these modifications related to the COVID-19 pandemic and qualify under the provisions of either Section 4013 of the CARES act or Interagency Guidance, they are not considered troubled debt restructurings. The following table summarized the amortized cost of loans with payments currently in deferral and the accrued interest related to the loans with payments currently in deferral at September 30, 2020: (Dollars in thousands) Total Balance of Percentage Accrued September 30, 2020 Commercial real estate $ 762,531 $ 77,419 10.2 % $ 464 Construction, land development, land 244,512 116 — % 1 1-4 family residential 164,785 8,560 5.2 % 127 Farmland 110,966 — — % — Commercial 1,536,903 16,787 1.1 % 99 Factored receivables 1,016,337 — — % — Consumer 17,106 105 0.6 % 4 Mortgage warehouse 999,771 — — % — Total $ 4,852,911 $ 102,987 2.1 % $ 695 Residential Real Estate Loans In Process of Foreclosure At September 30, 2020 and December 31, 2019, the Company had $208,000 and $87,000, respectively, in 1-4 family residential real estate loans for which formal foreclosure proceedings were in process. Purchased Credit Impaired Loans (Prior to the Adoption of ASU 2016-13) The following table summarizes information pertaining to loans that were identified as purchased credit impaired prior to the adoption of ASU 2016-13: December 31, Contractually required principal and interest: Real estate loans $ 14,015 Commercial loans 677 Outstanding contractually required principal and interest $ 14,692 Gross carrying amount included in loans receivable $ 12,675 The changes in accretable yield related to loans that were identified as purchased credit impaired prior to the adoption of ASU 2016-13 were as follows: Three Months Ended Nine Months Ended Accretable yield, beginning balance $ 4,793 $ 5,711 Additions — — Accretion (460) (1,228) Reclassification from nonaccretable to accretable yield 50 64 Disposals (54) (218) Accretable yield, ending balance $ 4,329 $ 4,329

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	GOODWILL AND INTANGIBLE ASSETS Goodwill and intangible assets consist of the following: (Dollars in thousands) September 30, 2020 December 31, 2019 Goodwill $ 163,263 $ 158,743 September 30, 2020 December 31, 2019 (Dollars in thousands) Gross Carrying Accumulated Net Carrying Gross Carrying Accumulated Net Carrying Core deposit intangibles $ 43,578 $ (26,217) $ 17,361 $ 43,578 $ (22,258) $ 21,320 Other intangible assets 19,200 (7,783) 11,417 15,700 (5,477) 10,223 $ 62,778 $ (34,000) $ 28,778 $ 59,278 $ (27,735) $ 31,543 The changes in goodwill and intangible assets during the three and nine months ended September 30, 2020 and 2019 are as follows: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Beginning balance $ 186,162 $ 194,668 $ 190,286 $ 199,417 Acquired goodwill 4,520 — 4,520 — Acquired intangibles 3,500 — 3,500 — Amortization of intangibles (2,141) (2,228) (6,265) (6,977) Ending balance $ 192,041 $ 192,440 $ 192,041 $ 192,440

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	DERIVATIVE FINANCIAL INSTRUMENTS The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s interest bearing deposits. The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Beginning in 2020, such derivatives were used to hedge the variable cash flows associated with interest bearing deposits. For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate interest bearing deposits. During 2020, the Company estimates that an additional $132,000 will be reclassified as an increase in interest expense. The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet as of September 30, 2020. There were no such derivatives outstanding at December 31, 2019. Derivative Liabilities As of September 30, 2020 (Dollars in thousands) Notional Balance Fair Value Derivatives designated as hedging instruments: Interest rate swaps $ 200,000 Other Liabilities $ 16 The table below presents the effect of fair value and cash flow hedge accounting on Accumulated Other Comprehensive Income, net of tax, as of September 30, 2020: (Dollars in thousands) Amount of Amount of Location of Amount of Amount of Three Months Ended September 30, 2020 Derivatives in cash flow hedging relationships: Interest rate swaps $ 257 $ 257 Interest Expense $ (16) $ (16) (Dollars in thousands) Amount of Amount of Location of Amount of Amount of Nine Months Ended September 30, 2020 Derivatives in cash flow hedging relationships: Interest rate swaps $ 11 $ 11 Interest Expense $ (16) $ (16) The Company has agreements with each of its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, then the Company could also be declared in default on its derivative obligations. The Company has agreements with certain of its derivative counterparties that contain a provision where if the company fails to maintain its status as a well capitalized institution, then the Company could be required to post additional collateral. As of September 30, 2020, the fair value of derivatives in a net liability position, which includes accrued interest, related to these agreements was $0. As of September 30, 2020, the Company has not posted any collateral related to these agreements. If the Company had breached any of these provisions at September 30, 2020, it could have been required to settle its obligations under the agreements at their termination value of $0.

Variable Interest Entities

Variable Interest Entities	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	VARIABLE INTEREST ENTITIES Collateralized Loan Obligation Funds – Closed The Company holds investments in the subordinated notes of the following closed Collateralized Loan Obligation (“CLO”) funds: (Dollars in thousands) Offering Offering Trinitas CLO IV, LTD (Trinitas IV) June 2, 2016 $ 406,650 Trinitas CLO V, LTD (Trinitas V) September 22, 2016 $ 409,000 Trinitas CLO VI, LTD (Trinitas VI) June 20, 2017 $ 717,100 The net carrying amounts of the Company’s investments in the subordinated notes of the CLO funds, which represent the Company’s maximum exposure to loss as a result of its involvement with the CLO funds, totaled $6,096,000 and $8,417,000 at September 30, 2020 and December 31, 2019, respectively, and are classified as held to maturity securities within the Company’s consolidated balance sheets. The Company performed a consolidation analysis to confirm whether the Company was required to consolidate the assets, liabilities, equity or operations of the closed CLO funds in its financial statements. The Company concluded that the closed CLO funds were variable interest entities and that the Company holds variable interests in the entities in the form of its investments in the subordinated notes of entities. However, the Company also concluded that the Company does not have the power to direct the activities that most significantly impact the entities’ economic performance. As a result, the Company was not the primary beneficiary and therefore was not required to consolidate the assets, liabilities, equity, or operations of the closed CLO funds in the Company’s financial statements.

Borrowings and Borrowing Capaci

Borrowings and Borrowing Capacity	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Borrowings and Borrowing Capacity	BORROWINGS AND BORROWING CAPACITY Customer Repurchase Agreements Customer repurchase agreements are overnight customer sweep arrangements. Information concerning customer repurchase agreements is summarized as follows for the nine months ended September 30, 2020 and the year ended December 31, 2019: (Dollars in thousands) September 30, December 31, Amount outstanding at end of period $ 14,192 $ 2,033 Weighted average interest rate at end of period 0.03 % 0.03 % Average daily balance during the period $ 6,520 $ 7,823 Weighted average interest rate during the period 0.03 % 0.02 % Maximum month-end balance during the period $ 14,192 $ 14,463 Customer repurchase agreements were secured by pledged securities with carrying amounts of $14,544,000 and $2,997,000 at September 30, 2020 and December 31, 2019, respectively. FHLB Advances FHLB advances are collateralized by assets, including a blanket pledge of certain loans. FHLB advances and weighted average interest rates at end of period by contractual maturity are summarized as follows: Fixed Rate Variable Rate (Dollars in thousands) Balance Weighted Balance Weighted 2020 $ 405,000 0.13 % $ — — 2027 — — 30,000 0.33 % $ 405,000 0.13 % 30,000 0.33 % Information concerning FHLB advances is summarized as follows for the nine months ended September 30, 2020 and the year ended December 31, 2019: (Dollars in thousands) September 30, December 31, Amount outstanding at end of period $ 435,000 $ 430,000 Weighted average interest rate at end of period 0.15 % 1.58 % Average amount outstanding during the period 430,250 369,548 Weighted average interest rate during the period 0.61 % 2.32 % Highest month end balance during the period 850,000 530,000 The Company’s unused borrowing capacity with the FHLB is as follows: (Dollars in thousands) September 30, December 31, Borrowing capacity $ 1,323,927 $ 1,300,985 Borrowings outstanding 435,000 430,000 Unused borrowing capacity $ 888,927 $ 870,985 Paycheck Protection Program Liquidity Facility (“PPPLF”) The PPPLF is a lending facility offered by the Federal Reserve Banks to facilitate lending to small businesses under the Paycheck Protection Program. Borrowings under the PPPLF are secured by Paycheck Protection Program Loans (“PPP loans”) guaranteed by the Small Business Administration (“SBA”) and mature at the same time as the PPP Loan pledged to secure the extension of credit. The maturity dates of the borrowings will be accelerated if the underlying PPP Loan goes into default and Company sells the PPP Loan to the SBA to realize on the SBA guarantee or if the Company receives any loan forgiveness reimbursement from the SBA for the underlying PPP Loan. Information concerning borrowings under the PPPLF is summarized as follows for the nine months ended September 30, 2020: (Dollars in thousands) September 30, Amount outstanding at end of period $ 223,713 Weighted average interest rate at end of period 0.35 % Average amount outstanding during the period 119,236 Weighted average interest rate during the period 0.35 % Highest month end balance during the period 223,809 At September 30, 2020, scheduled maturities of PPPLF borrowings are as follows: (Dollars in thousands) September 30, Within one year $ — After one but within two years 223,713 Total $ 223,713 At September 30, 2020, the PPPLF borrowings are secured by PPP Loans totaling $223,713,000 and bear interest at a fixed rate of 0.35% annually. There were no borrowings under the PPPLF during the year ended December 31, 2019. Federal Funds Purchased The Company had no federal funds purchased at September 30, 2020 or December 31, 2019. However, as of September 30, 2020, the Company had unsecured federal funds lines of credit with seven unaffiliated banks totaling $227,500,000. Federal Reserve Bank Discount Window During the nine months ended September 30, 2020, the Company entered into agreements with the Federal Reserve Bank of Dallas to borrow from its discount window. The Company had no Federal Reserve Bank discount window borrowings outstanding at September 30, 2020. At September 30, 2020, the Company had $467,256,000 of unused borrowing capacity from the Federal Reserve Bank discount window, to which the Company pledged loans with an outstanding balance of $636,992,000. The Company did not participate in the Federal Reserve Bank discount window program during the year ended December 31, 2019. Subordinated Notes On September 30, 2016, the Company issued $50,000,000 of Fixed-to-Floating Rate Subordinated Notes due 2026 (the “2016 Notes”). The 2016 Notes initially bear interest at 6.50% per annum, payable semi-annually in arrears, to, but excluding, September 30, 2021, and, thereafter and to, but excluding, the maturity date or earlier redemption, interest shall be payable quarterly in arrears, at an annual floating rate equal to three-month LIBOR as determined for the applicable quarterly period, plus 5.345%. The Company may, at its option, beginning on September 30, 2021 and on any scheduled interest payment date thereafter, redeem the 2016 Notes, in whole or in part, at a redemption price equal to the outstanding principal amount of the 2016 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the date of redemption. On November 27, 2019, the Company issued $39,500,000 of Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2019 Notes”). The 2019 Notes initially bear interest at 4.875% per annum, payable semi-annually in arrears, to, but excluding, November 27, 2024, and, thereafter and to, but excluding, the maturity date or earlier redemption, interest shall be payable quarterly in arrears, at an annual floating rate equal to a benchmark rate, initially three-month LIBOR , as determined for the applicable quarterly period, plus 3.330%. The Company may, at its option, beginning on November 27, 2024 and on any scheduled interest payment date thereafter, redeem the 2019 Notes, in whole or in part, at a redemption price equal to the outstanding principal amount of the 2019 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the date of redemption. The 2016 Notes and the 2019 Notes are included on our consolidated balance sheet as liabilities; however, for regulatory purposes, the carrying value of these obligations is eligible for inclusion in Tier 2 regulatory capital. Issuance costs related to the 2016 Notes and the 2019 Notes totaled $1,324,000 and $1,218,000, respectively, and have been netted against the subordinated notes liability on the consolidated balance sheets. The debt issuance costs are being amortized using the effective interest method over the life of the 2016 Notes and the 2019 Notes as a component of interest expense. The carrying value of the 2016 Notes and the 2019 Notes totaled $87,455,000 and $87,327,000 at September 30, 2020 and December 31, 2019, respectively. The 2016 Notes and the 2019 Notes are subordinated in right of payment to the Company’s existing and future senior indebtedness and are structurally subordinated to the Company’s subsidiaries’ existing and future indebtedness and other obligations. Junior Subordinated Debentures The following provides a summary of the Company’s junior subordinated debentures as of September 30, 2020: (Dollars in thousands) Face Value Carrying Value Maturity Date Interest Rate National Bancshares Capital Trust II $ 15,464 $ 13,187 September 2033 LIBOR + 3.00% National Bancshares Capital Trust III 17,526 12,924 July 2036 LIBOR + 1.64% ColoEast Capital Trust I 5,155 3,594 September 2035 LIBOR + 1.60% ColoEast Capital Trust II 6,700 4,684 March 2037 LIBOR + 1.79% Valley Bancorp Statutory Trust I 3,093 2,876 September 2032 LIBOR + 3.40% Valley Bancorp Statutory Trust II 3,093 2,679 July 2034 LIBOR + 2.75% $ 51,031 $ 39,944 These debentures are unsecured obligations due to trusts that are unconsolidated subsidiaries. The debentures were issued in conjunction with the trusts’ issuances of obligated capital securities. The trusts used the proceeds from the issuances of their capital securities to buy floating rate junior subordinated deferrable interest debentures that bear the same interest rate and terms as the capital securities. These debentures are the trusts’ only assets and the interest payments from the debentures finance the distributions paid on the capital securities. These debentures rank junior and are subordinate in the right of payment to all other debt of the Company. As part of the purchase accounting adjustments made with the National Bancshares, Inc. acquisition on October 15, 2013, the ColoEast acquisition on August 1, 2016, and the Valley acquisition on December 9, 2017, the Company adjusted the carrying value of the junior subordinated debentures to fair value as of the respective acquisition dates. The discount on the debentures will continue to be amortized through maturity and recognized as a component of interest expense. The debentures may be called by the Company at par plus any accrued but unpaid interest. Interest on the debentures is calculated quarterly, based on a contractual rate equal to three-month LIBOR plus a weighted average spread of 2.24%. The distribution rate payable on the capital securities is cumulative and payable quarterly in arrears. The Company has the right to defer payments on interest on the debentures at any time by extending the interest payment period for a period not exceeding 20 consecutive quarters with respect to each deferral period, provided that no extension period may extend beyond the redemption or maturity date of the debentures. The debentures are included on the consolidated balance sheet as liabilities; however, for regulatory purposes, the carrying value of these obligations are eligible for inclusion in Tier I regulatory capital, subject to certain limitations. All of the carrying value of $39,944,000 and $39,566,000 was allowed in the calculation of Tier I regulatory capital as of September 30, 2020 and December 31, 2019, respectively.

Legal Contingencies

Legal Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Legal Contingencies	Legal ContingenciesVarious legal claims have arisen from time to time in the normal course of business which, in the opinion of management, will have no material effect on the Company’s consolidated financial statements.

Off-Balance Sheet Loan Commitme

Off-Balance Sheet Loan Commitments	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Off-Balance Sheet Loan Commitments	OFF-BALANCE SHEET LOAN COMMITMENTS From time to time, the Company is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit. Those instruments involve, to varying degrees, elements of credit risk in excess of the amount recognized in the balance sheet. The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and standby letters of credit is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet financial instruments. The contractual amounts of financial instruments with off-balance sheet risk were as follows: September 30, 2020 December 31, 2019 (Dollars in thousands) Fixed Rate Variable Rate Total Fixed Rate Variable Rate Total Unused lines of credit $ 35,764 $ 594,305 $ 630,069 $ 49,057 $ 444,028 $ 493,085 Standby letters of credit $ 5,382 $ 3,259 $ 8,641 $ 3,017 $ 3,781 $ 6,798 Commitments to purchase loans $ — $ 51,747 $ 51,747 $ — $ 22,004 $ 22,004 Mortgage warehouse commitments $ — $ 318,972 $ 318,972 $ — $ 340,502 $ 340,502 Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being fully drawn upon, the total commitment amounts disclosed above do not necessarily represent future cash requirements. The Company evaluates each customer’s creditworthiness on a case-by-case basis. The amount of collateral obtained, if considered necessary by the Company, upon extension of credit, is based on management’s credit evaluation of the customer. Standby letters of credit are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. In the event of nonperformance by the customer, the Company has rights to the underlying collateral, which can include commercial real estate, physical plant and property, inventory, receivables, cash and marketable securities. The credit risk to the Company in issuing letters of credit is essentially the same as that involved in extending loan facilities to its customers. Commitments to purchase loans represent loans purchased by the Company that have not yet settled. Mortgage warehouse commitments are unconditionally cancellable and represent the unused capacity on mortgage warehouse facilities the Company has approved. The Company reserves the right to refuse to buy any mortgage loans offered for sale by a customer, for any reason, at the Company’s sole and absolute discretion. The Company records an allowance for credit losses on off-balance sheet credit exposures through a charge to credit loss expense on the Company’s consolidated statements of income. At September 30, 2020 and December 31, 2019, the allowance for credit losses on off-balance sheet credit exposures totaled $6,395,000 and $638,000, respectively, and was included in other liabilities on the Company’s consolidated balance sheets. For the three and nine months ended September 30, 2020, credit loss expense for off balance sheet credit exposures was $(8,000) and $3,840,000, respectively. For the three and nine months ended September 30, 2019, credit loss expense for off balance sheet credit exposures was a credit of $150,000 and $116,000, respectively, and was included in other noninterest expense on the Company’s consolidated statements of income.

Fair Value Disclosures

Fair Value Disclosures	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Disclosures	Fair Value Disclosures Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values: Level 1 – Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2 – Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 3 – Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. The methods of determining the fair value of assets and liabilities presented in this note are consistent with our methodologies disclosed in Note 15 of the Company’s 2019 Form 10-K, except for the valuation of derivative financial instruments, the indemnification asset recognized in connection with the factored receivables acquired from TFS, and Paycheck Protection Program Liquidity Fund borrowings, which the Company entered into in during the three months ended June 30, 2020. Derivative Financial Instruments Currently, the Company uses interest rate swaps as part of its cash flow strategy to manage its interest rate risk. The valuation of these instruments is determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. The derivative financial instrument fair value is considered a Level 2 classification. Indemnification Asset The fair value of the indemnification asset is calculated as the present value of the estimated cash payments expected to be received from Covenant for probable losses on the covered Over-Formula Advance Portfolio. The cash flows are discounted at a rate to reflect the uncertainty of the timing and receipt of the payments from Covenant . This discount rate was 4% at September 30, 2020. The indemnification asset, which is included in other assets in the Consolidated Balance Sheets, is reviewed quarterly and changes to the asset are recorded as adjustments to other noninterest income or expense, as appropriate, within the Consolidated Statements of Income. The Company's estimate of probable losses on the covered portfolio did not change between the acquisition date and September 30, 2020 and therefore, no activity related to the indemnification asset was recorded during the three and nine months ended September 30, 2020. The indemnification asset fair value is considered a Level 3 classification. Paycheck Protection Program Liquidity Fund The Company’s PPPLF borrowings correspond to PPP loans and are expected to be short term in duration, therefore fair value materially approximates carrying value and is considered a Level 2 classification. Assets and liabilities measured at fair value on a recurring basis are summarized in the table below. (Dollars in thousands) Fair Value Measurements Using Total September 30, 2020 Level 1 Level 2 Level 3 Assets measured at fair value on a recurring basis Securities available for sale U.S. Government agency obligations $ — $ 18,448 $ — $ 18,448 Mortgage-backed securities, residential — 29,790 — 29,790 Asset-backed securities — 7,091 — 7,091 State and municipal — 43,362 — 43,362 CLO securities — 117,491 — 117,491 Corporate bonds — 22,927 — 22,927 SBA pooled securities — 3,693 — 3,693 $ — $ 242,802 $ — $ 242,802 Equity securities Mutual fund $ 6,040 $ — $ — $ 6,040 Loans held for sale $ — $ 36,716 $ — $ 36,716 Derivative financial instruments (cash flow hedges) Interest rate swap $ — $ 16 $ — $ 16 Liabilities measured at fair value on a recurring basis ICC Contingent consideration $ — $ — $ 21,991 $ 21,991 (Dollars in thousands) Fair Value Measurements Using Total December 31, 2019 Level 1 Level 2 Level 3 Assets measured at fair value on a recurring basis Securities available for sale U.S. Government agency obligations $ — $ 39,760 $ — $ 39,760 Mortgage-backed securities, residential — 38,016 — 38,016 Asset-backed securities — 7,959 — 7,959 State and municipal — 32,065 — 32,065 CLO Securities — 75,273 — 75,273 Corporate bonds — 51,583 — 51,583 SBA pooled securities — 4,164 — 4,164 $ — $ 248,820 $ — $ 248,820 Equity securities Mutual fund $ 5,437 $ — $ — $ 5,437 Loans held for sale $ — $ 2,735 $ — $ 2,735 Liabilities measured at fair value on a recurring basis ICC Contingent consideration $ — $ — $ 21,622 $ 21,622 There were no transfers between levels during 2020 or 2019. On June 2, 2018, the Company acquired substantially all of the operating assets of, and assumed certain liabilities associated with, Interstate Capital Corporation’s (“ICC”) accounts receivable factoring business and other related financial services. Consideration for the acquisition included contingent consideration, which is based on a proprietary index designed to approximate the rise and fall of transportation invoice prices subsequent to acquisition. The index is calculated by a third party data analytics firm and is correlated to monthly movements in average invoice prices historically experienced by ICC. At the end of a 30 month earnout period after closing, a final average index price will be calculated and the contingent consideration will be settled in cash based on the final average index price, with a payout ranging from $0 to $22,000,000. The fair value of the contingent consideration is calculated each reporting period, and changes in the fair value of the contingent consideration are recorded in noninterest income in the consolidated statements of income. At September 30, 2020 and December 31, 2019, the ICC contingent consideration liability was the only recurring fair value measurement with Level 3 unobservable inputs. At September 30, 2020 and December 31, 2019, the fair value calculation of the contingent consideration resulted in a payout of $22,000,000, and discount rates of 0.2% and 1.7%, respectively, were applied to calculate the present value of the contingent consideration. A reconciliation of the opening balance to the closing balance of the fair value of the contingent consideration is as follows: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Beginning balance $ 21,963 $ 21,302 $ 21,622 $ 20,745 Contingent consideration recognized in business combination — — — — Change in fair value of contingent consideration recognized in earnings 28 124 369 681 Consideration settlement payments — — — — Ending balance $ 21,991 $ 21,426 $ 21,991 $ 21,426 Assets measured at fair value on a non-recurring basis are summarized in the table below. There were no liabilities measured at fair value on a non-recurring basis at September 30, 2020 and December 31, 2019. (Dollars in thousands) Fair Value Measurements Using Total September 30, 2020 Level 1 Level 2 Level 3 Collateral dependent loans Commercial real estate $ — $ — $ 5,302 $ 5,302 Construction, land development, land — — 637 637 1-4 family residential — — 5 5 Commercial — — 3,584 3,584 Factored receivables — — 33,803 33,803 Consumer — — 46 46 Other real estate owned (1) 1-4 family residential properties — — 189 189 $ — $ — $ 43,566 $ 43,566 (Dollars in thousands) Fair Value Measurements Using Total December 31, 2019 Level 1 Level 2 Level 3 Impaired loans Commercial real estate $ — $ — $ 534 $ 534 Construction, land development, land — — 664 664 1-4 family residential — — 2 2 Commercial — — 4,754 4,754 Factored receivables — — 12,762 12,762 Consumer — — 8 8 PCI — — 67 67 Other real estate owned (1) Commercial real estate — — 388 388 1-4 family residential — — 89 89 $ — $ — $ 19,268 $ 19,268 (1) Represents the fair value of OREO that was adjusted during the year to date period and subsequent to its initial classification as OREO. Collateral Dependent Loans Specific Allocation of ACL : A loan is considered to be a collateral dependent loan when, based on current information and events, the Company expects repayment of the financial assets to be provided substantially through the operation or sale of the collateral and the Company has determined that the borrower is experiencing financial difficulty as of the measurement date. The ACL is measured by estimating the fair value of the loan based on the present value of expected cash flows, the market price of the loan, or the underlying fair value of the loan’s collateral. For real estate loans, fair value of the loan’s collateral is determined by third party appraisals, which are then adjusted for the estimated selling and closing costs related to liquidation of the collateral. For this asset class, the actual valuation methods (income, sales comparable, or cost) vary based on the status of the project or property. For example, land is generally based on the sales comparable method while construction is based on the income and/or sales comparable methods. The unobservable inputs may vary depending on the individual assets with no one of the three methods being the predominant approach. The Company reviews the third party appraisal for appropriateness and adjusts the value downward to consider selling and closing costs, which typically range from 5% to 8% of the appraised value. For non-real estate loans, fair value of the loan’s collateral may be determined using an appraisal, net book value per the borrower’s financial statements, or aging reports, adjusted or discounted based on management’s historical knowledge, changes in market conditions from the time of the valuation, and management’s expertise and knowledge of the client and client’s business. OREO : OREO is primarily comprised of real estate acquired in partial or full satisfaction of loans. OREO is recorded at its estimated fair value less estimated selling and closing costs at the date of transfer, with any excess of the related loan balance over the fair value less expected selling costs charged to the ACL. Subsequent changes in fair value are reported as adjustments to the carrying amount and are recorded against earnings. The Company outsources the valuation of OREO with material balances to third party appraisers. For this asset class, the actual valuation methods (income, sales comparable, or cost) vary based on the status of the project or property. For example, land is generally based on the sales comparable method while construction is based on the income and/or sales comparable methods. The unobservable inputs may vary depending on the individual assets with no one of the three methods being the predominant approach. The Company reviews the third party appraisal for appropriateness and adjusts the value downward to consider selling and closing costs, which typically range from 5% to 8% of the appraised value. The estimated fair values of the Company’s financial instruments not measured at fair value on a recurring or non-recurring basis at September 30, 2020 and December 31, 2019 were as follows: (Dollars in thousands) Carrying Fair Value Measurements Using Total September 30, 2020 Level 1 Level 2 Level 3 Financial assets: Cash and cash equivalents $ 288,278 $ 288,278 $ — $ — $ 288,278 Securities - held to maturity 6,096 — — 5,473 5,473 Loans not previously presented, gross 4,810,731 197,859 — 4,593,233 4,791,092 FHLB and other restricted stock 18,464 N/A N/A N/A N/A Indemnification asset 31,218 — — 31,218 31,218 Accrued interest receivable 20,254 20,254 — — 20,254 Financial liabilities: Deposits 4,248,101 — 4,254,371 — 4,254,371 Customer repurchase agreements 14,192 — 14,192 — 14,192 Federal Home Loan Bank advances 435,000 — 435,000 — 435,000 Paycheck Protection Program Liquidity Facility 223,713 — 223,713 — 223,713 Subordinated notes 87,455 — 89,806 — 89,806 Junior subordinated debentures 39,944 — 40,135 — 40,135 Accrued interest payable 6,006 6,006 — — 6,006 (Dollars in thousands) Carrying Fair Value Measurements Using Total December 31, 2019 Level 1 Level 2 Level 3 Financial assets: Cash and cash equivalents $ 197,880 $ 197,880 $ — $ — $ 197,880 Securities - held to maturity 8,417 — — 6,907 6,907 Loans not previously presented, gross 4,170,604 83,454 — 4,086,597 4,170,051 FHLB and other restricted stock 19,860 N/A N/A N/A N/A Accrued interest receivable 20,322 20,322 — — 20,322 Financial liabilities: Deposits 3,789,906 — 3,793,603 — 3,793,603 Customer repurchase agreements 2,033 — 2,033 — 2,033 Federal Home Loan Bank advances 430,000 — 430,000 — 430,000 Subordinated notes 87,327 — 93,877 — 93,877 Junior subordinated debentures 39,566 — 40,700 — 40,700 Accrued interest payable 9,367 9,367 — — 9,367

Regulatory Matters

Regulatory Matters	9 Months Ended
	Sep. 30, 2020
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]
Regulatory Matters	Regulatory Matters The Company (on a consolidated basis) and TBK Bank are subject to various regulatory capital requirements administered by federal and state banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory and possibly additional discretionary actions by regulators that, if undertaken, could have a direct material effect on the Company’s or TBK Bank’s financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Company and TBK Bank must meet specific capital guidelines that involve quantitative measures of their assets, liabilities, and certain off-balance sheet items as calculated under regulatory accounting practices. The capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk weightings, and other factors. Quantitative measures established by regulation to ensure capital adequacy require the Company and TBK Bank to maintain minimum amounts and ratios (set forth in the table below) of total, common equity Tier 1, and Tier 1 capital to risk weighted assets, and of Tier 1 capital to average assets. Management believes, as of September 30, 2020 and December 31, 2019, the Company and TBK Bank meet all capital adequacy requirements to which they are subject. As of September 30, 2020 and December 31, 2019, TBK Bank’s capital ratios exceeded those levels necessary to be categorized as “well capitalized” under the regulatory framework for prompt corrective action. To be categorized as “well capitalized,” TBK Bank must maintain minimum total risk based, common equity Tier 1 risk based, Tier 1 risk based, and Tier 1 leverage ratios as set forth in the table below. There are no conditions or events since September 30, 2020 that management believes have changed TBK Bank’s category. The actual capital amounts and ratios for the Company and TBK Bank are presented in the following table. (Dollars in thousands) Actual Minimum for Capital To Be Well September 30, 2020 Amount Ratio Amount Ratio Amount Ratio Total capital (to risk weighted assets) Triumph Bancorp, Inc. $ 689,050 12.9% $ 427,318 8.0% N/A N/A TBK Bank, SSB $ 624,406 11.9% $ 419,769 8.0% $ 524,711 10.0% Tier 1 capital (to risk weighted assets) Triumph Bancorp, Inc. $ 549,445 10.3% $ 320,065 6.0% N/A N/A TBK Bank, SSB $ 573,637 10.9% $ 315,763 6.0% $ 421,018 8.0% Common equity Tier 1 capital (to risk weighted assets) Triumph Bancorp, Inc. $ 464,501 8.7% $ 240,259 4.5% N/A N/A TBK Bank, SSB $ 573,637 10.9% $ 236,823 4.5% $ 342,077 6.5% Tier 1 capital (to average assets) Triumph Bancorp, Inc. $ 549,445 10.8% $ 203,498 4.0% N/A N/A TBK Bank, SSB $ 573,637 11.3% $ 203,057 4.0% $ 253,822 5.0% As of December 31, 2019 Total capital (to risk weighted assets) Triumph Bancorp, Inc. $ 604,832 12.8% $ 378,020 8.0% N/A N/A TBK Bank, SSB $ 555,213 12.0% $ 370,142 8.0% $ 462,678 10.0% Tier 1 capital (to risk weighted assets) Triumph Bancorp, Inc. $ 487,775 10.3% $ 284,141 6.0% N/A N/A TBK Bank, SSB $ 525,490 11.4% $ 276,574 6.0% $ 368,765 8.0% Common equity Tier 1 capital (to risk weighted assets) Triumph Bancorp, Inc. $ 448,209 9.5% $ 212,310 4.5% N/A N/A TBK Bank, SSB $ 525,490 11.4% $ 207,430 4.5% $ 299,621 6.5% Tier 1 capital (to average assets) Triumph Bancorp, Inc. $ 487,775 10.0% $ 195,110 4.0% N/A N/A TBK Bank, SSB $ 525,490 10.9% $ 192,840 4.0% $ 241,050 5.0% As permitted by the interim final rule issued on March 27, 2020 by the federal banking regulatory agencies, the Company has elected the option to delay the estimated impact on regulatory capital of ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”, which was effective January 1, 2020. The initial impact of adoption of ASU 2016-13 as well as 25% of the quarterly increases in the allowance for credit losses subsequent to adoption of ASU 2016-13 (collectively the “transition adjustments”) will be delayed for two years. After two years, the cumulative amount of the transition adjustments will become fixed and will be phased out of the regulatory capital calculations evenly over a three year period, with 75% recognized in year three, 50% recognized in year four, and 25% recognized in year five. After five years, the temporary regulatory capital benefits will be fully reversed. Dividends paid by TBK Bank are limited to, without prior regulatory approval, current year earnings and earnings less dividends paid during the preceding two years. The capital conservation buffer set forth by the Basel III regulatory capital framework was 2.5% at September 30, 2020 and December 31, 2019. The capital conservation buffer is designed to absorb losses during periods of economic stress and requires increased capital levels for the purpose of capital distributions and other payments. Failure to meet the full amount of the buffer will result in restrictions on the Company’s ability to make capital distributions, including dividend payments and stock repurchases, and to pay discretionary bonuses to executive officers. At September 30, 2020 and December 31, 2019, the Company’s and TBK Bank’s risk based capital exceeded the required capital conservation buffer.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Stockholders' Equity	STOCKHOLDERS’ EQUITY The following summarizes the capital structure of Triumph Bancorp, Inc. Preferred Stock Series C (Dollars in thousands, except per share amounts) September 30, 2020 Shares authorized 51,750 Shares issued 45,000 Shares outstanding 45,000 Par value per share $ 0.01 Liquidation preference per share $ 1,000 Liquidation preference amount $ 45,000 Dividend rate 7.125 % Dividend payment dates Quarterly There were no preferred shares issued or outstanding at December 31, 2019. Common Stock September 30, 2020 December 31, 2019 Shares authorized 50,000,000 50,000,000 Shares issued 27,932,671 27,163,642 Treasury shares (3,081,070) (2,198,681) Shares outstanding 24,851,601 24,964,961 Par value per share $ 0.01 $ 0.01 Preferred Stock Offering On June 19, 2020, the Company issued 45,000 shares of 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock, par value $0.01 per share, with a liquidation preference of $1,000 per share through an underwritten public offering of 1,800,000 depositary shares, each representing a 1/40t h ownership interest in a share of the Series C Preferred Stock. Total gross proceeds from the preferred stock offering were $45,000,000. Net proceeds after underwriting discounts and offering expenses were $42,364,000. The net proceeds will be used for general corporate purposes. Series C Preferred Stock holders are entitled to quarterly cash dividends accruing at the rate per annum of 7.125% beginning September 30, 2020, applied to the liquidation preference value of the stock. Any dividends not paid shall not accumulate but will be waived and not payable by the Company. Payments of dividends are subject to declaration by the board of the Company. The Series C Preferred Stock is not redeemable by the holder and is senior to the Company’s common stock. The Series C Preferred stock may be redeemed in whole or in part by the Company at liquidation value (i) on any dividend payment date on or after June 30, 2025 or (ii) within 90 days following a regulatory capital treatment event (as defined in the Statement of Designation), subject to regulatory approval. Stock Repurchase Programs During the three months ended March 31, 2020, the Company repurchased 871,319 shares into treasury stock under the Company’s stock repurchase program at an average price of $40.81, for a total of $35,600,000, effectively completing the $50,000,000 stock repurchase program authorized by the Company’s board of directors on October 16, 2019. No shares were repurchased during the three months ended September 30, 2020 or June 30, 2020 under a stock repurchase program. During the three and nine months ended September 30, 2019, the Company repurchased 850,093 shares into treasury stock under the Company’s stock repurchase program at an average price of $29.38 for a total of $24,972,000 and 1,688,234 shares at an average price of $29.56 for a total of $49,902,000, respectively.

Stock Based Compensation

Stock Based Compensation	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Stock Based Compensation	STOCK BASED COMPENSATION Stock based compensation expense that has been charged against income was $1,309,000 and $3,443,000 for the three and nine months ended September 30, 2020, respectively, and $1,058,000 and $2,794,000 for the three and nine months ended September 30, 2019, respectively. 2014 Omnibus Incentive Plan The Company’s 2014 Omnibus Incentive Plan (“Omnibus Incentive Plan”) provides for the grant of nonqualified and incentive stock options, stock appreciation rights, restricted stock awards, restricted stock units, and other awards that may be settled in, or based upon the value of, the Company’s common stock. The maximum number of shares of common stock available for issuance under the Omnibus Incentive Plan is 2,000,000 shares. Restricted Stock Awards A summary of changes in the Company’s nonvested Restricted Stock Awards (“RSAs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2020 were as follows: Nonvested RSAs Shares Weighted-Average Nonvested at January 1, 2020 148,349 31.86 Granted 138,417 26.54 Vested (75,103) 29.64 Forfeited (3,634) 31.07 Nonvested at September 30, 2020 208,029 29.14 RSAs granted to employees under the Omnibus Incentive Plan typically vest over three Restricted Stock Units A summary of changes in the Company’s nonvested Restricted Stock Units (“RSUs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2020 were as follows: Nonvested RSUs Shares Weighted-Average Nonvested at January 1, 2020 55,228 38.75 Granted 38,801 26.25 Vested — — Forfeited (4,316) 38.75 Nonvested at September 30, 2020 89,713 33.34 RSUs granted to employees under the Omnibus Incentive Plan vest after five years. Compensation expense for the RSUs will be recognized over the vesting period of the awards based on the fair value of the stock at the issue date. As of September 30, 2020, there was $1,872,000 of unrecognized compensation cost related to the nonvested RSUs. The cost is expected to be recognized over a remaining period of 2.58 years. Market Based Performance Stock Units A summary of changes in the Company’s nonvested Market Based Performance Stock Units (“Market Based PSUs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2020 were as follows: Nonvested Market Based PSUs Shares Weighted-Average Nonvested at January 1, 2020 67,707 $ 37.71 Granted 22,220 29.93 Vested — — Forfeited (4,316) 38.57 Nonvested at September 30, 2020 85,611 $ 35.65 Market Based PSUs granted to employees under the Omnibus Incentive Plan vest after three Nine Months Ended September 30, 2020 2019 Grant date May 1, 2020 May 1, 2019 Performance period 3.00 years 3.00 years Stock price $ 26.25 $ 30.82 Triumph stock price volatility 43.02 % 28.29 % Risk-free rate 0.25 % 2.25 % As of September 30, 2020, there was $1,786,000 of unrecognized compensation cost related to the nonvested Market Based PSUs. The cost is expected to be recognized over a remaining period of 2.46 years. Performance Based Performance Stock Units A summary of changes in the Company’s nonvested Performance Based Performance Stock Units (“Performance Based PSUs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2020 were as follows: Nonvested Performance Based PSUs Shares Weighted Average Nonvested at January 1, 2020 254,000 $ 38.02 Granted 10,125 26.25 Vested — — Forfeited (3,000) 38.02 Nonvested at September 30, 2020 261,125 $ 37.56 Performance Based PSUs granted to employees under the Omnibus Incentive Plan vest after three years. The number of shares issued upon vesting will range from 0% to 200% of the shares granted based on the Company’s cumulative diluted earnings per share over the performance period. Compensation expense for the Performance Based PSUs will be estimated each period based on the fair value of the stock at the grant date and the most probable outcome of the performance condition, adjusted for the passage of time within the vesting period of the awards. As of September 30, 2020, the maximum unrecognized compensation cost related to the nonvested Performance Based PSUs was $19,618,000, and the remaining performance period over which the cost could be recognized was 2.25 years. No compensation cost was recorded during the three and nine months ended September 30, 2020. Stock Options A summary of the changes in the Company’s stock options under the Omnibus Incentive Plan for the nine months ended September 30, 2020 were as follows: Stock Options Shares Weighted-Average Weighted-Average Aggregate Outstanding at January 1, 2020 225,055 $ 24.10 Granted 32,937 24.66 Exercised (743) 15.87 Forfeited or expired (443) 38.75 Outstanding at September 30, 2020 256,806 $ 24.18 6.82 $ 2,141 Fully vested shares and shares expected to vest at September 30, 2020 256,806 $ 24.18 6.82 $ 2,141 Shares exercisable at September 30, 2020 174,073 $ 21.48 6.06 $ 1,859 Information related to the stock options for the nine months ended September 30, 2020 and 2019 was as follows: Nine Months Ended September 30, (Dollars in thousands, except per share amounts) 2020 2019 Aggregate intrinsic value of options exercised $ 10 $ 148 Cash received from option exercises — — Tax benefit realized from option exercises 2 31 Weighted average fair value per share of options granted $ 8.85 $ 10.03 Stock options awarded to employees under the Omnibus Incentive Plan are generally granted with an exercise price equal to the market price of the Company’s common stock at the date of grant, vest over four years, and have ten year contractual terms. The fair value of stock options granted is estimated at the date of grant using the Black-Scholes option-pricing model. Expected volatilities were determined based on a blend of the Company’s historical volatility and historical volatilities of a peer group of companies with a similar size, industry, stage of life cycle, and capital structure. The expected term of the options granted was determined based on the SEC simplified method, which calculates the expected term as the mid-point between the weighted average time to vesting and the contractual term. The risk-free interest rate for the expected term of the options was derived from the Treasury constant maturity yield curve on the valuation date. The fair value of the stock options granted was determined using the following weighted-average assumptions: Nine Months Ended September 30, 2020 2019 Risk-free interest rate 0.46 % 2.33 % Expected term 6.25 years 6.25 years Expected stock price volatility 33.83 % 27.46 % Dividend yield — — As of September 30, 2020, there was $401,000 of unrecognized compensation cost related to nonvested stock options granted under the Omnibus Incentive Plan. The cost is expected to be recognized over a remaining period of 2.86 years. Employee Stock Purchase Plan On April 1, 2019, the Company’s Board of Directors adopted the Triumph Bancorp, Inc. 2019 Employee Stock Purchase Plan (“ESPP”) and reserved 2,500,000 shares of common stock for issuance. The ESPP was approved by the Company’s stockholders on May 16, 2019. The ESPP enables eligible employees to purchase the Company’s common stock at a price per share equal to 85% of the lower of the fair market value of the common stock at the beginning or end of each nine month offering period. The first offering period has not yet commenced.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Earnings Per Share	EARNINGS PER SHARE The factors used in the earnings per share computation follow: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Basic Net income to common stockholders $ 22,005 $ 14,317 $ 30,995 $ 41,835 Weighted average common shares outstanding 24,592,092 25,621,054 24,298,897 26,228,499 Basic earnings per common share $ 0.89 $ 0.56 $ 1.28 $ 1.60 Diluted Net income to common stockholders $ 22,005 $ 14,317 $ 30,995 $ 41,835 Weighted average common shares outstanding 24,592,092 25,621,054 24,298,897 26,228,499 Dilutive effects of: Assumed exercises of stock options 48,102 60,068 53,232 61,054 Restricted stock awards 67,907 45,631 65,893 40,572 Restricted stock units 18,192 3,045 15,198 57 Performance stock units - market based 76,095 4,673 30,995 1,558 Performance stock units - performance based — — — — Average shares and dilutive potential common shares 24,802,388 25,734,471 24,464,215 26,331,740 Diluted earnings per common share $ 0.89 $ 0.56 $ 1.27 $ 1.59 Shares that were not considered in computing diluted earnings per common share because they were antidilutive are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Stock options 98,513 67,023 98,513 67,023 Restricted stock awards — 3,209 — 3,209 Restricted stock units — — — 54,077 Performance stock units - market based — 55,228 — 55,228 Performance stock units - performance based 261,125 — 261,125 —

Business Segment Information

Business Segment Information	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Business Segment Information	BUSINESS SEGMENT INFORMATION The following table presents the Company’s operating segments. The accounting policies of the segments are the same as those described in the “Summary of Significant Accounting Policies” in Note 1 of the Company’s 2019 Form 10-K. Transactions between segments consist primarily of borrowed funds. Intersegment interest expense is allocated to the Factoring segment based on Federal Home Loan Bank advance rates. Credit loss expense is allocated based on the segment’s allowance for credit losses determination. Noninterest income and expense directly attributable to a segment are assigned to it. Taxes are paid on a consolidated basis but not allocated for segment purposes. The Factoring segment includes only factoring originated by TBC. General factoring services not originated through TBC are included in the Banking segment. (Dollars in thousands) Three months ended September 30, 2020 Banking Factoring Corporate Consolidated Total interest income $ 52,288 $ 30,068 $ 8 $ 82,364 Intersegment interest allocations 3,312 (3,312) — — Total interest expense 6,176 — 1,809 7,985 Net interest income (expense) 49,424 26,756 (1,801) 74,379 Credit loss expense (benefit) (3,417) 3,053 106 (258) Net interest income after credit loss expense 52,841 23,703 (1,907) 74,637 Other noninterest income 7,490 3,157 (154) 10,493 Noninterest expense 40,584 13,665 1,048 55,297 Operating income (loss) $ 19,747 $ 13,195 $ (3,109) $ 29,833 (Dollars in thousands) Three months ended September 30, 2019 Banking Factoring Corporate Consolidated Total interest income $ 54,266 $ 24,869 $ 280 $ 79,415 Intersegment interest allocations 2,918 (2,918) — — Total interest expense 13,091 — 1,559 14,650 Net interest income (expense) 44,093 21,951 (1,279) 64,765 Credit loss expense 2,019 846 — 2,865 Net interest income after credit loss expense 42,074 21,105 (1,279) 61,900 Noninterest income 6,401 1,291 50 7,742 Noninterest expense 38,371 12,792 990 52,153 Operating income (loss) $ 10,104 $ 9,604 $ (2,219) $ 17,489 (Dollars in thousands) Nine months ended September 30, 2020 Banking Factoring Corporate Consolidated Total interest income $ 157,957 $ 73,952 $ 267 $ 232,176 Intersegment interest allocations 8,873 (8,873) — — Total interest expense 25,368 — 5,678 31,046 Net interest income (expense) 141,462 65,079 (5,411) 201,130 Credit loss expense 27,378 4,437 1,834 33,649 Net interest income after credit loss expense 114,084 60,642 (7,245) 167,481 Gain on sale of subsidiary or division 9,758 — — 9,758 Other noninterest income 22,586 5,524 131 28,241 Noninterest expense 122,001 37,695 3,080 162,776 Operating income (loss) $ 24,427 $ 28,471 $ (10,194) $ 42,704 (Dollars in thousands) Nine months ended September 30, 2019 Banking Factoring Corporate Consolidated Total interest income $ 155,645 $ 73,435 $ 902 $ 229,982 Intersegment interest allocations 8,188 (8,188) — — Total interest expense 35,746 — 4,741 40,487 Net interest income (expense) 128,087 65,247 (3,839) 189,495 Credit loss expense (benefit) 5,847 1,789 (76) 7,560 Net interest income after credit loss expense 122,240 63,458 (3,763) 181,935 Noninterest income 19,150 3,572 181 22,903 Noninterest expense 109,406 39,340 2,677 151,423 Operating income (loss) $ 31,984 $ 27,690 $ (6,259) $ 53,415 (Dollars in thousands) September 30, 2020 Banking Factoring Corporate Eliminations Consolidated Total assets $ 5,767,857 $ 1,042,571 $ 828,065 $ (1,801,706) $ 5,836,787 Gross loans $ 4,759,135 $ 948,987 $ 800 $ (856,011) $ 4,852,911 (Dollars in thousands) December 31, 2019 Banking Factoring Corporate Eliminations Consolidated Total assets $ 4,976,009 $ 662,002 $ 771,048 $ (1,348,762) $ 5,060,297 Gross loans $ 4,108,735 $ 573,372 $ 1,519 $ (489,114) $ 4,194,512

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Nature of Operations	Nature of Operations Triumph Bancorp, Inc. (collectively with its subsidiaries, “Triumph”, or the “Company” as applicable) is a financial holding company headquartered in Dallas, Texas. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries Triumph CRA Holdings, LLC (“TCRA”), TBK Bank, SSB (“TBK Bank”), TBK Bank’s wholly owned subsidiary Advance Business Capital LLC, which currently operates under the d/b/a of Triumph Business Capital (“TBC”), and TBK Bank’s wholly owned subsidiary Triumph Insurance Group, Inc. (“TIG”). On June 30, 2020, the Company sold the assets of Triumph Premium Finance (“TPF”) and exited its premium finance line of business. TPF operated within the Company’s TBK Bank subsidiary. See Note 2 – Business Combinations and Divestitures for details of the TPF sale and its impact on our consolidated financial statements.
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”) for interim financial information and in accordance with guidance provided by the Securities and Exchange Commission (“SEC”). Accordingly, the condensed financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal and recurring adjustments considered necessary for a fair presentation. Transactions between the subsidiaries have been eliminated. These condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. The Company has three reportable segments consisting of Banking, Factoring, and Corporate. The Company’s Chief Executive Officer uses segment results to make operating and strategic decisions.
Risks and Uncertainties	Risks and Uncertainties The outbreak of COVID-19 has adversely impacted a broad range of industries in which the Company’s customers operate and could impair their ability to fulfill their financial obligations to the Company. The Company’s business is dependent upon the willingness and ability of its employees and customers to conduct banking and other financial transactions. If the global response to contain COVID-19 escalates further or is unsuccessful, the Company could experience further material adverse effects on its business, financial condition, results of operations and cash flows. While it is not possible to know the full universe or extent that the impact of COVID-19, and resulting measures to curtail its spread, will have on the Company’s operations, the Company is disclosing potentially material items of which it is aware. Financial position and results of operations In keeping with guidance from regulators, the Company continues to actively work with COVID-19 affected customers. During the second quarter of 2020 we waived fees from a variety of sources, such as, but not limited to, insufficient funds and overdraft fees, ATM fees, account maintenance fees, etc. These reductions in fees were temporary and expired on June 1, 2020 resulting in a decrease in service charges on deposits fee income for the nine months ended September 30, 2020 compared to the same period during 2019. Should the pandemic and the global response escalate further, it is possible that the Company could reduce such fees in future periods; however, at this time, the Company is unable to project the materiality of such an impact on the results of operations in future periods. The Company’s interest income could be reduced due to COVID-19. In keeping with guidance from regulators, the Company continues to work with COVID-19 affected borrowers to defer their payments, interest, and fees. While interest and fees continue to accrue to income, through normal GAAP accounting, should eventual credit losses on these deferred payments emerge, the related loans would be placed on nonaccrual status and interest income and fees accrued would be reversed. In such a scenario, interest income in future periods could be negatively impacted. As of September 30, 2020 the Company has recognized $695,000 of accrued interest income and fees on outstanding deferrals made to COVID-19 affected borrowers. At this time, the Company is unable to project the materiality of such an impact on future deferrals to COVID-19 affected borrowers, but recognizes the breadth of the economic impact may affect its borrowers’ ability to repay in future periods. Capital and liquidity Our reported and regulatory capital ratios could be adversely impacted by further credit loss expense. We rely on cash on hand as well as dividends from our subsidiary bank to service our debt. If our capital deteriorates such that our subsidiary bank is unable to pay dividends to us for an extended period of time, we may not be able to service our debt. We maintain access to multiple sources of liquidity. Wholesale funding markets have remained open to us, but rates for short term funding have recently been volatile. If funding costs are elevated for an extended period of time, it could have an adverse effect on our net interest margin. If an extended recession caused large numbers of our deposit customers to withdraw their funds, we might become more reliant on volatile or more expensive sources of funding. Asset valuation COVID-19 could cause a decline in the Company’s stock price or the occurrence of what management would deem to be a triggering event that could, under certain circumstances, cause us to perform a goodwill impairment test and result in an impairment charge being recorded for that period. In the event that the Company concludes that all or a portion of its goodwill is impaired, a non-cash charge for the amount of such impairment would be recorded to earnings. Such a charge would have no impact on tangible capital or regulatory capital. It is possible that the lingering effects of COVID-19 could cause the occurrence of what management would deem to be a triggering event that could, under certain circumstances, cause us to perform an intangible asset impairment test and result in an impairment charge being recorded for that period. In the event that the Company concludes that all or a portion of its intangible assets are impaired, a non-cash charge for the amount of such impairment would be recorded to earnings. Such a charge would have no impact on tangible capital or regulatory capital. Lending operations and accommodations to borrowers In keeping with regulatory guidance to work with borrowers during this unprecedented situation and as outlined in the Section 4013 of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) , the Company is executing a payment deferral program for its commercial lending clients that are adversely affected by the pandemic. Depending on the demonstrated need of the client, the Company is deferring either the full loan payment or the principal component of the loan payment for 60 or 90 days. As of September 30, 2020, the Company’s balance sheet reflected 77 of these deferrals on outstanding loan balances of $102,987,000. In accordance with the CARES Act and March 2020 interagency guidance, these short term deferrals are not considered troubled debt restructurings. It is possible that these deferrals could be extended further under the CARES Act; however, the volume of these future potential extensions is unknown. It is also possible that in spite of our best efforts to assist our borrowers and achieve full collection of our investment, these deferred loans could result in future charge-offs with additional credit loss expense charged to earnings; however, the amount of any future charge-offs on deferred loans is unknown. With the passage of the Paycheck Protection Program (“PPP”), administered by the Small Business Administration (“SBA”), the Company has actively participated in assisting its customers with applications for resources through the program. PPP loans have two-year and five-year terms and earn interest at a 1% coupon. The Company believes that the majority of these loans will ultimately be forgiven by the SBA in accordance with the terms of the program. As of September 30, 2020, the Company carried 2,080 PPP loans representing a book value of $223,000,000. The Company has received approximately $7,700,000 in total fees from the SBA, $2,600,000 of which were recognized in interest income and fees during the nine months ended September 30, 2020. The remaining fees will be amortized and recognized over the remaining lives of the loans. It is the Company’s understanding that loans funded through the PPP program are fully guaranteed by the U.S. government. Should those circumstances change, the Company could be required to establish an allowance for credit loss through additional credit loss expense charged to earnings. Credit The Company is working with customers directly affected by COVID-19. The Company is prepared to offer short-term assistance in accordance with regulator guidelines. As a result of the current economic environment caused by the COVID-19 virus, the Company is engaging in more frequent communication with borrowers to better understand their situation and the challenges faced, allowing it to respond proactively as needs and issues arise. Should economic conditions worsen, the Company could experience further increases in its required allowance for credit losses (“ACL”) and record additional credit loss expense. It is possible that the Company’s asset quality measures could worsen at future measurement periods if the effects of COVID-19 are prolonged. Held to Maturity Securities At September 30, 2020, we held $8,057,000 in subordinated notes of three CLO securities managed by our former subsidiary. These securities are the junior-most in securitization capital structures, and are subject to suspension of distributions if the credit of the underlying loan portfolios deteriorates materially. During the nine months ended September 30, 2020, pandemic-related downgrades and default activity caused overcollateralization triggers to be tripped on two of the three CLO investments which had a material impact on expected cash flows used to calculate the ACL. The required ACL on these balances was $1,961,000 September 30, 2020 resulting in $1,835,000 of credit loss expense recognized during the nine months ended September 30, 2020. Ultimately, the realized cash flows on CLO securities such as these will be driven by a variety of factors, including credit performance of the underlying loan portfolio, adjustments to the portfolio by the asset manager, and the timing of a potential call. Thus, we may not receive the full amount of cash distributions we expect to receive, which would cause us to record additional allowance for credit losses with a corresponding charge to credit loss expense through earnings. As of September 30, 2020, the Company’s held to maturity securities were classified as nonaccrual. Transportation The Company’s transportation businesses may be affected by COVID-19 and the volatility in oil prices. The global supply disruption from China and Mexico, in combination with the U.S. supply chain challenges due to business disruptions and an overall decrease in consumer demand could have a material impact on freight volumes in the U.S., which could impact our factoring and transportation lending operations in future periods; however, the ultimate impact is unknown.
Debt Securities	Debt Securities The Company determines the classification of debt securities at the time of purchase. Debt securities that management has the positive intent and ability to hold to maturity are classified as held to maturity and recorded at amortized cost. Trading securities are recorded at fair value with changes in fair value included in earnings. Debt securities not classified as held to maturity or trading are classified as available for sale and recorded at fair value, with unrealized gains and losses excluded from earnings and reported in other comprehensive income (loss), net of tax. Gains and losses on the sale of securities are recorded on the trade date and are determined using the specific-identification method. Amortization of premiums and discounts are recognized in interest income over the period to maturity using the interest method, except for premiums on callable debt securities, which are amortized to their earliest call date. The Company has made a policy election to exclude accrued interest from the amortized cost basis of debt securities and report accrued interest separately in other assets in the consolidated balance sheets. A debt security is placed on nonaccrual status at the time any principal or interest payments become more than 90 days delinquent or if full collection of interest or principal becomes uncertain. Accrued interest for a security placed on nonaccrual is reversed against interest income. There was no accrued interest related to debt securities reversed against interest income for the three and nine months ended September 30, 2020 and 2019.
Allowance for Credit Losses-Available for Sale Securities	Allowance for Credit Losses – Available for Sale Securities For available for sale debt securities in an unrealized loss position, the Company evaluates the securities to determine whether the decline in the fair value below the amortized cost basis (impairment) is due to credit-related factors or noncredit-related factors. Any impairment that is not credit related is recognized in other comprehensive income, net of applicable taxes. Credit-related impairment is recognized as an allowance for credit losses (“ACL”) on the balance sheet, limited to the amount by which the amortized cost basis exceeds the fair value, with a corresponding adjustment to earnings. Both the ACL and the adjustment to net income may be reversed if conditions change. However, if the Company intends to sell an impaired available for sale debt security or more likely than not will be required to sell such a security before recovering its amortized cost basis, the entire impairment amount must be recognized in earnings with a corresponding adjustment to the security’s amortized cost basis. Because the security’s amortized cost basis is adjusted to fair value, there is no ACL in this situation. In evaluating available for sale debt securities in unrealized loss positions for impairment and the criteria regarding its intent or requirement to sell such securities, the Company considers the extent to which fair value is less than amortized cost, whether the securities are issued by the federal government or its agencies, whether downgrades by bond rating agencies have occurred, and the results of reviews of the issuers’ financial condition, among other factors. Changes in the allowance for credit losses are recorded as provision for (or reversal of) credit loss expense. Losses are charged against the ACL when management believes the uncollectability of an available for sale debt security is confirmed or when either of the criteria regarding intent or requirement to sell is met. Accrued interest receivable is excluded from the estimate of credit losses.
Allowance for Credit Losses-Held to Maturity Securities	Allowance for Credit Losses – Held to Maturity Securities The allowance for credit losses on held to maturity securities is estimated on a collective basis by major security type. At September 30, 2020 and December 31, 2019, the Company’s held to maturity securities consisted of investments in the subordinated notes of collateralized loan obligation (“CLO”) funds. Expected credit losses for these securities are estimated using a discounted cash flow methodology which considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Accrued interest receivable is excluded from the estimate of credit losses.
Loans	Loans Loans that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are reported at their amortized cost basis, which is the unpaid principal balance outstanding, net of unearned income, deferred loan fees and costs, premiums and discounts associated with acquisition date fair value adjustments on acquired loans, and any direct principal charge-offs. The Company has made a policy election to exclude accrued interest from the amortized cost basis of loans and report accrued interest separately from the related loan balance in other assets on consolidated balance sheets. Interest income is accrued on the unpaid principal balance. Loan origination fees, net of certain direct origination costs, are deferred and recognized in interest income over the remaining life of the loan without anticipating prepayments. Loans are considered past due or delinquent when the contractual principal or interest due in accordance with the terms of the loan agreement or any portion thereof remains unpaid after the due date of the scheduled payment. Loans are classified as nonaccrual when, in the opinion of management, collection of principal or interest is doubtful. The accrual of interest income on loans is typically discontinued at the time the loan is 90 days delinquent unless the loan is well-secured and in process of collection, or if full collection of interest or principal becomes uncertain. Consumer loans are typically charged off no later than 120 days past due. All interest accrued but not received for a loan placed on nonaccrual is reversed against interest income. Interest received on such loans is accounted for on the cash-basis or cost recovery method, until qualifying for return to accrual. Under the cost-recovery method, interest income is not recognized until the loan balance is reduced to zero. Under the cash basis method, interest income is recorded when the payment is received in cash. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured. Factored Receivables The Company purchases invoices from its factoring clients in schedules or batches. To a much lesser extent, the Company will also make short-term advances to its clients on transportation contracts for upcoming loads. Cash is advanced to the client to the extent of the applicable advance rate, less fees, as set forth in the individual factoring agreements. The face value of the invoices purchased or amount advanced is recorded by the Company as factored receivables, and the unadvanced portions of the invoices purchased, less fees, are considered client reserves. The client reserves are held to settle any payment disputes or collection shortfalls, may be used to pay clients’ obligations to various third parties as directed by the client, are periodically released to or withdrawn by clients, and are reported as deposits in the consolidated balance sheets. Unearned factoring fees and unearned net origination fees are deferred and recognized over the weighted average collection period for each client. Subsequent factoring fees are recognized in interest income as incurred by the client and deducted from the clients’ reserve balances. Other factoring-related fees, which include wire transfer fees, carrier payment fees, fuel advance fees, and other similar fees, are reported by the Company as non-interest income as incurred by the client. Acquired Loans Acquired loans are recorded at fair value at the date of acquisition based on a discounted cash flow methodology that considers various factors including the type of loan and related collateral, classification status, fixed or variable interest rate, term of loan and whether or not the loan was amortizing, and a discount rate reflecting the Company’s assessment of risk inherent in the cash flow estimates. Certain larger purchased loans are individually evaluated while certain purchased loans are grouped together according to similar risk characteristics and are treated in the aggregate when applying various valuation techniques. These cash flow evaluations are inherently subjective as they require material estimates, all of which may be susceptible to significant change. Prior to January 1, 2020, loans acquired in a business combination that had evidence of deterioration of credit quality since origination and for which it was probable, at acquisition, that the Company would be unable to collect all contractually required payments receivable were considered purchased credit impaired (“PCI”). PCI loans were individually evaluated and recorded at fair value at the date of acquisition with no initial valuation allowance based on a discounted cash flow methodology that considered various factors including the type of loan and related collateral, classification status, fixed or variable interest rate, term of loan and whether or not the loan was amortizing, and a discount rate reflecting the Company’s assessment of risk inherent in the cash flow estimates. The difference between the undiscounted cash flows expected at acquisition and the investment in the loan, or the “accretable yield,” was recognized as interest income on a level-yield method over the life of the loan. Contractually required payments for interest and principal that exceed the undiscounted cash flows expected at acquisition, or the “nonaccretable difference,” were not recognized on the balance sheet and did not result in any yield adjustments, loss accruals or valuation allowances. Increases in expected cash flows, including prepayments, subsequent to the initial investment were recognized prospectively through adjustment of the yield on the loan over its remaining life. Decreases in expected cash flows were recognized as impairment. Valuation allowances on PCI loans reflected only losses incurred after the acquisition (meaning the present value of all cash flows expected at acquisition that ultimately were not to be received). Subsequent to January 1, 2020, loans acquired in a business combination that have experienced more-than-insignificant deterioration in credit quality since origination are considered purchased credit deteriorated (“PCD”) loans. At the acquisition date, an estimate of expected credit losses is made for groups of PCD loans with similar risk characteristics and individual PCD loans without similar risk characteristics. This initial allowance for credit losses is allocated to individual PCD loans and added to the purchase price or acquisition date fair values to establish the initial amortized cost basis of the PCD loans. As the initial allowance for credit losses is added to the purchase price, there is no credit loss expense recognized upon acquisition of a PCD loan. Any difference between the unpaid principal balance of PCD loans and the amortized cost basis is considered to relate to noncredit factors and results in a discount or premium. Discounts and premiums are recognized through interest income on a level-yield method over the life of the loans. All loans considered to be PCI prior to January 1, 2020 were converted to PCD on that date. For acquired loans not deemed purchased credit deteriorated at acquisition, the differences between the initial fair value and the unpaid principal balance are recognized as interest income on a level-yield basis over the lives of the related loans. At the acquisition date, an initial allowance for expected credit losses is estimated and recorded as credit loss expense. The subsequent measurement of expected credit losses for all acquired loans is the same as the subsequent measurement of expected credit losses for originated loans.
Allowance for Credit Losses-Loans	Allowance for Credit Losses – Loans Under the current expected credit loss model, the allowance for credit losses on loans is a valuation allowance estimated at each balance sheet date in accordance with US GAAP that is deducted from the loans’ amortized cost basis to present the net amount expected to be collected on the loans. The Company estimates the ACL on loans based on the underlying assets’ amortized cost basis, which is the amount at which the financing receivable is originated or acquired, adjusted for applicable accretion or amortization of premium, discount, and net deferred fees or costs, collection of cash, and charge-offs. In the event that collection of principal becomes uncertain, the Company has policies in place to reverse accrued interest in a timely manner. Therefore, the Company has made a policy election to exclude accrued interest from the measurement of ACL. Expected credit losses are reflected in the allowance for credit losses through a charge to credit loss expense. When the Company deems all or a portion of a financial asset to be uncollectible the appropriate amount is written off and the ACL is reduced by the same amount. The Company applies judgment to determine when a financial asset is deemed uncollectible; however, generally speaking, an asset will be considered uncollectible no later than when all efforts at collection have been exhausted. Subsequent recoveries, if any, are credited to the ACL when received. The Company measures expected credit losses of financial assets on a collective (pool) basis, when the financial assets share similar risk characteristics. Depending on the nature of the pool of financial assets with similar risk characteristics, the Company uses a discounted cash flow (“DCF”) method or a loss-rate method to estimate expected credit losses. The Company’s methodologies for estimating the ACL consider available relevant information about the collectability of cash flows, including information about past events, current conditions, and reasonable and supportable forecasts. The methodologies apply historical loss information, adjusted for asset-specific characteristics, economic conditions at the measurement date, and forecasts about future economic conditions expected to exist through the contractual lives of the financial assets that are reasonable and supportable, to the identified pools of financial assets with similar risk characteristics for which the historical loss experience was observed. The Company’s methodologies revert back to historical loss information on a straight line basis over eight quarters when it can no longer develop reasonable and supportable forecasts. The Company has identified the following pools of financial assets with similar risk characteristics for measuring expected credit losses: Commercial Real Estate — This category of loans consists of the following loan types: Non-farm Non-residential — This category includes real estate loans for a variety of commercial property types and purposes, including owner occupied commercial real estate loans primarily secured by commercial office or industrial buildings, warehouses or retail buildings where the owner of the building occupies the property. Repayment terms vary considerably, interest rates are fixed or variable, and are structured for full, partial, or no amortization of principal. This category also includes investment real estate loans that are primarily secured by office and industrial buildings, warehouses, small retail shopping centers and various special purpose properties. Generally, these types of loans are thought to involve a greater degree of credit risk than owner occupied commercial real estate as they are more sensitive to adverse economic conditions. Multi-family residential — Investment real estate loans are primarily secured by non-owner occupied apartment or multifamily residential buildings. Generally, these types of loans are thought to involve a greater degree of credit risk than owner occupied commercial real estate as they are more sensitive to adverse economic conditions. Construction, land development, land —This category of loans consists of loans to finance the ground up construction, improvement and/or carrying for sale after the completion of construction of owner occupied and non-owner occupied residential and commercial properties, and loans secured by raw or improved land. The repayment of construction loans is generally dependent upon the successful completion of the improvements by the builder for the end user, or sale of the property to a third party. Repayment of land secured loans are dependent upon the successful development and sale of the property, the sale of the land as is, or the outside cash flow of the owners to support the retirement of the debt. 1-4 family residential — This category of loans includes both first and junior liens on residential real estate. Home equity revolving lines of credit and home equity term loans are included in this group of loans. Farmland — These loans are principally loans to purchase farmland. Commercial — Commercial loans are loans for commercial, corporate and business purposes. The Company’s commercial business loan portfolio is comprised of loans for a variety of purposes and across a variety of industries. These loans include general commercial and industrial loans, loans to purchase capital equipment, agriculture operating loans and other business loans for working capital and operational purposes. Commercial loans are generally secured by accounts receivable, inventory and other business assets. A portion of the commercial loan portfolio consists of specialty commercial finance products as follows: Equipment — Equipment finance loans are commercial loans primarily secured by new or used revenue producing, essential-use equipment from major manufacturers that is movable, may be used in more than one type of business, and generally has broad resale markets. Core markets include transportation, construction, and waste. Loan terms do not exceed the economic life of the equipment and typically are 60 months or less . Asset-based Lending — These loans are originated to borrowers to support general working capital needs. The asset-based loan structure involves advances of loan proceeds against a borrowing base which typically consists of accounts receivable, identified readily marketable inventory, or other collateral of the borrower. The maximum amount a customer may borrow at any time is fixed as a percentage of the borrowing base outstanding. A portion of the commercial loan portfolio also consists of the following national lending product: Liquid Credit — Broadly syndicated leveraged loans secured by a variety of collateral types. Factored Receivables — The Company operates as a factor by purchasing accounts receivable from its clients, then collecting the receivable from the account debtor. The Company’s smaller factoring relationships are typically structured as “non-recourse” relationships ( i.e. , the Company retains the credit risk associated with the ability of the account debtor on a purchased invoice to ultimately make payment) and the Company’s larger factoring relationships are typically structured as “recourse” relationships ( i.e. , the Company’s client agrees to repurchase any invoices for which payment is not ultimately received from the account debtor). Advances initially made to the client to acquire the receivables are typically at a discount to the invoice value. The discount balance is held in client reserves, net of the Company’s compensation. The client reserves are held to settle any payment disputes or collection shortfalls, may be used to pay clients’ obligations to various third parties as directed by the client, are periodically released to or withdrawn by clients, and are reported as deposits. Consumer — Loans used for personal use, typically on an unsecured basis, and client overdrafts. Mortgage Warehouse — Mortgage Warehouse facilities are provided to unaffiliated mortgage origination companies and are collateralized by 1-4 family residential loans. The originator closes new mortgage loans with the intent to sell these loans to third party investors for a profit. The Company provides funding to the mortgage companies for the period between the origination and their sale of the loan. The Company has a policy that requires that it separately validate that each residential mortgage loan was underwritten consistent with the underwriting requirements of the final investor or market standards prior to advancing funds. The Company is repaid with the proceeds received from sale of the mortgage loan to the final investor. Discounted Cash Flow Method The Company uses the discounted cash flow method to estimate expected credit losses for the commercial real estate, construction, land development, land, 1-4 family residential, commercial (excluding liquid credit), and consumer loan pools. For each of these loan segments, the Company generates cash flow projections at the instrument level wherein payment expectations are adjusted for estimated prepayment speed, curtailments, time to recovery, probability of default, and loss given default. The modeling of expected prepayment speeds, curtailment rates, and time to recovery are based on historical internal data. The Company uses regression analysis of historical internal and peer data to determine suitable loss drivers to utilize when modeling lifetime probability of default and loss given default. This analysis also determines how expected probability of default and loss given default will react to forecasted levels of the loss drivers. For all loan pools utilizing the DCF method, management utilizes and forecasts national unemployment as a loss driver. Management also utilizes and forecasts either one-year percentage change in national retail sales, one-year percentage change in the national home price index, or one-year percentage change in national gross domestic product as a second loss driver depending on the nature of the underlying loan pool and how well that loss driver correlates to expected future losses. For all DCF models, management has determined that four quarters represents a reasonable and supportable forecast period and reverts back to a historical loss rate over eight quarters on a straight-line basis. Management leverages economic projections from a reputable and independent third party to inform its loss driver forecasts over the four-quarter forecast period. Other internal and external indicators of economic forecasts are also considered by management when developing the forecast metrics. The combination of adjustments for credit expectations (default and loss) and timing expectations (prepayment, curtailment, and time to recovery) produces an expected cash flow stream at the instrument level. Instrument effective yield is calculated, net of the impacts of prepayment assumptions, and the instrument expected cash flows are then discounted at that effective yield to produce an instrument-level net present value of expected cash flows (“NPV”). An ACL is established for the difference between the instrument’s NPV and amortized cost basis. Loss-Rate Method The Company uses a loss-rate method to estimate expected credit losses for the farmland, liquid credit, premium finance, factored receivable, and mortgage warehouse loan pools. For each of these loan segments, the Company applies an expected loss ratio based on internal and peer historical losses adjusted as appropriate for qualitative factors. Qualitative loss factors are based on management's judgment of company, market, industry or business specific data, changes in underlying loan composition of specific portfolios, trends relating to credit quality, delinquency, non-performing and adversely rated loans, and reasonable and supportable forecasts of economic conditions. Collateral Dependent Financial Assets Loans that do not share risk characteristics are evaluated on an individual basis. For collateral dependent financial assets where the Company has determined that foreclosure of the collateral is probable, or where the borrower is experiencing financial difficulty and the Company expects repayment of the financial asset to be provided substantially through the operation or sale of the collateral, the ACL is measured based on the difference between the fair value of the collateral and the amortized cost basis of the asset as of the measurement date. When repayment is expected to be from the operation of the collateral, expected credit losses are calculated as the amount by which the amortized cost basis of the financial asset exceeds the present value of expected cash flows from the operation of the collateral. When repayment is expected to be from the sale of the collateral, expected credit losses are calculated as the amount by which the amortized costs basis of the financial asset exceeds the fair value of the underlying collateral less estimated cost to sell. The ACL may be zero if the fair value of the collateral at the measurement date exceeds the amortized cost basis of the financial asset. The Company’s estimate of the ACL reflects losses expected over the remaining contractual life of the assets. The contractual term does not consider extensions, renewals or modifications unless the Company has identified an expected troubled debt restructuring. A loan that has been modified or renewed is considered a troubled debt restructuring (“TDR”) when two conditions are met: 1) the borrower is experiencing financial difficulty and 2) concessions are made for the borrower's benefit that would not otherwise be considered for a borrower or transaction with similar credit risk characteristics. The Company’s ACL reflects all effects of a TDR when an individual asset is specifically identified as a reasonably expected TDR. The Company has determined that a TDR is reasonably expected no later than the point when the lender concludes that modification is the best course of action and it is at least reasonably possible that the troubled borrower will accept some form of concession from the lender to avoid a default. Reasonably expected TDRs and executed non-performing TDRs are evaluated individually to determine the required ACL. TDRs performing in accordance with their modified contractual terms for a reasonable period of time may be included in the Company’s existing pools based on the underlying risk characteristics of the loan to measure the ACL. Paycheck Protection Program With the passage of the PPP, the Company has actively participated in assisting its customers with applications for loans through the program. Loans funded through the PPP program are fully guaranteed by the U.S. government subject to certain representations and warranties. This guarantee exists at the inception of the loans and throughout the lives of the loans and was not entered into separately and apart from the loans. ASC 326 requires credit enhancements that mitigate credit losses, such as the U.S. government guarantee on PPP loans, to be considered in estimating credit losses. The guarantee is considered “embedded” and, therefore, is considered when estimating credit loss on the PPP loans. Given that the loans are fully guaranteed by the U.S. government and absent any specific loss information on any of our PPP loans, the Company does not carry an ACL on its PPP loans at September 30, 2020.
Loan Commitments and Allowance for Credit Losses on Off-Balance Sheet Credit Exposures	Loan Commitments and Allowance for Credit Losses on Off-Balance Sheet Credit Exposures Financial instruments include off-balance sheet credit instruments, such as commitments to make loans, commitments to purchase broadly syndicated loans, and commercial letters of credit, issued to meet customer financing needs. The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for off-balance sheet loan commitments is represented by the contractual amount of those instruments. Such financial instruments are recorded when they are funded.
Derivatives Financial Instruments	Derivative Financial Instruments The Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. At September 30, 2020, the Company had one cash flow hedge position and no fair value or foreign currency hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. To qualify for the use of hedge accounting, a derivative must be effective at inception and expected to be continuously effective in offsetting the risk being hedged. A statistical regression analysis is performed at inception and at each reporting period thereafter to evaluate hedge effectiveness. In accordance with the FASB’s fair value measurement guidance, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Adoption of New Accounting Standards	Adoption of New Accounting Standards In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 makes significant changes to the accounting for credit losses on financial instruments presented on an amortized cost basis and disclosures about them. The new current expected credit loss (“CECL”) impairment model requires an estimate of expected credit losses, measured over the contractual life of an instrument, which considers reasonable and supportable forecasts of future economic conditions in addition to information about past events and current conditions. The standard provides significant flexibility and requires a high degree of judgment with regards to pooling financial assets with similar risk characteristics and adjusting the relevant historical loss information in order to develop an estimate of expected lifetime losses. ASU 2016-13 permits the use of estimation techniques that are practical and relevant to the Company’s circumstances, as long as they are applied consistently over time and faithfully estimate expected credit losses in accordance with the standard. The ASU lists several common credit loss methods that are acceptable such as a discounted cash flow (“DCF”) method, loss-rate method and roll-rate method. In addition, ASU 2016-13 amends the accounting for credit losses on debt securities and purchased financial assets with credit deterioration. The Company adopted ASU 2016-13 on January 1, 2020 using the modified retrospective approach. Results for the periods beginning after January 1, 2020 are presented under Accounting Standards Codification (“ASC”) 326 while prior period amounts continue to be reported in accordance with previously applicable US GAAP. The Company recorded a net reduction of retained earnings of $1,771,000 upon adoption. The transition adjustment includes an increase in the allowance for credit losses on loans of $269,000, an increase in the allowance for credit losses on held to maturity debt securities of $126,000, and an increase in the allowance for credit losses on off-balance sheet credit exposures of $1,918,000, net of the corresponding increases in deferred tax assets of $542,000. The Company adopted ASU 2016-13 using the prospective transition approach for financial assets purchased with credit deterioration (“PCD”) that were previously classified as purchased credit impaired (“PCI”) and accounted for under ASC 310-30. In accordance with the standard, the Company did not reassess whether PCI assets met the criteria of PCD assets as of the date of adoption. The remaining discount on the PCD assets was determined to be related to noncredit factors and will be accreted into interest income on a level-yield method over the life of the loans. In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other (Topic 350) - Simplifying the Test for Goodwill Impairment” (“ASU 2017-04”). ASU 2017-04 simplifies the accounting for goodwill impairment for all entities by requiring impairment charges to be based on the first step in the previous two-step impairment test. Under the new guidance, if a reporting unit’s carrying amount exceeds its fair value, an entity will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard eliminates the prior requirement to calculate a goodwill impairment charge using Step 2, which requires an entity to calculate any impairment charge by comparing the implied fair value of goodwill with its carrying amount. ASU 2017-04 was effective for the Company on January 1, 2020 and did not have a material impact on the Company’s financial statements. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820) - Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 modifies the disclosure requirements on fair value measurements by requiring that Level 3 fair value disclosures include the range and weighted average of significant unobservable inputs used to develop those fair value measurements. For certain unobservable inputs, an entity may disclose other quantitative information in lieu of the weighted average if the entity determines that other quantitative information would be a more reasonable and rational method to reflect the distribution of unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 was effective for the Company on January 1, 2020 and did not have a material impact on the Company’s financial statement disclosures. In August 2018, the FASB issued ASU 2018-15, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) - Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by these amendments. ASU 2018-15 was effective for the Company on January 1, 2020 and did not have a material impact on the Company’s financial statements. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. Section 4013 of the CARES Act, “Temporary Relief From Troubled Debt Restructurings,” provides banks the option to temporarily suspend certain requirements under U.S. GAAP related to troubled debt restructurings (“TDR”) for a limited period of time to account for the effects of COVID-19. To qualify for Section 4013 of the CARES Act, borrowers must have been current at December 31, 2019. All modifications are eligible so long as they are executed between March 1, 2020 and the earlier of (i) December 31, 2020, or (ii) the 60th day after the end of the COVID-19 national emergency declared by the President of the U.S. Multiple modifications of the same credits are allowed and there is no cap on the duration of the modification. See Note 4 of the condensed footnotes to the consolidated financial statements for disclosure of the impact to date. In March 2020, various regulatory agencies, including the Board of Governors of the Federal Reserve System and the Federal Deposit Insurance Corporation, (“the agencies”) issued an interagency statement on loan modifications and reporting for financial institutions working with customers affected by the Coronavirus. The interagency statement was effective immediately and impacted accounting for loan modifications. Under Accounting Standards Codification 310-40, “Receivables – Troubled Debt Restructurings by Creditors,” (“ASC 310-40”), a restructuring of debt constitutes a troubled debt restructuring (“TDR”) if the creditor, for economic or legal reasons related to the debtor’s financial difficulties, grands a concession to the debtor that it would not otherwise consider. The agencies confirmed with the staff of the FASB that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief, are not to be considered TDRs. This includes short-term (e.g., six months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. Borrowers considered current are those that are less than 30 days past due on their contractual payments at the time a modification program is implemented. Almost all of the Company’s modifications fall under Section 4013 of the CARES Act and thus, the interagency statement has had very little impact on the Company to date.

Business Combinations and Div_2

Business Combinations and Divestitures (Tables)	9 Months Ended
	Sep. 30, 2020
Business Acquisition [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	A summary of the estimated fair values of assets acquired, liabilities assumed, consideration transferred, and the resulting goodwill is as follows: (Dollars in thousands) Assets acquired: Factored receivables $107,524 Allowance for credit losses (37,415) Factored receivables, net of ACL 70,109 Intangible assets 3,500 Indemnification asset 31,218 Deferred income taxes 1,387 106,214 Liabilities assumed: Deposits 5,613 5,613 Fair value of net assets acquired $100,601 Consideration: Cash paid $108,375 Stock consideration 13,942 Cash due from seller subsequent to liquidation of stock consideration (17,196) Total consideration $105,121 Goodwill $4,520
Summary of Factored Receivables, Purchased with Credit Deterioration	The following table presents information at the acquisition date for factored receivables purchased for which there was, at acquisition, evidence of more than insignificant deterioration of credit quality since origination: (Dollars in thousands) Purchase price of loans at acquisition $25,148 Allowance for credit losses at acquisition 37,415 Non-credit discount/(premium) at acquisition 941 Par value of acquired loans at acquisition $63,504
Triumph Premium Finance
Business Acquisition [Line Items]
Summary of Carrying Amount of Assets in Disposal Group and Gain on Sale	A summary of the carrying amount of the assets in the Disposal Group and the gain on sale is as follows: (Dollars in thousands) Carrying amount of assets in the disposal group: Loans $ 84,504 Premises and equipment, net 45 Other assets 11 84,560 Carrying amount of liabilities in the disposal group: Other liabilities 479 Total carrying amount $ 84,081 Total consideration received 94,531 Gain on sale of division 10,450 Transaction costs 692 Gain on sale of division, net of transaction costs $ 9,758

Securities (Tables)

Securities (Tables)	9 Months Ended
	Sep. 30, 2020
Schedule Of Debt Securities And Equity Securities [Line Items]
Schedule of Gross Realized and Unrealized Losses Recognized on Equity Securities	The gross realized and unrealized losses recognized on equity securities with readily determinable fair values in noninterest income in the Company’s consolidated statements of income were as follows: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Unrealized gains (losses) on equity securities still held at the reporting date $ (371) $ 64 $ 603 $ 499 Realized gains (losses) on equity securities sold during the period — — — — $ (371) $ 64 $ 603 $ 499
Schedule of Amortized Cost and Estimated Fair Value of Debt Securities by Contractual Maturity	The amortized cost and estimated fair value of securities at September 30, 2020, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Available for Sale Securities Held to Maturity Securities (Dollars in thousands) Amortized Fair Amortized Fair Due in one year or less $ 38,449 $ 38,799 $ — $ — Due from one year to five years 19,799 20,264 — — Due from five years to ten years 24,878 26,456 8,057 5,473 Due after ten years 113,545 116,709 — — 196,671 202,228 8,057 5,473 Mortgage-backed securities, residential 28,604 29,790 — — Asset-backed securities 7,173 7,091 — — SBA pooled securities 3,536 3,693 — — $ 235,984 $ 242,802 $ 8,057 $ 5,473
Schedule of Proceeds from Sales of Debt Securities and the Associated Gross Gains and Losses as well as Net Gains and Losses from Calls of Debt Securities	Proceeds from sales of debt securities and the associated gross gains and losses as well as net gains and losses from calls of debt securities are as follows: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Proceeds $ 65,184 $ — $ 65,184 $ 40,617 Gross gains 3,217 — 3,217 133 Gross losses (140) — (140) (130) Net gains and losses from calls of securities 32 19 133 19
Schedule of Available for Sale Debt Securities in an Unrealized Loss Position	The following table summarizes available for sale debt securities in an unrealized loss position for which an allowance for credit losses has not been recorded, aggregated by investment category and length of time that individual securities have been in a continuous loss position: Less than 12 Months 12 Months or More Total (Dollars in thousands) Fair Unrealized Fair Unrealized Fair Unrealized September 30, 2020 Available for sale securities: U.S. Government agency obligations $ — $ — $ — $ — $ — $ — Mortgage-backed securities, residential 127 (1) 288 (2) 415 (3) Asset-backed securities 150 (1) 6,941 (81) 7,091 (82) State and municipal — — — — — — CLO securities 16,591 (144) 34,739 (218) 51,330 (362) Corporate bonds 996 (7) 150 0 1,146 (7) SBA pooled securities 726 (5) 32 0 758 (5) $ 18,590 $ (158) $ 42,150 $ (301) $ 60,740 $ (459) Less than 12 Months 12 Months or More Total (Dollars in thousands) Fair Unrealized Fair Unrealized Fair Unrealized December 31, 2019 Available for sale securities: U.S. Government agency obligations $ — $ — $ 12,331 $ (34) $ 12,331 $ (34) Mortgage-backed securities, residential 3,549 (29) 777 (7) 4,326 (36) Asset-backed securities 2,986 (36) 4,973 (44) 7,959 (80) State and municipal 562 — 3,426 (8) 3,988 (8) CLO Securities 58,160 (358) — — 58,160 (358) Corporate bonds — — 149 (1) 149 (1) SBA pooled securities 354 — 9 (1) 363 (1) $ 65,611 $ (423) $ 21,665 $ (95) $ 87,276 $ (518)
Summary of Activity in Allowance for Credit Losses for Held To Maturity Debt Securities	The following table presents the activity in the allowance for credit losses for held to maturity debt securities: (Dollars in thousands) Three Months Ended Nine Months Ended Held to Maturity CLO Securities Allowance for credit losses: Beginning balance $ 1,855 $ — Impact of adopting ASC 326 — 126 Credit loss expense 106 1,835 Allowance for credit losses ending balance $ 1,961 $ 1,961
Debt Securities
Schedule Of Debt Securities And Equity Securities [Line Items]
Schedule of Amortized Cost of Securities and Their Estimated Fair Values	The following table summarizes the amortized cost, fair value, and allowance for credit losses of debt securities and the corresponding amounts of gross unrealized gains and losses of available for sale securities recognized in accumulated other comprehensive income (loss) and gross unrecognized gains and losses of held to maturity securities: (Dollars in thousands) Amortized Gross Gross Allowance Fair September 30, 2020 Available for sale securities: U.S. Government agency obligations $ 18,227 $ 221 $ — $ — $ 18,448 Mortgage-backed securities, residential 28,604 1,189 (3) — 29,790 Asset-backed securities 7,173 — (82) — 7,091 State and municipal 42,034 1,328 — — 43,362 CLO securities 113,795 4,058 (362) — 117,491 Corporate bonds 22,615 319 (7) — 22,927 SBA pooled securities 3,536 162 (5) — 3,693 Total available for sale securities $ 235,984 $ 7,277 $ (459) $ — $ 242,802 (Dollars in thousands) Amortized Gross Gross Fair September 30, 2020 Held to maturity securities: CLO securities $ 8,057 $ — $ (2,584) $ 5,473 Allowance for credit losses (1,961) Total held to maturity securities, net of ACL $ 6,096 (Dollars in thousands) Amortized Gross Gross Fair December 31, 2019 Available for sale securities: U.S. Government agency obligations $ 39,679 $ 115 $ (34) $ 39,760 Mortgage-backed securities, residential 37,324 728 (36) 38,016 Asset-backed securities 8,039 — (80) 7,959 State and municipal 31,746 327 (8) 32,065 CLO Securities 75,592 39 (358) 75,273 Corporate bonds 50,889 695 (1) 51,583 SBA pooled securities 4,112 53 (1) 4,164 Total available for sale securities $ 247,381 $ 1,957 $ (518) $ 248,820 (Dollars in thousands) Amortized Gross Gross Fair December 31, 2019 Held to maturity securities: CLO securities $ 8,417 $ — $ (1,510) $ 6,907

Loans and Allowance for Credi_2

Loans and Allowance for Credit Losses (Tables)	9 Months Ended
	Sep. 30, 2020
Loans and Leases Receivable Disclosure [Abstract]
Schedule of Loans Held for Sale	The following table presents loans held for sale: (Dollars in thousands) September 30, 2020 December 31, 2019 Commercial real estate $ 19,919 $ — 1-4 family residential 11,644 2,735 Commercial 5,153 — Total loans held for sale $ 36,716 $ 2,735
Schedule of Amortized Cost and Unpaid Principal	The following table presents the amortized cost and unpaid principal balance of loans held for investment: September 30, 2020 December 31, 2019 (Dollars in thousands) Amortized Unpaid Difference Amortized Unpaid Difference Commercial real estate $ 762,531 $ 766,471 $ (3,940) $ 1,046,961 $ 1,051,684 $ (4,723) Construction, land development, land 244,512 244,966 (454) 160,569 162,335 (1,766) 1-4 family residential 164,785 165,442 (657) 179,425 180,340 (915) Farmland 110,966 111,870 (904) 154,975 156,995 (2,020) Commercial 1,536,903 1,554,805 (17,902) 1,342,683 1,346,444 (3,761) Factored receivables 1,016,337 1,017,805 (1,468) 619,986 621,697 (1,711) Consumer 17,106 17,139 (33) 21,925 21,994 (69) Mortgage warehouse 999,771 999,771 — 667,988 667,988 — Total loans held for investment 4,852,911 $ 4,878,269 $ (25,358) 4,194,512 $ 4,209,477 $ (14,965) Allowance for credit losses (90,995) (29,092) $ 4,761,916 $ 4,165,420
Summary of Allowance for Loan and Lease Losses	The activity in the allowance for credit losses (“ACL”) related to loans held for investment is as follows: (Dollars in thousands) Beginning Impact of Initial ACL on Loans Purchased Credit Loss Charge-offs Recoveries Reclassification Ending Three months ended September 30, 2020 Commercial real estate $ 15,539 $ — $ — $ (2,440) $ — $ 53 $ — $ 13,152 Construction, land development, land 5,917 — — (319) — 2 — 5,600 1-4 family residential 2,027 — — (56) (6) 7 — 1,972 Farmland 958 — — (95) — — — 863 Commercial 23,283 — — (657) (528) 615 — 22,713 Factored receivables 5,244 — 37,415 3,059 (773) 40 — 44,985 Consumer 768 — — 29 (118) 31 — 710 Mortgage warehouse 877 — — 123 — — — 1,000 $ 54,613 $ — $ 37,415 $ (356) $ (1,425) $ 748 $ — $ 90,995 (Dollars in thousands) Beginning Credit Loss Charge-offs Recoveries Ending Three months ended September 30, 2019 Commercial real estate $ 5,677 $ 147 $ (26) $ — $ 5,798 Construction, land development, land 1,035 47 — 2 1,084 1-4 family residential 409 4 — 4 417 Farmland 590 349 — — 939 Commercial 13,899 1,195 (557) 234 14,771 Factored receivables 6,861 851 (210) 215 7,717 Consumer 563 66 (85) 37 581 Mortgage warehouse 382 206 — — 588 $ 29,416 $ 2,865 $ (878) $ 492 $ 31,895 (Dollars in thousands) Beginning Impact of Initial ACL on Loans Purchased Credit Loss Charge-offs Recoveries Reclassification Ending Nine Months Ended September 30, 2020 Commercial real estate $ 5,353 $ 1,372 $ — $ 6,366 $ — $ 61 $ — $ 13,152 Construction, land development, land 1,382 (187) — 4,400 — 5 — 5,600 1-4 family residential 308 513 — 1,138 (27) 40 — 1,972 Farmland 670 437 — (324) — 80 — 863 Commercial 12,566 (184) — 11,004 (1,173) 949 (449) 22,713 Factored receivables 7,657 (1,630) 37,415 4,475 (3,027) 95 — 44,985 Consumer 488 (52) — 583 (410) 101 — 710 Mortgage warehouse 668 — — 332 — — — 1,000 $ 29,092 $ 269 $ 37,415 $ 27,974 $ (4,637) $ 1,331 $ (449) $ 90,995 (Dollars in thousands) Beginning Credit Loss Charge-offs Recoveries Ending Nine months ended September 30, 2019 Commercial real estate $ 4,493 $ 1,343 $ (39) $ 1 $ 5,798 Construction, land development, land 1,134 (63) (78) 91 1,084 1-4 family residential 317 86 (43) 57 417 Farmland 535 404 — — 939 Commercial 12,865 3,252 (1,671) 325 14,771 Factored receivables 7,299 1,839 (1,682) 261 7,717 Consumer 615 424 (594) 136 581 Mortgage warehouse 313 275 — — 588 $ 27,571 $ 7,560 $ (4,107) $ 871 $ 31,895
Individual And Collective Allowance For Credit Losses On Financing Receivables And Loan Balances	The following table presents the amortized cost basis of collateral dependent loans, which are individually evaluated to determine expected credit losses, and the related ACL allocated to these loans: (Dollars in thousands) Real Estate Accounts Equipment Other Total ACL September 30, 2020 Commercial real estate $ 14,198 $ — $ — $ 366 $ 14,564 $ 1,668 Construction, land development, land 2,112 — — — 2,112 271 1-4 family residential 1,962 — — 181 2,143 24 Farmland 1,914 — 148 572 2,634 — Commercial 2,875 4,893 7,034 4,124 18,926 4,563 Factored receivables — 73,875 — — 73,875 40,072 Consumer — — — 322 322 29 Mortgage warehouse — — — — — — Total $ 23,061 $ 78,768 $ 7,182 $ 5,565 $ 114,576 $ 46,627
Summary of Information Pertaining to Impaired Loans	The following table presents loans individually and collectively evaluated for impairment, as well as purchased credit impaired (“PCI”) loans, and their respective allowance for credit loss allocations as of December 31, 2019, as determined in accordance with ASC 310 prior to the adoption of ASU 2016-13: (Dollars in thousands) Loan Evaluation ALLL Allocations December 31, 2019 Individually Collectively PCI Total loans Individually Collectively PCI Total ALLL Commercial real estate $ 7,455 $ 1,030,439 $ 9,067 $ 1,046,961 $ 344 $ 5,009 $ — $ 5,353 Construction, land development, land 2,138 155,985 2,446 160,569 271 1,111 — 1,382 1-4 family residential 1,728 177,189 508 179,425 33 275 — 308 Farmland 6,638 148,233 104 154,975 — 670 — 670 Commercial 15,618 1,326,515 550 1,342,683 1,278 11,284 4 12,566 Factored receivables 15,947 604,039 — 619,986 3,178 4,479 — 7,657 Consumer 327 21,598 — 21,925 9 479 — 488 Mortgage warehouse — 667,988 — 667,988 — 668 — 668 $ 49,851 $ 4,131,986 $ 12,675 $ 4,194,512 $ 5,113 $ 23,975 $ 4 $ 29,092 The following table presents information pertaining to impaired loans as of December 31, 2019, as determined in accordance with ASC 310 prior to the adoption of ASU 2016-13: Impaired Loans and Purchased Credit Impaired Loans (Dollars in thousands) Recorded Unpaid Related Recorded Unpaid December 31, 2019 Commercial real estate $ 878 $ 907 $ 344 $ 6,577 $ 6,643 Construction, land development, land 935 935 271 1,203 1,305 1-4 family residential 35 22 33 1,693 1,799 Farmland — — — 6,638 6,819 Commercial 6,032 6,053 1,278 9,586 9,751 Factored receivables 15,940 15,940 3,178 7 7 Consumer 17 16 9 310 311 Mortgage warehouse — — — — — PCI 71 55 4 — — $ 23,908 $ 23,928 $ 5,117 $ 26,014 $ 26,635 The following table presents average impaired loans, as determined in accordance with ASC 310 prior to the adoption of ASU 2016-13, and interest recognized on such loans, for the three and nine months ended September 30, 2019: Three Months Ended Nine Months Ended Average Interest Average Interest (Dollars in thousands) Commercial real estate $ 7,500 $ 180 $ 7,675 $ 180 Construction, land development, land 1,087 5 624 5 1-4 family residential 2,353 13 2,326 15 Farmland 6,737 31 7,186 75 Commercial 15,222 321 16,397 373 Factored receivables 10,453 — 9,455 — Consumer 458 5 411 5 Mortgage warehouse — — — — PCI 71 — 71 — $ 43,881 $ 555 $ 44,145 $ 653
Summary of Contractually Past Due and Nonaccrual Loans	The following tables present an aging of contractually past due loans: (Dollars in thousands) Past Due Past Due Past Due 90 Total Current Total Past Due 90 September 30, 2020 Commercial real estate $ 1,714 $ 6,993 $ 2,666 $ 11,373 $ 751,158 $ 762,531 $ 1,287 Construction, land development, land 608 894 1,184 2,686 241,826 244,512 — 1-4 family residential 1,049 849 1,061 2,959 161,826 164,785 143 Farmland 400 — 284 684 110,282 110,966 — Commercial 5,954 1,548 6,319 13,821 1,523,082 1,536,903 276 Factored receivables 68,522 7,247 8,638 84,407 931,930 1,016,337 8,638 Consumer 442 83 141 666 16,440 17,106 — Mortgage warehouse — — — — 999,771 999,771 — Total $ 78,689 $ 17,614 $ 20,293 $ 116,596 $ 4,736,315 $ 4,852,911 $ 10,344 (Dollars in thousands) Past Due Past Due Past Due 90 Total Current Total Past Due 90 December 31, 2019 Commercial real estate $ 1,752 $ 1,328 $ 1,759 $ 4,839 $ 1,042,122 $ 1,046,961 $ — Construction, land development, land 1,785 842 361 2,988 157,581 160,569 — 1-4 family residential 1,396 723 554 2,673 176,752 179,425 286 Farmland 52 132 2,376 2,560 152,415 154,975 — Commercial 4,444 4,154 9,555 18,153 1,324,530 1,342,683 808 Factored receivables 29,118 7,182 4,226 40,526 579,460 619,986 4,226 Consumer 508 429 183 1,120 20,805 21,925 49 Mortgage warehouse — — — — 667,988 667,988 — Total $ 39,055 $ 14,790 $ 19,014 $ 72,859 $ 4,121,653 $ 4,194,512 $ 5,369
Summary of Amortized Cost Basis of Loans on Nonaccrual Status	The following table presents the amortized cost basis of loans on nonaccrual status and the amortized cost basis of loans on nonaccrual status for which there was no related allowance for credit losses: September 30, 2020 December 31, 2019 (Dollars in thousands) Nonaccrual Nonaccrual Nonaccrual Nonaccrual Commercial real estate $ 12,235 $ 4,700 $ 7,501 $ 6,623 Construction, land development, land 2,089 1,180 3,922 2,987 1-4 family residential 1,761 1,640 1,730 1,694 Farmland 2,452 2,452 6,494 6,494 Commercial 19,462 5,210 16,080 9,977 Factored receivables — — — — Consumer 322 247 327 310 Mortgage warehouse — — — — $ 38,321 $ 15,429 $ 36,054 $ 28,085
Schedule of Accrued Interest on Non Accrual Loans Reversed Through Interest Income	The following table presents accrued interest on nonaccrual loans reversed through interest income: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Commercial real estate $ 371 $ 13 $ 435 $ 32 Construction, land development, land 1 — 1 9 1-4 family residential 21 — 31 12 Farmland 36 26 36 27 Commercial 37 13 76 50 Factored receivables — — — — Consumer — 2 2 3 Mortgage warehouse — — — — $ 466 $ 54 $ 581 $ 133
Schedule of Nonperforming Loans	The following table presents information regarding nonperforming loans: (Dollars in thousands) September 30, 2020 December 31, 2019 Nonaccrual loans (1) $ 38,321 $ 36,054 Factored receivables greater than 90 days past due 8,638 4,226 Other nonperforming factored receivables (2) 10,029 — Troubled debt restructurings accruing interest 3 333 $ 56,991 $ 40,613 (1) Includes troubled debt restructurings of $15,743,000 and $4,888,000 at September 30, 2020 and December 31, 2019, respectively. (2) Other nonperforming factored receivables represent the portion of the Over-Formula Advance Portfolio that is not covered by Covenant's indemnification. This amount is also considered Classified from a risk rating perspective.
Summary of Risk Category of Loans	As of September 30, 2020 and December 31, 2019, based on the most recent analysis performed, the risk category of loans is as follows: Revolving Revolving Total (Dollars in thousands) Year of Origination September 30, 2020 2020 2019 2018 2017 2016 Prior Commercial real estate Pass $ 374,993 $ 85,458 $ 95,818 $ 92,112 $ 35,576 $ 53,189 $ 7,124 $ 908 $ 745,178 Classified 13,918 437 182 636 852 1,328 — — 17,353 Total commercial real estate $ 388,911 $ 85,895 $ 96,000 $ 92,748 $ 36,428 $ 54,517 $ 7,124 $ 908 $ 762,531 Construction, land development, land Pass $ 141,940 $ 29,654 $ 55,887 $ 12,362 $ 268 $ 1,776 $ 13 $ 500 $ 242,400 Classified 905 838 — — — 369 — — 2,112 Total construction, land development, land $ 142,845 $ 30,492 $ 55,887 $ 12,362 $ 268 $ 2,145 $ 13 $ 500 $ 244,512 1-4 family residential Pass $ 35,959 $ 12,614 $ 15,172 $ 13,316 $ 11,773 $ 30,076 $ 38,669 $ 5,320 $ 162,899 Classified 570 76 16 — 359 758 107 — 1,886 Total 1-4 family residential $ 36,529 $ 12,690 $ 15,188 $ 13,316 $ 12,132 $ 30,834 $ 38,776 $ 5,320 $ 164,785 Farmland Pass $ 19,870 $ 17,100 $ 16,458 $ 15,168 $ 13,829 $ 21,150 $ 2,130 $ 486 $ 106,191 Classified 1,207 417 1,672 145 — 560 774 — 4,775 Total farmland $ 21,077 $ 17,517 $ 18,130 $ 15,313 $ 13,829 $ 21,710 $ 2,904 $ 486 $ 110,966 Commercial Pass $ 848,660 $ 135,269 $ 48,573 $ 41,531 $ 6,013 $ 5,548 $ 405,676 $ 11,396 $ 1,502,666 Classified 7,186 7,357 4,725 1,445 731 348 12,445 — 34,237 Total commercial $ 855,846 $ 142,626 $ 53,298 $ 42,976 $ 6,744 $ 5,896 $ 418,121 $ 11,396 $ 1,536,903 Factored receivables Pass $ 995,046 $ — $ — $ — $ — $ — $ — $ — $ 995,046 Classified 21,291 — — — — — — — 21,291 Total factored receivables $ 1,016,337 $ — $ — $ — $ — $ — $ — $ — $ 1,016,337 Consumer Pass $ 3,820 $ 2,617 $ 1,614 $ 4,694 $ 3,088 $ 875 $ 73 $ — $ 16,781 Classified — 18 7 94 162 44 — — 325 Total consumer $ 3,820 $ 2,635 $ 1,621 $ 4,788 $ 3,250 $ 919 $ 73 $ — $ 17,106 Mortgage warehouse Pass $ — $ — $ — $ — $ — $ — $ 999,771 $ — $ 999,771 Classified — — — — — — — — — Total mortgage warehouse $ — $ — $ — $ — $ — $ — $ 999,771 $ — $ 999,771 Total loans Pass $ 2,420,288 $ 282,712 $ 233,522 $ 179,183 $ 70,547 $ 112,614 $ 1,453,456 $ 18,610 $ 4,770,932 Classified 45,077 9,143 6,602 2,320 2,104 3,407 13,326 — 81,979 Total loans $ 2,465,365 $ 291,855 $ 240,124 $ 181,503 $ 72,651 $ 116,021 $ 1,466,782 $ 18,610 $ 4,852,911 (Dollars in thousands) December 31, 2019 Pass Classified PCI Total Commercial real estate $ 1,030,358 $ 7,536 $ 9,067 $ 1,046,961 Construction, land development, land 155,985 2,138 2,446 160,569 1-4 family residential 177,177 1,740 508 179,425 Farmland 144,777 10,094 104 154,975 Commercial 1,313,042 29,091 550 1,342,683 Factored receivables 604,774 15,212 — 619,986 Consumer 21,594 331 — 21,925 Mortgage warehouse 667,988 — — 667,988 $ 4,115,695 $ 66,142 $ 12,675 $ 4,194,512
Schedule of Loans Modified as Troubled Debt Restructurings	The following table presents the pre- and post-modification recorded investment of loans modified as troubled debt restructurings during the three and nine months ended September 30, 2020 and 2019. The Company did not grant principal reductions on any restructured loans. (Dollars in thousands) Extended Payment AB Note Interest Rate Total Number of Nine months ended September 30, 2020 Commercial real estate $ — $ 246 $ — $ — $ 246 2 Construction, land development, land 8 — — — 8 1 Farmland 3,486 — — — 3,486 1 Commercial 4,714 9,296 — — 14,010 19 $ 8,208 $ 9,542 $ — $ — $ 17,750 23 Three months ended September 30, 2020 Commercial 123 3,503 — — 3,626 14 $ 123 $ 3,503 $ — $ — $ 3,626 14 Nine months ended September 30, 2019 Commercial real estate $ — $ — $ 4,597 $ — $ 4,597 1 Commercial 1,649 84 — 593 2,326 6 $ 1,649 $ 84 $ 4,597 $ 593 $ 6,923 7 Three months ended September 30, 2019 Commercial real estate $ — $ — $ — $ — $ — — Commercial 554 — — — 554 1 $ 554 $ — $ — $ — $ 554 1
Summary of Amortized Cost of Loans Currently in Deferral	The following table summarized the amortized cost of loans with payments currently in deferral and the accrued interest related to the loans with payments currently in deferral at September 30, 2020: (Dollars in thousands) Total Balance of Percentage Accrued September 30, 2020 Commercial real estate $ 762,531 $ 77,419 10.2 % $ 464 Construction, land development, land 244,512 116 — % 1 1-4 family residential 164,785 8,560 5.2 % 127 Farmland 110,966 — — % — Commercial 1,536,903 16,787 1.1 % 99 Factored receivables 1,016,337 — — % — Consumer 17,106 105 0.6 % 4 Mortgage warehouse 999,771 — — % — Total $ 4,852,911 $ 102,987 2.1 % $ 695
Schedule of Outstanding Contractually Required Principal and Interest and Carrying Amount of PCI Loans Receivable	The following table summarizes information pertaining to loans that were identified as purchased credit impaired prior to the adoption of ASU 2016-13: December 31, Contractually required principal and interest: Real estate loans $ 14,015 Commercial loans 677 Outstanding contractually required principal and interest $ 14,692 Gross carrying amount included in loans receivable $ 12,675
Schedule of Changes in Accretable Yield for the PCI Loans	The changes in accretable yield related to loans that were identified as purchased credit impaired prior to the adoption of ASU 2016-13 were as follows: Three Months Ended Nine Months Ended Accretable yield, beginning balance $ 4,793 $ 5,711 Additions — — Accretion (460) (1,228) Reclassification from nonaccretable to accretable yield 50 64 Disposals (54) (218) Accretable yield, ending balance $ 4,329 $ 4,329

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill	Goodwill and intangible assets consist of the following: (Dollars in thousands) September 30, 2020 December 31, 2019 Goodwill $ 163,263 $ 158,743 September 30, 2020 December 31, 2019 (Dollars in thousands) Gross Carrying Accumulated Net Carrying Gross Carrying Accumulated Net Carrying Core deposit intangibles $ 43,578 $ (26,217) $ 17,361 $ 43,578 $ (22,258) $ 21,320 Other intangible assets 19,200 (7,783) 11,417 15,700 (5,477) 10,223 $ 62,778 $ (34,000) $ 28,778 $ 59,278 $ (27,735) $ 31,543
Schedule of Changes in Goodwill and Intangible Assets	The changes in goodwill and intangible assets during the three and nine months ended September 30, 2020 and 2019 are as follows: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Beginning balance $ 186,162 $ 194,668 $ 190,286 $ 199,417 Acquired goodwill 4,520 — 4,520 — Acquired intangibles 3,500 — 3,500 — Amortization of intangibles (2,141) (2,228) (6,265) (6,977) Ending balance $ 192,041 $ 192,440 $ 192,041 $ 192,440

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Value of Derivative Financial Instruments Classification on Balance Sheet	The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet as of September 30, 2020. There were no such derivatives outstanding at December 31, 2019. Derivative Liabilities As of September 30, 2020 (Dollars in thousands) Notional Balance Fair Value Derivatives designated as hedging instruments: Interest rate swaps $ 200,000 Other Liabilities $ 16
Schedule of Effect of Fair Value and Cash Flow Hedge on Accumulated Other Comprehensive Income, Net of Tax	The table below presents the effect of fair value and cash flow hedge accounting on Accumulated Other Comprehensive Income, net of tax, as of September 30, 2020: (Dollars in thousands) Amount of Amount of Location of Amount of Amount of Three Months Ended September 30, 2020 Derivatives in cash flow hedging relationships: Interest rate swaps $ 257 $ 257 Interest Expense $ (16) $ (16) (Dollars in thousands) Amount of Amount of Location of Amount of Amount of Nine Months Ended September 30, 2020 Derivatives in cash flow hedging relationships: Interest rate swaps $ 11 $ 11 Interest Expense $ (16) $ (16)

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Variable Interest Entities	The Company holds investments in the subordinated notes of the following closed Collateralized Loan Obligation (“CLO”) funds: (Dollars in thousands) Offering Offering Trinitas CLO IV, LTD (Trinitas IV) June 2, 2016 $ 406,650 Trinitas CLO V, LTD (Trinitas V) September 22, 2016 $ 409,000 Trinitas CLO VI, LTD (Trinitas VI) June 20, 2017 $ 717,100

Borrowings and Borrowing Capa_2

Borrowings and Borrowing Capacity (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Schedule of Customer Repurchase Agreements	Information concerning customer repurchase agreements is summarized as follows for the nine months ended September 30, 2020 and the year ended December 31, 2019: (Dollars in thousands) September 30, December 31, Amount outstanding at end of period $ 14,192 $ 2,033 Weighted average interest rate at end of period 0.03 % 0.03 % Average daily balance during the period $ 6,520 $ 7,823 Weighted average interest rate during the period 0.03 % 0.02 % Maximum month-end balance during the period $ 14,192 $ 14,463
Schedule of FHLB Advances and Weighted Average Interest Rates by Contractual Maturity	FHLB advances are collateralized by assets, including a blanket pledge of certain loans. FHLB advances and weighted average interest rates at end of period by contractual maturity are summarized as follows: Fixed Rate Variable Rate (Dollars in thousands) Balance Weighted Balance Weighted 2020 $ 405,000 0.13 % $ — — 2027 — — 30,000 0.33 % $ 405,000 0.13 % 30,000 0.33 %
Schedule of Information Concerning FHLB Advances	Information concerning FHLB advances is summarized as follows for the nine months ended September 30, 2020 and the year ended December 31, 2019: (Dollars in thousands) September 30, December 31, Amount outstanding at end of period $ 435,000 $ 430,000 Weighted average interest rate at end of period 0.15 % 1.58 % Average amount outstanding during the period 430,250 369,548 Weighted average interest rate during the period 0.61 % 2.32 % Highest month end balance during the period 850,000 530,000
Schedule of FHLB Advances	The Company’s unused borrowing capacity with the FHLB is as follows: (Dollars in thousands) September 30, December 31, Borrowing capacity $ 1,323,927 $ 1,300,985 Borrowings outstanding 435,000 430,000 Unused borrowing capacity $ 888,927 $ 870,985
Summary of Information Concerning Borrowings under PPPLF	Information concerning borrowings under the PPPLF is summarized as follows for the nine months ended September 30, 2020: (Dollars in thousands) September 30, Amount outstanding at end of period $ 223,713 Weighted average interest rate at end of period 0.35 % Average amount outstanding during the period 119,236 Weighted average interest rate during the period 0.35 % Highest month end balance during the period 223,809
Summary of Scheduled Maturities of PPPLF Borrowings	At September 30, 2020, scheduled maturities of PPPLF borrowings are as follows: (Dollars in thousands) September 30, Within one year $ — After one but within two years 223,713 Total $ 223,713
Summary of Junior Subordinated Debentures	The following provides a summary of the Company’s junior subordinated debentures as of September 30, 2020: (Dollars in thousands) Face Value Carrying Value Maturity Date Interest Rate National Bancshares Capital Trust II $ 15,464 $ 13,187 September 2033 LIBOR + 3.00% National Bancshares Capital Trust III 17,526 12,924 July 2036 LIBOR + 1.64% ColoEast Capital Trust I 5,155 3,594 September 2035 LIBOR + 1.60% ColoEast Capital Trust II 6,700 4,684 March 2037 LIBOR + 1.79% Valley Bancorp Statutory Trust I 3,093 2,876 September 2032 LIBOR + 3.40% Valley Bancorp Statutory Trust II 3,093 2,679 July 2034 LIBOR + 2.75% $ 51,031 $ 39,944

Off-Balance Sheet Loan Commit_2

Off-Balance Sheet Loan Commitments (Tables)	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Summary of Financial Instruments with Off-Balance Sheet Risk	The contractual amounts of financial instruments with off-balance sheet risk were as follows: September 30, 2020 December 31, 2019 (Dollars in thousands) Fixed Rate Variable Rate Total Fixed Rate Variable Rate Total Unused lines of credit $ 35,764 $ 594,305 $ 630,069 $ 49,057 $ 444,028 $ 493,085 Standby letters of credit $ 5,382 $ 3,259 $ 8,641 $ 3,017 $ 3,781 $ 6,798 Commitments to purchase loans $ — $ 51,747 $ 51,747 $ — $ 22,004 $ 22,004 Mortgage warehouse commitments $ — $ 318,972 $ 318,972 $ — $ 340,502 $ 340,502

Fair Value Disclosures (Tables)

Fair Value Disclosures (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on a Recurring Basis	Assets and liabilities measured at fair value on a recurring basis are summarized in the table below. (Dollars in thousands) Fair Value Measurements Using Total September 30, 2020 Level 1 Level 2 Level 3 Assets measured at fair value on a recurring basis Securities available for sale U.S. Government agency obligations $ — $ 18,448 $ — $ 18,448 Mortgage-backed securities, residential — 29,790 — 29,790 Asset-backed securities — 7,091 — 7,091 State and municipal — 43,362 — 43,362 CLO securities — 117,491 — 117,491 Corporate bonds — 22,927 — 22,927 SBA pooled securities — 3,693 — 3,693 $ — $ 242,802 $ — $ 242,802 Equity securities Mutual fund $ 6,040 $ — $ — $ 6,040 Loans held for sale $ — $ 36,716 $ — $ 36,716 Derivative financial instruments (cash flow hedges) Interest rate swap $ — $ 16 $ — $ 16 Liabilities measured at fair value on a recurring basis ICC Contingent consideration $ — $ — $ 21,991 $ 21,991 (Dollars in thousands) Fair Value Measurements Using Total December 31, 2019 Level 1 Level 2 Level 3 Assets measured at fair value on a recurring basis Securities available for sale U.S. Government agency obligations $ — $ 39,760 $ — $ 39,760 Mortgage-backed securities, residential — 38,016 — 38,016 Asset-backed securities — 7,959 — 7,959 State and municipal — 32,065 — 32,065 CLO Securities — 75,273 — 75,273 Corporate bonds — 51,583 — 51,583 SBA pooled securities — 4,164 — 4,164 $ — $ 248,820 $ — $ 248,820 Equity securities Mutual fund $ 5,437 $ — $ — $ 5,437 Loans held for sale $ — $ 2,735 $ — $ 2,735 Liabilities measured at fair value on a recurring basis ICC Contingent consideration $ — $ — $ 21,622 $ 21,622
Reconciliation of Opening Balance to Closing Balance of Fair Value of Contingent Consideration	A reconciliation of the opening balance to the closing balance of the fair value of the contingent consideration is as follows: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Beginning balance $ 21,963 $ 21,302 $ 21,622 $ 20,745 Contingent consideration recognized in business combination — — — — Change in fair value of contingent consideration recognized in earnings 28 124 369 681 Consideration settlement payments — — — — Ending balance $ 21,991 $ 21,426 $ 21,991 $ 21,426
Fair Value of Assets Measured on Non-recurring Basis	There were no liabilities measured at fair value on a non-recurring basis at September 30, 2020 and December 31, 2019. (Dollars in thousands) Fair Value Measurements Using Total September 30, 2020 Level 1 Level 2 Level 3 Collateral dependent loans Commercial real estate $ — $ — $ 5,302 $ 5,302 Construction, land development, land — — 637 637 1-4 family residential — — 5 5 Commercial — — 3,584 3,584 Factored receivables — — 33,803 33,803 Consumer — — 46 46 Other real estate owned (1) 1-4 family residential properties — — 189 189 $ — $ — $ 43,566 $ 43,566 (Dollars in thousands) Fair Value Measurements Using Total December 31, 2019 Level 1 Level 2 Level 3 Impaired loans Commercial real estate $ — $ — $ 534 $ 534 Construction, land development, land — — 664 664 1-4 family residential — — 2 2 Commercial — — 4,754 4,754 Factored receivables — — 12,762 12,762 Consumer — — 8 8 PCI — — 67 67 Other real estate owned (1) Commercial real estate — — 388 388 1-4 family residential — — 89 89 $ — $ — $ 19,268 $ 19,268 (1) Represents the fair value of OREO that was adjusted during the year to date period and subsequent to its initial classification as OREO.
Estimated Fair Value of Company's Financial Assets and Financial Liabilities	The estimated fair values of the Company’s financial instruments not measured at fair value on a recurring or non-recurring basis at September 30, 2020 and December 31, 2019 were as follows: (Dollars in thousands) Carrying Fair Value Measurements Using Total September 30, 2020 Level 1 Level 2 Level 3 Financial assets: Cash and cash equivalents $ 288,278 $ 288,278 $ — $ — $ 288,278 Securities - held to maturity 6,096 — — 5,473 5,473 Loans not previously presented, gross 4,810,731 197,859 — 4,593,233 4,791,092 FHLB and other restricted stock 18,464 N/A N/A N/A N/A Indemnification asset 31,218 — — 31,218 31,218 Accrued interest receivable 20,254 20,254 — — 20,254 Financial liabilities: Deposits 4,248,101 — 4,254,371 — 4,254,371 Customer repurchase agreements 14,192 — 14,192 — 14,192 Federal Home Loan Bank advances 435,000 — 435,000 — 435,000 Paycheck Protection Program Liquidity Facility 223,713 — 223,713 — 223,713 Subordinated notes 87,455 — 89,806 — 89,806 Junior subordinated debentures 39,944 — 40,135 — 40,135 Accrued interest payable 6,006 6,006 — — 6,006 (Dollars in thousands) Carrying Fair Value Measurements Using Total December 31, 2019 Level 1 Level 2 Level 3 Financial assets: Cash and cash equivalents $ 197,880 $ 197,880 $ — $ — $ 197,880 Securities - held to maturity 8,417 — — 6,907 6,907 Loans not previously presented, gross 4,170,604 83,454 — 4,086,597 4,170,051 FHLB and other restricted stock 19,860 N/A N/A N/A N/A Accrued interest receivable 20,322 20,322 — — 20,322 Financial liabilities: Deposits 3,789,906 — 3,793,603 — 3,793,603 Customer repurchase agreements 2,033 — 2,033 — 2,033 Federal Home Loan Bank advances 430,000 — 430,000 — 430,000 Subordinated notes 87,327 — 93,877 — 93,877 Junior subordinated debentures 39,566 — 40,700 — 40,700 Accrued interest payable 9,367 9,367 — — 9,367

Regulatory Matters (Tables)

Regulatory Matters (Tables)	9 Months Ended
	Sep. 30, 2020
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]
Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations	The actual capital amounts and ratios for the Company and TBK Bank are presented in the following table. (Dollars in thousands) Actual Minimum for Capital To Be Well September 30, 2020 Amount Ratio Amount Ratio Amount Ratio Total capital (to risk weighted assets) Triumph Bancorp, Inc. $ 689,050 12.9% $ 427,318 8.0% N/A N/A TBK Bank, SSB $ 624,406 11.9% $ 419,769 8.0% $ 524,711 10.0% Tier 1 capital (to risk weighted assets) Triumph Bancorp, Inc. $ 549,445 10.3% $ 320,065 6.0% N/A N/A TBK Bank, SSB $ 573,637 10.9% $ 315,763 6.0% $ 421,018 8.0% Common equity Tier 1 capital (to risk weighted assets) Triumph Bancorp, Inc. $ 464,501 8.7% $ 240,259 4.5% N/A N/A TBK Bank, SSB $ 573,637 10.9% $ 236,823 4.5% $ 342,077 6.5% Tier 1 capital (to average assets) Triumph Bancorp, Inc. $ 549,445 10.8% $ 203,498 4.0% N/A N/A TBK Bank, SSB $ 573,637 11.3% $ 203,057 4.0% $ 253,822 5.0% As of December 31, 2019 Total capital (to risk weighted assets) Triumph Bancorp, Inc. $ 604,832 12.8% $ 378,020 8.0% N/A N/A TBK Bank, SSB $ 555,213 12.0% $ 370,142 8.0% $ 462,678 10.0% Tier 1 capital (to risk weighted assets) Triumph Bancorp, Inc. $ 487,775 10.3% $ 284,141 6.0% N/A N/A TBK Bank, SSB $ 525,490 11.4% $ 276,574 6.0% $ 368,765 8.0% Common equity Tier 1 capital (to risk weighted assets) Triumph Bancorp, Inc. $ 448,209 9.5% $ 212,310 4.5% N/A N/A TBK Bank, SSB $ 525,490 11.4% $ 207,430 4.5% $ 299,621 6.5% Tier 1 capital (to average assets) Triumph Bancorp, Inc. $ 487,775 10.0% $ 195,110 4.0% N/A N/A TBK Bank, SSB $ 525,490 10.9% $ 192,840 4.0% $ 241,050 5.0%

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Summary of Capital Structure	The following summarizes the capital structure of Triumph Bancorp, Inc. Preferred Stock Series C (Dollars in thousands, except per share amounts) September 30, 2020 Shares authorized 51,750 Shares issued 45,000 Shares outstanding 45,000 Par value per share $ 0.01 Liquidation preference per share $ 1,000 Liquidation preference amount $ 45,000 Dividend rate 7.125 % Dividend payment dates Quarterly Common Stock September 30, 2020 December 31, 2019 Shares authorized 50,000,000 50,000,000 Shares issued 27,932,671 27,163,642 Treasury shares (3,081,070) (2,198,681) Shares outstanding 24,851,601 24,964,961 Par value per share $ 0.01 $ 0.01

Stock Based Compensation (Table

Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2020
Summary of Changes in Company's Nonvested Restricted Stock Awards	A summary of changes in the Company’s nonvested Restricted Stock Awards (“RSAs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2020 were as follows: Nonvested RSAs Shares Weighted-Average Nonvested at January 1, 2020 148,349 31.86 Granted 138,417 26.54 Vested (75,103) 29.64 Forfeited (3,634) 31.07 Nonvested at September 30, 2020 208,029 29.14
Summary of Changes in Company's Nonvested Restricted Stock Units	A summary of changes in the Company’s nonvested Restricted Stock Units (“RSUs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2020 were as follows: Nonvested RSUs Shares Weighted-Average Nonvested at January 1, 2020 55,228 38.75 Granted 38,801 26.25 Vested — — Forfeited (4,316) 38.75 Nonvested at September 30, 2020 89,713 33.34
Summary of Changes in Company's Stock Options	A summary of the changes in the Company’s stock options under the Omnibus Incentive Plan for the nine months ended September 30, 2020 were as follows: Stock Options Shares Weighted-Average Weighted-Average Aggregate Outstanding at January 1, 2020 225,055 $ 24.10 Granted 32,937 24.66 Exercised (743) 15.87 Forfeited or expired (443) 38.75 Outstanding at September 30, 2020 256,806 $ 24.18 6.82 $ 2,141 Fully vested shares and shares expected to vest at September 30, 2020 256,806 $ 24.18 6.82 $ 2,141 Shares exercisable at September 30, 2020 174,073 $ 21.48 6.06 $ 1,859
Schedule of Information Related to Stock Options	Information related to the stock options for the nine months ended September 30, 2020 and 2019 was as follows: Nine Months Ended September 30, (Dollars in thousands, except per share amounts) 2020 2019 Aggregate intrinsic value of options exercised $ 10 $ 148 Cash received from option exercises — — Tax benefit realized from option exercises 2 31 Weighted average fair value per share of options granted $ 8.85 $ 10.03
Fair Value of Stock Options Granted Weighted-Average Assumptions	The fair value of the stock options granted was determined using the following weighted-average assumptions: Nine Months Ended September 30, 2020 2019 Risk-free interest rate 0.46 % 2.33 % Expected term 6.25 years 6.25 years Expected stock price volatility 33.83 % 27.46 % Dividend yield — —
Performance stock units - market based
Summary of Changes in Company's Nonvested Performance Stock Units	A summary of changes in the Company’s nonvested Market Based Performance Stock Units (“Market Based PSUs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2020 were as follows: Nonvested Market Based PSUs Shares Weighted-Average Nonvested at January 1, 2020 67,707 $ 37.71 Granted 22,220 29.93 Vested — — Forfeited (4,316) 38.57 Nonvested at September 30, 2020 85,611 $ 35.65
Schedule of Performance Stock Units, Valuation Assumptions	The risk-free interest rate for the performance period was derived from the Treasury constant maturities yield curve on the valuation date. Nine Months Ended September 30, 2020 2019 Grant date May 1, 2020 May 1, 2019 Performance period 3.00 years 3.00 years Stock price $ 26.25 $ 30.82 Triumph stock price volatility 43.02 % 28.29 % Risk-free rate 0.25 % 2.25 %
Performance Based Performance Stock Units (Performance Based PSUs)
Summary of Changes in Company's Nonvested Performance Stock Units	A summary of changes in the Company’s nonvested Performance Based Performance Stock Units (“Performance Based PSUs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2020 were as follows: Nonvested Performance Based PSUs Shares Weighted Average Nonvested at January 1, 2020 254,000 $ 38.02 Granted 10,125 26.25 Vested — — Forfeited (3,000) 38.02 Nonvested at September 30, 2020 261,125 $ 37.56

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Factors Used in Computation of Earnings Per Share	The factors used in the earnings per share computation follow: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2020 2019 2020 2019 Basic Net income to common stockholders $ 22,005 $ 14,317 $ 30,995 $ 41,835 Weighted average common shares outstanding 24,592,092 25,621,054 24,298,897 26,228,499 Basic earnings per common share $ 0.89 $ 0.56 $ 1.28 $ 1.60 Diluted Net income to common stockholders $ 22,005 $ 14,317 $ 30,995 $ 41,835 Weighted average common shares outstanding 24,592,092 25,621,054 24,298,897 26,228,499 Dilutive effects of: Assumed exercises of stock options 48,102 60,068 53,232 61,054 Restricted stock awards 67,907 45,631 65,893 40,572 Restricted stock units 18,192 3,045 15,198 57 Performance stock units - market based 76,095 4,673 30,995 1,558 Performance stock units - performance based — — — — Average shares and dilutive potential common shares 24,802,388 25,734,471 24,464,215 26,331,740 Diluted earnings per common share $ 0.89 $ 0.56 $ 1.27 $ 1.59
Schedule of Shares not Considered in Computing Diluted Earnings per Common Share	Shares that were not considered in computing diluted earnings per common share because they were antidilutive are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Stock options 98,513 67,023 98,513 67,023 Restricted stock awards — 3,209 — 3,209 Restricted stock units — — — 54,077 Performance stock units - market based — 55,228 — 55,228 Performance stock units - performance based 261,125 — 261,125 —

Business Segment Information (T

Business Segment Information (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	The following table presents the Company’s operating segments. The accounting policies of the segments are the same as those described in the “Summary of Significant Accounting Policies” in Note 1 of the Company’s 2019 Form 10-K. Transactions between segments consist primarily of borrowed funds. Intersegment interest expense is allocated to the Factoring segment based on Federal Home Loan Bank advance rates. Credit loss expense is allocated based on the segment’s allowance for credit losses determination. Noninterest income and expense directly attributable to a segment are assigned to it. Taxes are paid on a consolidated basis but not allocated for segment purposes. The Factoring segment includes only factoring originated by TBC. General factoring services not originated through TBC are included in the Banking segment. (Dollars in thousands) Three months ended September 30, 2020 Banking Factoring Corporate Consolidated Total interest income $ 52,288 $ 30,068 $ 8 $ 82,364 Intersegment interest allocations 3,312 (3,312) — — Total interest expense 6,176 — 1,809 7,985 Net interest income (expense) 49,424 26,756 (1,801) 74,379 Credit loss expense (benefit) (3,417) 3,053 106 (258) Net interest income after credit loss expense 52,841 23,703 (1,907) 74,637 Other noninterest income 7,490 3,157 (154) 10,493 Noninterest expense 40,584 13,665 1,048 55,297 Operating income (loss) $ 19,747 $ 13,195 $ (3,109) $ 29,833 (Dollars in thousands) Three months ended September 30, 2019 Banking Factoring Corporate Consolidated Total interest income $ 54,266 $ 24,869 $ 280 $ 79,415 Intersegment interest allocations 2,918 (2,918) — — Total interest expense 13,091 — 1,559 14,650 Net interest income (expense) 44,093 21,951 (1,279) 64,765 Credit loss expense 2,019 846 — 2,865 Net interest income after credit loss expense 42,074 21,105 (1,279) 61,900 Noninterest income 6,401 1,291 50 7,742 Noninterest expense 38,371 12,792 990 52,153 Operating income (loss) $ 10,104 $ 9,604 $ (2,219) $ 17,489 (Dollars in thousands) Nine months ended September 30, 2020 Banking Factoring Corporate Consolidated Total interest income $ 157,957 $ 73,952 $ 267 $ 232,176 Intersegment interest allocations 8,873 (8,873) — — Total interest expense 25,368 — 5,678 31,046 Net interest income (expense) 141,462 65,079 (5,411) 201,130 Credit loss expense 27,378 4,437 1,834 33,649 Net interest income after credit loss expense 114,084 60,642 (7,245) 167,481 Gain on sale of subsidiary or division 9,758 — — 9,758 Other noninterest income 22,586 5,524 131 28,241 Noninterest expense 122,001 37,695 3,080 162,776 Operating income (loss) $ 24,427 $ 28,471 $ (10,194) $ 42,704 (Dollars in thousands) Nine months ended September 30, 2019 Banking Factoring Corporate Consolidated Total interest income $ 155,645 $ 73,435 $ 902 $ 229,982 Intersegment interest allocations 8,188 (8,188) — — Total interest expense 35,746 — 4,741 40,487 Net interest income (expense) 128,087 65,247 (3,839) 189,495 Credit loss expense (benefit) 5,847 1,789 (76) 7,560 Net interest income after credit loss expense 122,240 63,458 (3,763) 181,935 Noninterest income 19,150 3,572 181 22,903 Noninterest expense 109,406 39,340 2,677 151,423 Operating income (loss) $ 31,984 $ 27,690 $ (6,259) $ 53,415 (Dollars in thousands) September 30, 2020 Banking Factoring Corporate Eliminations Consolidated Total assets $ 5,767,857 $ 1,042,571 $ 828,065 $ (1,801,706) $ 5,836,787 Gross loans $ 4,759,135 $ 948,987 $ 800 $ (856,011) $ 4,852,911 (Dollars in thousands) December 31, 2019 Banking Factoring Corporate Eliminations Consolidated Total assets $ 4,976,009 $ 662,002 $ 771,048 $ (1,348,762) $ 5,060,297 Gross loans $ 4,108,735 $ 573,372 $ 1,519 $ (489,114) $ 4,194,512

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Details)	Jan. 01, 2020USD ($)	Sep. 30, 2020USD ($)loanssecurities	Mar. 31, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)loansinvestmentSegmentssecurities	Sep. 30, 2019USD ($)	Jun. 30, 2020USD ($)	Dec. 31, 2019USD ($)
Summary Of Significant Accounting Policies [Line Items]
Number of reportable segments | Segments					3
Accrued interest income and fees recognized on outstanding deferrals		$ 695,000			$ 695,000
Financing receivables payment of deferral modification, Number of loans | loans		77			77
Financing receivables payment of deferral modification		$ 102,987,000			$ 102,987,000
Loans, including fees		48,774,000		$ 50,249,000	147,491,000	$ 143,253,000
Held to maturity in subordinated notes		8,057,000			8,057,000
Held to maturity in subordinated notes, allowance for credit loss balances		1,961,000			1,961,000			$ 0
Debt securities accrued interest reversed		0		$ 0	$ 0	$ 0
Number of days within which accrual of interest income discontinues					90 days
Period of consumer loans charged off					120 days
Interest income is not recognized until loan balance reduced amount					$ 0
Useful life of assets					60 months
Change in national retail sales forecast period					1 year
Change in national home price index forecast period					1 year
Change in national gross domestic product forecast period					1 year
Economic projections forecast period					12 months
ASU 2016-13
Summary Of Significant Accounting Policies [Line Items]
Net reduction of retained earnings	$ 1,771,000		$ 1,771,000
Increase in the allowance for credit losses on loans	269,000	$ 0			$ 269,000
Increase in the allowance for credit losses on held to maturity debt securities	126,000
Increase in the allowance for credit losses on off-balance sheet credit exposures	1,918,000
Increases in deferred tax assets	$ 542,000
Fair Value Hedge
Summary Of Significant Accounting Policies [Line Items]
Number of position held | securities		0			0
CLO securities
Summary Of Significant Accounting Policies [Line Items]
Held to maturity in subordinated notes		$ 8,057,000			$ 8,057,000			8,417,000
Number of investments | investment					3
Number of investments impacted | investment					2
Held to maturity in subordinated notes, allowance for credit loss balances		1,961,000			$ 1,961,000		$ 1,855,000	$ 0
Held to maturity in subordinated notes, credit loss expense		106,000			$ 1,835,000
Paycheck Protection Program
Summary Of Significant Accounting Policies [Line Items]
Paycheck protection program loan interest rate coupon					1.00%
Number of PPP loans | loans					2,080
Paycheck protection program loans book value		$ 223,000,000			$ 223,000,000
Total fees received from Small Business Administration					7,700,000
Loans, including fees					$ 2,600,000
Minimum
Summary Of Significant Accounting Policies [Line Items]
Financing receivable payment deferral term					60 days
Number of days within which debt security placed on nonaccrual					90 days
Minimum | Paycheck Protection Program
Summary Of Significant Accounting Policies [Line Items]
Paycheck protection program loan term					2 years
Maximum
Summary Of Significant Accounting Policies [Line Items]
Financing receivable payment deferral term					90 days
Maximum | Paycheck Protection Program
Summary Of Significant Accounting Policies [Line Items]
Paycheck protection program loan term					5 years

Business Combinations and Div_3

Business Combinations and Divestitures - Additional Information (Details)	Sep. 23, 2020USD ($)shares	Jul. 08, 2020USD ($)clientshares	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)	Jul. 09, 2020USD ($)	Dec. 31, 2019USD ($)
Business Acquisition [Line Items]
Loans			$ 4,852,911,000	$ 4,852,911,000		$ 4,194,512,000
Line of credit, maximum borrowing capacity			227,500,000	227,500,000
Goodwill			163,263,000	163,263,000		158,743,000
Factored receivables
Business Acquisition [Line Items]
Loans			1,016,337,000	1,016,337,000		$ 619,986,000
Over-Formula Advances | Factored receivables
Business Acquisition [Line Items]
Loans			62,200,000	62,200,000
Transport Financial Solutions
Business Acquisition [Line Items]
Cash paid		$ 108,375,000
Number of common stock (in shares) | shares		630,268
Stock consideration		$ 13,942,000
Number of large clients | client		3
Portion of purchase price returned (in shares) | shares	630,268
Elimination amount of contingent consideration	$ 9,900,000
Goodwill		$ 4,520,000
Cash due from seller subsequent to liquidation of stock consideration		17,196,000
Total consideration		105,121,000		19,248,000
Noninterest Income, Other				2,000,000
Intangible assets		$ 3,500,000
Intangible asset, estimated useful life		8 years
Indemnification asset		$ 31,218,000
Factored receivables acquired, contractual amount		45,228,000
Factored receivables acquired, fair value		44,962,000
Acquisition related costs			827,000
Transport Financial Solutions | Over-Formula Advances
Business Acquisition [Line Items]
Loans	$ 62,200,000				$ 62,200,000
Transport Financial Solutions | Over-Formula Advances | Factored receivables
Business Acquisition [Line Items]
Loans			$ 62,200,000	$ 62,200,000
Transport Financial Solutions | Indemnification Agreement
Business Acquisition [Line Items]
Percent indemnified, first $30 million of losses	100.00%
First increment of losses incurred	$ 30,000,000
Percent indemnified, second $30 million of losses	50.00%
Second increment of losses incurred	$ 30,000,000
Total indemnification amount	45,000,000
Net orderly liquidation value	60,000,000
Transport Financial Solutions | Indemnification Agreement | CVLG
Business Acquisition [Line Items]
Line of credit, maximum borrowing capacity	$ 45,000,000
Transport Financial Solutions | Maximum
Business Acquisition [Line Items]
Fair value of consideration paid included contingent consideration		$ 9,900,000

Business Combinations and Div_4

Business Combinations and Divestitures - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($)	Jul. 08, 2020	Sep. 30, 2020	Dec. 31, 2019
Consideration:
Goodwill		$ 163,263,000	$ 158,743,000
Transport Financial Solutions
Assets acquired:
Factored receivables	$ 107,524,000
Allowance for credit losses	(37,415,000)
Factored receivables, net of ACL	70,109,000
Intangible assets	3,500,000
Indemnification asset	31,218,000
Deferred income taxes	1,387,000
Asset acquired	106,214,000
Liabilities assumed:
Deposits	5,613,000
Liabilities assumed	5,613,000
Fair value of net assets acquired	100,601,000
Consideration:
Cash paid	108,375,000
Stock consideration	13,942,000
Cash due from seller subsequent to liquidation of stock consideration	(17,196,000)
Total consideration	105,121,000	$ 19,248,000
Goodwill	$ 4,520,000

Business Combinations and Div_5

Business Combinations and Divestitures - Factored Receivables Purchased with Credit Deterioration (Details) - Transport Financial Solutions - Factored receivables - Over-Formula Advances $ in Thousands	Jul. 08, 2020USD ($)
Business Acquisition [Line Items]
Purchase price of loans at acquisition	$ 25,148
Allowance for credit losses at acquisition	37,415
Non-credit discount/(premium) at acquisition	941
Par value of acquired loans at acquisition	$ 63,504

Business Combinations and Div_6

Business Combinations and Divestitures - Summary of Carrying Amount of Assets in Disposal Group and Gain on Sale (Details) - USD ($) $ in Thousands	Apr. 20, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Carrying amount of liabilities in the disposal group:
Gain on sale of division, net of transaction costs		$ 0	$ 0	$ 9,758	$ 0
Triumph Premium Finance
Carrying amount of assets in the disposal group:
Loans	$ 84,504
Premises and equipment, net	45
Other assets	11
Total carrying amount	84,560
Carrying amount of liabilities in the disposal group:
Other liabilities	479
Total carrying amount	84,081
Total consideration received	94,531
Gain on sale of division	10,450
Transaction costs	692
Gain on sale of division, net of transaction costs	$ 9,758

Securities - Additional Informa

Securities - Additional Information (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)securitiesinvestment	Dec. 31, 2019USD ($)
Schedule Of Equity And Debt Securities [Line Items]
Equity securities, fair value	$ 6,040	$ 5,437
Pledged debt securities, at carrying value	$ 83,013	48,237
Number of securities in an unrealized loss position | securities	45
CLO securities
Schedule Of Equity And Debt Securities [Line Items]
Number of investments impacted | investment	2
Other Assets
Schedule Of Equity And Debt Securities [Line Items]
Accrued interest on available for sale securities	$ 1,316	1,685
Mutual fund
Schedule Of Equity And Debt Securities [Line Items]
Equity securities, fair value	$ 6,040	$ 5,437

Securities - Schedule of Gross

Securities - Schedule of Gross Realized and Unrealized Losses Recognized on Equity Securities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]
Unrealized gains (losses) on equity securities still held at the reporting date	$ (371)	$ 64	$ 603	$ 499
Realized gains (losses) on equity securities sold during the period	0	0	0	0
Gross realized and unrealized gains (losses) recognized on equity securities	$ (371)	$ 64	$ 603	$ 499

Securities - Schedule of Amorti

Securities - Schedule of Amortized Cost of Securities and Their Estimated Fair Values (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Available for sale securities:
Amortized Cost	$ 235,984		$ 247,381
Gross Unrealized Gains	7,277		1,957
Gross Unrealized Losses	(459)		(518)
Allowance for Credit Losses	0
Fair Value	242,802		248,820
Held to maturity securities:
Amortized Cost	8,057
Fair Value	5,473		6,907
Allowance for credit losses	(1,961)		0
U.S. Government agency obligations
Available for sale securities:
Amortized Cost	18,227		39,679
Gross Unrealized Gains	221		115
Gross Unrealized Losses	0		(34)
Allowance for Credit Losses	0
Fair Value	18,448		39,760
Mortgage-backed securities, residential
Available for sale securities:
Amortized Cost	28,604		37,324
Gross Unrealized Gains	1,189		728
Gross Unrealized Losses	(3)		(36)
Allowance for Credit Losses	0
Fair Value	29,790		38,016
Asset-backed securities
Available for sale securities:
Amortized Cost	7,173		8,039
Gross Unrealized Gains	0		0
Gross Unrealized Losses	(82)		(80)
Allowance for Credit Losses	0
Fair Value	7,091		7,959
State and municipal
Available for sale securities:
Amortized Cost	42,034		31,746
Gross Unrealized Gains	1,328		327
Gross Unrealized Losses	0		(8)
Allowance for Credit Losses	0
Fair Value	43,362		32,065
CLO securities
Available for sale securities:
Amortized Cost	113,795		75,592
Gross Unrealized Gains	4,058		39
Gross Unrealized Losses	(362)		(358)
Allowance for Credit Losses	0
Fair Value	117,491		75,273
Held to maturity securities:
Amortized Cost	8,057		8,417
Gross Unrealized Gains	0		0
Gross Unrecognized Losses	(2,584)		(1,510)
Fair Value	5,473		6,907
Allowance for credit losses	(1,961)	$ (1,855)	0
Corporate bonds
Available for sale securities:
Amortized Cost	22,615		50,889
Gross Unrealized Gains	319		695
Gross Unrealized Losses	(7)		(1)
Allowance for Credit Losses	0
Fair Value	22,927		51,583
SBA pooled securities
Available for sale securities:
Amortized Cost	3,536		4,112
Gross Unrealized Gains	162		53
Gross Unrealized Losses	(5)		(1)
Allowance for Credit Losses	0
Fair Value	$ 3,693		$ 4,164

Securities - Schedule of Amor_2

Securities - Schedule of Amortized Cost and Estimated Fair Value of Debt Securities by Contractual Maturity (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Available for Sale Securities, Amortized Cost
Due in one year or less, Amortized Cost	$ 38,449
Due from one year to five years, Amortized Cost	19,799
Due from five years to ten years, Amortized Cost	24,878
Due after ten years, Amortized Cost	113,545
Available for Sale Securities, with single maturity date, Amortized Cost	196,671
Available for sale securities, Amortized Cost	235,984	$ 247,381
Available for Sale Securities, Fair Value
Due in one year or less, Fair Value	38,799
Due from one year to five years, Fair Value	20,264
Due from five years to ten years, Fair Value	26,456
Due after ten years, Fair Value	116,709
Available for Sale Securities, with single maturity date, Fair Value	202,228
Available for Sale Securities, Fair Value	242,802	248,820
Held to Maturity Securities, Amortized Cost
Due in one year or less, Amortized Cost	0
Due from one year to five years, Amortized Cost	0
Due from five years to ten years, Amortized Cost	8,057
Due after ten years, Amortized Cost	0
Held to Maturity Securities, with single maturity date, Amortized Cost	8,057
Amortized Cost	8,057
Held to Maturity Securities, Fair Value
Due in one year or less, Fair Value	0
Due from one year to five years, Fair Value	0
Due from five years to ten years, Fair Value	5,473
Due after ten years, Fair Value	0
Held to Maturity Securities, with single maturity date, Fair Value	5,473
Held to Maturity Securities, Fair Value	5,473	6,907
Mortgage-backed securities, residential
Available for Sale Securities, Amortized Cost
Available for Sale Securities, without single maturity date, Amortized Cost	28,604
Available for sale securities, Amortized Cost	28,604	37,324
Available for Sale Securities, Fair Value
Available for Sale Securities, without single maturity date, Fair Value	29,790
Available for Sale Securities, Fair Value	29,790	38,016
Held to Maturity Securities, Amortized Cost
Held to Maturity Securities, without single maturity date, Amortized Cost	0
Held to Maturity Securities, Fair Value
Held to Maturity Securities, without single maturity date, Fair Value	0
Asset-backed securities
Available for Sale Securities, Amortized Cost
Available for Sale Securities, without single maturity date, Amortized Cost	7,173
Available for sale securities, Amortized Cost	7,173	8,039
Available for Sale Securities, Fair Value
Available for Sale Securities, without single maturity date, Fair Value	7,091
Available for Sale Securities, Fair Value	7,091	7,959
Held to Maturity Securities, Amortized Cost
Held to Maturity Securities, without single maturity date, Amortized Cost	0
Held to Maturity Securities, Fair Value
Held to Maturity Securities, without single maturity date, Fair Value	0
SBA pooled securities
Available for Sale Securities, Amortized Cost
Available for Sale Securities, without single maturity date, Amortized Cost	3,536
Available for sale securities, Amortized Cost	3,536	4,112
Available for Sale Securities, Fair Value
Available for Sale Securities, without single maturity date, Fair Value	3,693
Available for Sale Securities, Fair Value	3,693	$ 4,164
Held to Maturity Securities, Amortized Cost
Held to Maturity Securities, without single maturity date, Amortized Cost	0
Held to Maturity Securities, Fair Value
Held to Maturity Securities, without single maturity date, Fair Value	$ 0

Securities - Schedule of Procee

Securities - Schedule of Proceeds from Sales of Debt Securities and the Associated Gross Gains and Losses as well as Net Gains and Losses from Calls of Debt Securities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]
Proceeds	$ 65,184	$ 0	$ 65,184	$ 40,617
Gross gains	3,217	0	3,217	133
Gross losses	(140)	0	(140)	(130)
Net gains and losses from calls of securities	$ 32	$ 19	$ 133	$ 19

Securities - Schedule of Availa

Securities - Schedule of Available for Sale Debt Securities in an Unrealized Loss Position (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	$ 18,590	$ 65,611
Less than 12 Months, Unrealized Losses	(158)	(423)
12 Months or More, Fair Value	42,150	21,665
12 Months or More, Unrealized Losses	(301)	(95)
Total, Fair Value	60,740	87,276
Total, Unrealized Losses	(459)	(518)
U.S. Government agency obligations
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	0	0
Less than 12 Months, Unrealized Losses	0	0
12 Months or More, Fair Value	0	12,331
12 Months or More, Unrealized Losses	0	(34)
Total, Fair Value	0	12,331
Total, Unrealized Losses	0	(34)
Mortgage-backed securities, residential
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	127	3,549
Less than 12 Months, Unrealized Losses	(1)	(29)
12 Months or More, Fair Value	288	777
12 Months or More, Unrealized Losses	(2)	(7)
Total, Fair Value	415	4,326
Total, Unrealized Losses	(3)	(36)
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	150	2,986
Less than 12 Months, Unrealized Losses	(1)	(36)
12 Months or More, Fair Value	6,941	4,973
12 Months or More, Unrealized Losses	(81)	(44)
Total, Fair Value	7,091	7,959
Total, Unrealized Losses	(82)	(80)
State and municipal
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	0	562
Less than 12 Months, Unrealized Losses	0	0
12 Months or More, Fair Value	0	3,426
12 Months or More, Unrealized Losses	0	(8)
Total, Fair Value	0	3,988
Total, Unrealized Losses	0	(8)
CLO securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	16,591	58,160
Less than 12 Months, Unrealized Losses	(144)	(358)
12 Months or More, Fair Value	34,739	0
12 Months or More, Unrealized Losses	(218)	0
Total, Fair Value	51,330	58,160
Total, Unrealized Losses	(362)	(358)
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	996	0
Less than 12 Months, Unrealized Losses	(7)	0
12 Months or More, Fair Value	150	149
12 Months or More, Unrealized Losses	0	(1)
Total, Fair Value	1,146	149
Total, Unrealized Losses	(7)	(1)
SBA pooled securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	726	354
Less than 12 Months, Unrealized Losses	(5)	0
12 Months or More, Fair Value	32	9
12 Months or More, Unrealized Losses	0	(1)
Total, Fair Value	758	363
Total, Unrealized Losses	$ (5)	$ (1)

Securities - Summary of Activit

Securities - Summary of Activity in Allowance for Credit Losses for Held To Maturity Debt Securities (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses beginning balance		$ 0
Allowance for credit losses ending balance	$ 1,961	1,961
CLO securities
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses beginning balance	1,855	0
Credit loss expense	106	1,835
Allowance for credit losses ending balance	1,961	1,961
ASU 2016-13 | CLO securities
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Roll Forward]
Impact of adopting ASC 326	$ 0	$ 126

Loans and Allowance for Credi_3

Loans and Allowance for Credit Losses - Schedule of Loans Held for Sale (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for sale	$ 36,716	$ 2,735
Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for sale	19,919	0
1-4 family residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for sale	11,644	2,735
Commercial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans held for sale	$ 5,153	$ 0

Loans and Allowance for Credi_4

Loans and Allowance for Credit Losses - Schedule of Amortized Cost and Unpaid Principal for Impaired Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total	$ 4,852,911		$ 4,194,512
Unpaid Principal	4,878,269		4,209,477
Difference	(25,358)		(14,965)
Allowance for credit losses	(90,995)	$ (54,613)	(29,092)	$ (31,895)	$ (29,416)	$ (27,571)
Loans, net	4,761,916		4,165,420
Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total	762,531		1,046,961
Unpaid Principal	766,471		1,051,684
Difference	(3,940)		(4,723)
Allowance for credit losses	(13,152)	(15,539)	(5,353)	(5,798)	(5,677)	(4,493)
Construction, land development, land
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total	244,512		160,569
Unpaid Principal	244,966		162,335
Difference	(454)		(1,766)
Allowance for credit losses	(5,600)	(5,917)	(1,382)	(1,084)	(1,035)	(1,134)
1-4 family residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total	164,785		179,425
Unpaid Principal	165,442		180,340
Difference	(657)		(915)
Allowance for credit losses	(1,972)	(2,027)	(308)	(417)	(409)	(317)
Farmland
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total	110,966		154,975
Unpaid Principal	111,870		156,995
Difference	(904)		(2,020)
Allowance for credit losses	(863)	(958)	(670)	(939)	(590)	(535)
Commercial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total	1,536,903		1,342,683
Unpaid Principal	1,554,805		1,346,444
Difference	(17,902)		(3,761)
Allowance for credit losses	(22,713)	(23,283)	(12,566)	(14,771)	(13,899)	(12,865)
Factored receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total	1,016,337		619,986
Unpaid Principal	1,017,805		621,697
Difference	(1,468)		(1,711)
Allowance for credit losses	(44,985)	(5,244)	(7,657)	(7,717)	(6,861)	(7,299)
Consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total	17,106		21,925
Unpaid Principal	17,139		21,994
Difference	(33)		(69)
Allowance for credit losses	(710)	(768)	(488)	(581)	(563)	(615)
Mortgage warehouse
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total	999,771		667,988
Unpaid Principal	999,771		667,988
Difference	0		0
Allowance for credit losses	$ (1,000)	$ (877)	$ (668)	$ (588)	$ (382)	$ (313)

Loans and Allowance for Credi_5

Loans and Allowance for Credit Losses - Additional Information (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)loan	Sep. 30, 2019USD ($)loan	Jun. 30, 2020USD ($)	Dec. 31, 2019USD ($)	Jun. 30, 2019USD ($)	Dec. 31, 2018USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for sale	$ 36,716,000		$ 36,716,000			$ 2,735,000
Premiums and discounts on acquired loans	20,121,000		20,121,000			13,573,000
Net deferred origination and factoring fees	5,237,000		5,237,000			1,392,000
Accrued interest on loans	18,933,000		18,933,000			18,553,000
Loans	4,852,911,000		4,852,911,000			4,194,512,000
Pledged loans	2,185,499,000		2,185,499,000			1,301,851,000
Loans transferred to loans held for sale	56,934,000	$ 21,180,000	172,565,000	$ 27,411,000
Proceeds from loans transferred to loans held for sale	58,313,000	19,322,000	145,513,000	25,653,000
Net gains (losses) on sale of loans			2,323,000	409,000
Allowance for credit loss on loans purchased with credit deterioration	37,415,000		37,415,000
Loans past due	116,596,000		116,596,000			72,859,000
Interest earned on nonaccrual loans	0	0	0	0
Recorded investments in troubled debt restructurings	18,326,000		18,326,000			5,221,000
Allowance for credit losses	90,995,000	31,895,000	$ 90,995,000	$ 31,895,000	$ 54,613,000	29,092,000	$ 29,416,000	$ 27,571,000
Number of defaults on modified loans | loan			2	2
Recorded investments in troubled debt restructurings			$ 18,000	$ 240,000
Financing receivable, modifications of loans cares act	12,625,000		617,976,000
Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	78,689,000		78,689,000			39,055,000
Troubled Debt Restructuring
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses	2,030,000		2,030,000			718,000
Changes in Allowance for Credit Losses
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses change due to loss drivers	600,000		23,300,000
Net charge-offs	700,000		3,300,000
Allowance for credit losses on charged off loans	800,000		1,600,000
Change in allowance for credit losses due to net new specific reserves	800,000		5,700,000
Other non interest income
Accounts, Notes, Loans and Financing Receivable [Line Items]
Net gains (losses) on sale of loans	(515,000)	129,000	(466,000)	229,000
Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for sale	19,919,000		19,919,000			0
Loans	762,531,000		762,531,000			1,046,961,000
Allowance for credit loss on loans purchased with credit deterioration	0		0
Loans past due	11,373,000		11,373,000			4,839,000
Allowance for credit losses	13,152,000	5,798,000	13,152,000	5,798,000	15,539,000	5,353,000	5,677,000	4,493,000
Commercial real estate | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	1,714,000		1,714,000			1,752,000
Factored receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Customer reserves	110,510,000		110,510,000			66,754,000
Loans	1,016,337,000		1,016,337,000			619,986,000
Allowance for credit loss on loans purchased with credit deterioration	37,415,000		37,415,000
Loans past due	84,407,000		84,407,000			40,526,000
Allowance for credit losses	44,985,000	7,717,000	44,985,000	7,717,000	5,244,000	7,657,000	6,861,000	7,299,000
Factored receivables | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	68,522,000		68,522,000			29,118,000
Factored receivables | Over-Formula Advances
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	62,200,000		62,200,000
Allowance for credit loss on loans purchased with credit deterioration	37,400,000		37,400,000
Factored receivables | Over-Formula Advances | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	38,500,000		38,500,000
1-4 family residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for sale	11,644,000		11,644,000			2,735,000
Loans	164,785,000		164,785,000			179,425,000
Allowance for credit loss on loans purchased with credit deterioration	0		0
Loans past due	2,959,000		2,959,000			2,673,000
Allowance for credit losses	1,972,000	$ 417,000	1,972,000	$ 417,000	$ 2,027,000	308,000	$ 409,000	$ 317,000
1-4 family residential | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	1,049,000		1,049,000			1,396,000
1-4 family residential | Real Eatate Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Residential real estate loans in process of foreclosure	$ 208,000		$ 208,000			$ 87,000

Loans and Allowance for Credi_6

Loans and Allowance for Credit Losses - Summary of Allowance for Loan and Lease Losses (Details) - USD ($) $ in Thousands	Jan. 01, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 29,092	$ 54,613	$ 29,416	$ 29,092	$ 27,571
Initial ACL on Loans Purchased with Credit Deterioration		37,415		37,415
Credit Loss Expense		(356)	2,865	27,974	7,560
Charge-offs		(1,425)	(878)	(4,637)	(4,107)
Recoveries		748	492	1,331	871
Reclassification to Held For Sale		0		(449)
Ending Balance		90,995	31,895	90,995	31,895
ASU 2016-13
Allowance for Loan and Lease Losses [Roll Forward]
Impact of Adopting ASC 326	269	0		269
Commercial real estate
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	5,353	15,539	5,677	5,353	4,493
Initial ACL on Loans Purchased with Credit Deterioration		0		0
Credit Loss Expense		(2,440)	147	6,366	1,343
Charge-offs		0	(26)	0	(39)
Recoveries		53	0	61	1
Reclassification to Held For Sale		0		0
Ending Balance		13,152	5,798	13,152	5,798
Commercial real estate | ASU 2016-13
Allowance for Loan and Lease Losses [Roll Forward]
Impact of Adopting ASC 326		0		1,372
Construction, land development, land
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	1,382	5,917	1,035	1,382	1,134
Initial ACL on Loans Purchased with Credit Deterioration		0		0
Credit Loss Expense		(319)	47	4,400	(63)
Charge-offs		0	0	0	(78)
Recoveries		2	2	5	91
Reclassification to Held For Sale		0		0
Ending Balance		5,600	1,084	5,600	1,084
Construction, land development, land | ASU 2016-13
Allowance for Loan and Lease Losses [Roll Forward]
Impact of Adopting ASC 326		0		(187)
1-4 family residential
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	308	2,027	409	308	317
Initial ACL on Loans Purchased with Credit Deterioration		0		0
Credit Loss Expense		(56)	4	1,138	86
Charge-offs		(6)	0	(27)	(43)
Recoveries		7	4	40	57
Reclassification to Held For Sale		0		0
Ending Balance		1,972	417	1,972	417
1-4 family residential | ASU 2016-13
Allowance for Loan and Lease Losses [Roll Forward]
Impact of Adopting ASC 326		0		513
Farmland
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	670	958	590	670	535
Initial ACL on Loans Purchased with Credit Deterioration		0		0
Credit Loss Expense		(95)	349	(324)	404
Charge-offs		0	0	0	0
Recoveries		0	0	80	0
Reclassification to Held For Sale		0		0
Ending Balance		863	939	863	939
Farmland | ASU 2016-13
Allowance for Loan and Lease Losses [Roll Forward]
Impact of Adopting ASC 326		0		437
Commercial
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	12,566	23,283	13,899	12,566	12,865
Initial ACL on Loans Purchased with Credit Deterioration		0		0
Credit Loss Expense		(657)	1,195	11,004	3,252
Charge-offs		(528)	(557)	(1,173)	(1,671)
Recoveries		615	234	949	325
Reclassification to Held For Sale		0		(449)
Ending Balance		22,713	14,771	22,713	14,771
Commercial | ASU 2016-13
Allowance for Loan and Lease Losses [Roll Forward]
Impact of Adopting ASC 326		0		(184)
Factored receivables
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	7,657	5,244	6,861	7,657	7,299
Initial ACL on Loans Purchased with Credit Deterioration		37,415		37,415
Credit Loss Expense		3,059	851	4,475	1,839
Charge-offs		(773)	(210)	(3,027)	(1,682)
Recoveries		40	215	95	261
Reclassification to Held For Sale		0		0
Ending Balance		44,985	7,717	44,985	7,717
Factored receivables | ASU 2016-13
Allowance for Loan and Lease Losses [Roll Forward]
Impact of Adopting ASC 326		0		(1,630)
Consumer
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	488	768	563	488	615
Initial ACL on Loans Purchased with Credit Deterioration		0		0
Credit Loss Expense		29	66	583	424
Charge-offs		(118)	(85)	(410)	(594)
Recoveries		31	37	101	136
Reclassification to Held For Sale		0		0
Ending Balance		710	581	710	581
Consumer | ASU 2016-13
Allowance for Loan and Lease Losses [Roll Forward]
Impact of Adopting ASC 326		0		(52)
Mortgage warehouse
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 668	877	382	668	313
Initial ACL on Loans Purchased with Credit Deterioration		0		0
Credit Loss Expense		123	206	332	275
Charge-offs		0	0	0	0
Recoveries		0	0	0	0
Reclassification to Held For Sale		0		0
Ending Balance		1,000	$ 588	1,000	$ 588
Mortgage warehouse | ASU 2016-13
Allowance for Loan and Lease Losses [Roll Forward]
Impact of Adopting ASC 326		$ 0		$ 0

Loans and Allowance for Credi_7

Loans and Allowance for Credit Losses - Summary of Amortized Cost Basis of Collateral Dependent Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Financing Receivable, Allowance for Credit Loss [Line Items]
ACL Allocation	$ 90,995	$ 54,613	$ 29,092	$ 31,895	$ 29,416	$ 27,571
Collateral dependent loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	114,576
ACL Allocation	46,627
Collateral dependent loans | Real Estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	23,061
Collateral dependent loans | Accounts Receivable
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	78,768
Collateral dependent loans | Equipment
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	7,182
Collateral dependent loans | Other
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	5,565
Commercial real estate
Financing Receivable, Allowance for Credit Loss [Line Items]
ACL Allocation	13,152	15,539	5,353	5,798	5,677	4,493
Commercial real estate | Collateral dependent loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	14,564
ACL Allocation	1,668
Commercial real estate | Collateral dependent loans | Real Estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	14,198
Commercial real estate | Collateral dependent loans | Accounts Receivable
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Commercial real estate | Collateral dependent loans | Equipment
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Commercial real estate | Collateral dependent loans | Other
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	366
Construction, land development, land
Financing Receivable, Allowance for Credit Loss [Line Items]
ACL Allocation	5,600	5,917	1,382	1,084	1,035	1,134
Construction, land development, land | Collateral dependent loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	2,112
ACL Allocation	271
Construction, land development, land | Collateral dependent loans | Real Estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	2,112
Construction, land development, land | Collateral dependent loans | Accounts Receivable
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Construction, land development, land | Collateral dependent loans | Equipment
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Construction, land development, land | Collateral dependent loans | Other
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
1-4 family residential
Financing Receivable, Allowance for Credit Loss [Line Items]
ACL Allocation	1,972	2,027	308	417	409	317
1-4 family residential | Collateral dependent loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	2,143
ACL Allocation	24
1-4 family residential | Collateral dependent loans | Real Estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	1,962
1-4 family residential | Collateral dependent loans | Accounts Receivable
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
1-4 family residential | Collateral dependent loans | Equipment
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
1-4 family residential | Collateral dependent loans | Other
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	181
Farmland
Financing Receivable, Allowance for Credit Loss [Line Items]
ACL Allocation	863	958	670	939	590	535
Farmland | Collateral dependent loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	2,634
ACL Allocation	0
Farmland | Collateral dependent loans | Real Estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	1,914
Farmland | Collateral dependent loans | Accounts Receivable
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Farmland | Collateral dependent loans | Equipment
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	148
Farmland | Collateral dependent loans | Other
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	572
Commercial
Financing Receivable, Allowance for Credit Loss [Line Items]
ACL Allocation	22,713	23,283	12,566	14,771	13,899	12,865
Commercial | Collateral dependent loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	18,926
ACL Allocation	4,563
Commercial | Collateral dependent loans | Real Estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	2,875
Commercial | Collateral dependent loans | Accounts Receivable
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	4,893
Commercial | Collateral dependent loans | Equipment
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	7,034
Commercial | Collateral dependent loans | Other
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	4,124
Factored receivables
Financing Receivable, Allowance for Credit Loss [Line Items]
ACL Allocation	44,985	5,244	7,657	7,717	6,861	7,299
Factored receivables | Collateral dependent loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	73,875
ACL Allocation	40,072
Factored receivables | Collateral dependent loans | Real Estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Factored receivables | Collateral dependent loans | Accounts Receivable
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	73,875
Factored receivables | Collateral dependent loans | Equipment
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Factored receivables | Collateral dependent loans | Other
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Consumer
Financing Receivable, Allowance for Credit Loss [Line Items]
ACL Allocation	710	768	488	581	563	615
Consumer | Collateral dependent loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	322
ACL Allocation	29
Consumer | Collateral dependent loans | Real Estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Consumer | Collateral dependent loans | Accounts Receivable
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Consumer | Collateral dependent loans | Equipment
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Consumer | Collateral dependent loans | Other
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	322
Mortgage warehouse
Financing Receivable, Allowance for Credit Loss [Line Items]
ACL Allocation	1,000	$ 877	$ 668	$ 588	$ 382	$ 313
Mortgage warehouse | Collateral dependent loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
ACL Allocation	0
Mortgage warehouse | Collateral dependent loans | Real Estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Mortgage warehouse | Collateral dependent loans | Accounts Receivable
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Mortgage warehouse | Collateral dependent loans | Equipment
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	0
Mortgage warehouse | Collateral dependent loans | Other
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost	$ 0

Loans and Allowance for Credi_8

Loans and Allowance for Credit Losses - Summary of Individual and Collective Allowance for Loan Losses and Loan Balances by Class (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Financing Receivable, Allowance for Credit Loss [Line Items]
Loan Evaluation, Individually			$ 49,851
Loan Evaluation, Collectively			4,131,986
Loans	$ 4,852,911		4,194,512
ALLL Allocations, Individually			5,113
ALLL Allocations, Collectively			23,975
Allowance for credit losses	90,995	$ 54,613	29,092	$ 31,895	$ 29,416	$ 27,571
Purchased Credit Impaired Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans			12,675
Allowance for credit losses			4
Commercial real estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Loan Evaluation, Individually			7,455
Loan Evaluation, Collectively			1,030,439
Loans	762,531		1,046,961
ALLL Allocations, Individually			344
ALLL Allocations, Collectively			5,009
Allowance for credit losses	13,152	15,539	5,353	5,798	5,677	4,493
Commercial real estate | Purchased Credit Impaired Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans			9,067
Allowance for credit losses			0
Construction, land development, land
Financing Receivable, Allowance for Credit Loss [Line Items]
Loan Evaluation, Individually			2,138
Loan Evaluation, Collectively			155,985
Loans	244,512		160,569
ALLL Allocations, Individually			271
ALLL Allocations, Collectively			1,111
Allowance for credit losses	5,600	5,917	1,382	1,084	1,035	1,134
Construction, land development, land | Purchased Credit Impaired Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans			2,446
Allowance for credit losses			0
1-4 family residential
Financing Receivable, Allowance for Credit Loss [Line Items]
Loan Evaluation, Individually			1,728
Loan Evaluation, Collectively			177,189
Loans	164,785		179,425
ALLL Allocations, Individually			33
ALLL Allocations, Collectively			275
Allowance for credit losses	1,972	2,027	308	417	409	317
1-4 family residential | Purchased Credit Impaired Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans			508
Allowance for credit losses			0
Farmland
Financing Receivable, Allowance for Credit Loss [Line Items]
Loan Evaluation, Individually			6,638
Loan Evaluation, Collectively			148,233
Loans	110,966		154,975
ALLL Allocations, Individually			0
ALLL Allocations, Collectively			670
Allowance for credit losses	863	958	670	939	590	535
Farmland | Purchased Credit Impaired Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans			104
Allowance for credit losses			0
Commercial
Financing Receivable, Allowance for Credit Loss [Line Items]
Loan Evaluation, Individually			15,618
Loan Evaluation, Collectively			1,326,515
Loans	1,536,903		1,342,683
ALLL Allocations, Individually			1,278
ALLL Allocations, Collectively			11,284
Allowance for credit losses	22,713	23,283	12,566	14,771	13,899	12,865
Commercial | Purchased Credit Impaired Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans			550
Allowance for credit losses			4
Factored receivables
Financing Receivable, Allowance for Credit Loss [Line Items]
Loan Evaluation, Individually			15,947
Loan Evaluation, Collectively			604,039
Loans	1,016,337		619,986
ALLL Allocations, Individually			3,178
ALLL Allocations, Collectively			4,479
Allowance for credit losses	44,985	5,244	7,657	7,717	6,861	7,299
Factored receivables | Purchased Credit Impaired Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans			0
Allowance for credit losses			0
Consumer
Financing Receivable, Allowance for Credit Loss [Line Items]
Loan Evaluation, Individually			327
Loan Evaluation, Collectively			21,598
Loans	17,106		21,925
ALLL Allocations, Individually			9
ALLL Allocations, Collectively			479
Allowance for credit losses	710	768	488	581	563	615
Consumer | Purchased Credit Impaired Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans			0
Allowance for credit losses			0
Mortgage warehouse
Financing Receivable, Allowance for Credit Loss [Line Items]
Loan Evaluation, Individually			0
Loan Evaluation, Collectively			667,988
Loans	999,771		667,988
ALLL Allocations, Individually			0
ALLL Allocations, Collectively			668
Allowance for credit losses	$ 1,000	$ 877	668	$ 588	$ 382	$ 313
Mortgage warehouse | Purchased Credit Impaired Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans			0
Allowance for credit losses			$ 0

Loans and Allowance for Credi_9

Loans and Allowance for Credit Losses - Summary of Information Pertaining to Impaired Loans (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019	Dec. 31, 2019
Financing Receivable, Impaired [Line Items]
Recorded Investment, With Valuation Allowance			$ 23,908
Unpaid Principal, With Valuation Allowance			23,928
Related Allowance, With Valuation Allowance			5,117
Recorded Investment, Without Valuation Allowance			26,014
Unpaid Principal, Without Valuation Allowance			26,635
Average Impaired Loans	$ 43,881	$ 44,145
Interest Recognized	555	653
Purchased Credit Impaired Loans
Financing Receivable, Impaired [Line Items]
Recorded Investment, With Valuation Allowance			71
Unpaid Principal, With Valuation Allowance			55
Related Allowance, With Valuation Allowance			4
Recorded Investment, Without Valuation Allowance			0
Unpaid Principal, Without Valuation Allowance			0
Average Impaired Loans	71	71
Interest Recognized	0	0
Commercial real estate
Financing Receivable, Impaired [Line Items]
Recorded Investment, With Valuation Allowance			878
Unpaid Principal, With Valuation Allowance			907
Related Allowance, With Valuation Allowance			344
Recorded Investment, Without Valuation Allowance			6,577
Unpaid Principal, Without Valuation Allowance			6,643
Average Impaired Loans	7,500	7,675
Interest Recognized	180	180
Construction, land development, land
Financing Receivable, Impaired [Line Items]
Recorded Investment, With Valuation Allowance			935
Unpaid Principal, With Valuation Allowance			935
Related Allowance, With Valuation Allowance			271
Recorded Investment, Without Valuation Allowance			1,203
Unpaid Principal, Without Valuation Allowance			1,305
Average Impaired Loans	1,087	624
Interest Recognized	5	5
1-4 family residential
Financing Receivable, Impaired [Line Items]
Recorded Investment, With Valuation Allowance			35
Unpaid Principal, With Valuation Allowance			22
Related Allowance, With Valuation Allowance			33
Recorded Investment, Without Valuation Allowance			1,693
Unpaid Principal, Without Valuation Allowance			1,799
Average Impaired Loans	2,353	2,326
Interest Recognized	13	15
Farmland
Financing Receivable, Impaired [Line Items]
Recorded Investment, With Valuation Allowance			0
Unpaid Principal, With Valuation Allowance			0
Related Allowance, With Valuation Allowance			0
Recorded Investment, Without Valuation Allowance			6,638
Unpaid Principal, Without Valuation Allowance			6,819
Average Impaired Loans	6,737	7,186
Interest Recognized	31	75
Commercial
Financing Receivable, Impaired [Line Items]
Recorded Investment, With Valuation Allowance			6,032
Unpaid Principal, With Valuation Allowance			6,053
Related Allowance, With Valuation Allowance			1,278
Recorded Investment, Without Valuation Allowance			9,586
Unpaid Principal, Without Valuation Allowance			9,751
Average Impaired Loans	15,222	16,397
Interest Recognized	321	373
Factored receivables
Financing Receivable, Impaired [Line Items]
Recorded Investment, With Valuation Allowance			15,940
Unpaid Principal, With Valuation Allowance			15,940
Related Allowance, With Valuation Allowance			3,178
Recorded Investment, Without Valuation Allowance			7
Unpaid Principal, Without Valuation Allowance			7
Average Impaired Loans	10,453	9,455
Interest Recognized	0	0
Consumer
Financing Receivable, Impaired [Line Items]
Recorded Investment, With Valuation Allowance			17
Unpaid Principal, With Valuation Allowance			16
Related Allowance, With Valuation Allowance			9
Recorded Investment, Without Valuation Allowance			310
Unpaid Principal, Without Valuation Allowance			311
Average Impaired Loans	458	411
Interest Recognized	5	5
Mortgage warehouse
Financing Receivable, Impaired [Line Items]
Recorded Investment, With Valuation Allowance			0
Unpaid Principal, With Valuation Allowance			0
Related Allowance, With Valuation Allowance			0
Recorded Investment, Without Valuation Allowance			0
Unpaid Principal, Without Valuation Allowance			$ 0
Average Impaired Loans	0	0
Interest Recognized	$ 0	$ 0

Loans and Allowance for Cred_10

Loans and Allowance for Credit Losses - Summary of Contractually Past Due and Nonaccrual Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	$ 116,596	$ 72,859
Current	4,736,315	4,121,653
Total	4,852,911	4,194,512
Past Due 90 Days or More and Accruing	10,344	5,369
Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	78,689	39,055
Past Due 60-90 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	17,614	14,790
Past Due 90 Days or More
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	20,293	19,014
Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	11,373	4,839
Current	751,158	1,042,122
Total	762,531	1,046,961
Past Due 90 Days or More and Accruing	1,287	0
Commercial real estate | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	1,714	1,752
Commercial real estate | Past Due 60-90 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	6,993	1,328
Commercial real estate | Past Due 90 Days or More
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	2,666	1,759
Construction, land development, land
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	2,686	2,988
Current	241,826	157,581
Total	244,512	160,569
Past Due 90 Days or More and Accruing	0	0
Construction, land development, land | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	608	1,785
Construction, land development, land | Past Due 60-90 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	894	842
Construction, land development, land | Past Due 90 Days or More
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	1,184	361
1-4 family residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	2,959	2,673
Current	161,826	176,752
Total	164,785	179,425
Past Due 90 Days or More and Accruing	143	286
1-4 family residential | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	1,049	1,396
1-4 family residential | Past Due 60-90 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	849	723
1-4 family residential | Past Due 90 Days or More
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	1,061	554
Farmland
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	684	2,560
Current	110,282	152,415
Total	110,966	154,975
Past Due 90 Days or More and Accruing	0	0
Farmland | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	400	52
Farmland | Past Due 60-90 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	0	132
Farmland | Past Due 90 Days or More
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	284	2,376
Commercial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	13,821	18,153
Current	1,523,082	1,324,530
Total	1,536,903	1,342,683
Past Due 90 Days or More and Accruing	276	808
Commercial | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	5,954	4,444
Commercial | Past Due 60-90 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	1,548	4,154
Commercial | Past Due 90 Days or More
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	6,319	9,555
Factored receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	84,407	40,526
Current	931,930	579,460
Total	1,016,337	619,986
Past Due 90 Days or More and Accruing	8,638	4,226
Factored receivables | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	68,522	29,118
Factored receivables | Past Due 60-90 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	7,247	7,182
Factored receivables | Past Due 90 Days or More
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	8,638	4,226
Consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	666	1,120
Current	16,440	20,805
Total	17,106	21,925
Past Due 90 Days or More and Accruing	0	49
Consumer | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	442	508
Consumer | Past Due 60-90 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	83	429
Consumer | Past Due 90 Days or More
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	141	183
Mortgage warehouse
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	0	0
Current	999,771	667,988
Total	999,771	667,988
Past Due 90 Days or More and Accruing	0	0
Mortgage warehouse | Past Due 30-59 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	0	0
Mortgage warehouse | Past Due 60-90 Days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	0	0
Mortgage warehouse | Past Due 90 Days or More
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans past due	$ 0	$ 0

Loans and Allowance for Cred_11

Loans and Allowance for Credit Losses - Summary of Amortized Cost Basis of Loans on Nonaccrual Status (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual	$ 38,321	$ 36,054
Nonaccrual With No ACL	15,429	28,085
Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual	12,235	7,501
Nonaccrual With No ACL	4,700	6,623
Construction, land development, land
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual	2,089	3,922
Nonaccrual With No ACL	1,180	2,987
1-4 family residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual	1,761	1,730
Nonaccrual With No ACL	1,640	1,694
Farmland
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual	2,452	6,494
Nonaccrual With No ACL	2,452	6,494
Commercial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual	19,462	16,080
Nonaccrual With No ACL	5,210	9,977
Factored receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual	0	0
Nonaccrual With No ACL	0	0
Consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual	322	327
Nonaccrual With No ACL	247	310
Mortgage warehouse
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual	0	0
Nonaccrual With No ACL	$ 0	$ 0

Loans and Allowance for Cred_12

Loans and Allowance for Credit Losses - Summary of Accrued Interest on Non Accrual Loans Reversed Through Interest Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Financing Receivable, Allowance for Credit Loss [Line Items]
Accrued interest reversed through interest income	$ 466	$ 54	$ 581	$ 133
Commercial real estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Accrued interest reversed through interest income	371	13	435	32
Construction, land development, land
Financing Receivable, Allowance for Credit Loss [Line Items]
Accrued interest reversed through interest income	1	0	1	9
1-4 family residential
Financing Receivable, Allowance for Credit Loss [Line Items]
Accrued interest reversed through interest income	21	0	31	12
Farmland
Financing Receivable, Allowance for Credit Loss [Line Items]
Accrued interest reversed through interest income	36	26	36	27
Commercial
Financing Receivable, Allowance for Credit Loss [Line Items]
Accrued interest reversed through interest income	37	13	76	50
Factored receivables
Financing Receivable, Allowance for Credit Loss [Line Items]
Accrued interest reversed through interest income	0	0	0	0
Consumer
Financing Receivable, Allowance for Credit Loss [Line Items]
Accrued interest reversed through interest income	0	2	2	3
Mortgage warehouse
Financing Receivable, Allowance for Credit Loss [Line Items]
Accrued interest reversed through interest income	$ 0	$ 0	$ 0	$ 0

Loans and Allowance for Cred_13

Loans and Allowance for Credit Losses - Schedule of Nonperforming Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual loans	$ 38,321	$ 36,054
Factored receivables greater than 90 days past due	10,344	5,369
Troubled Debt Restructuring
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual loans	15,743	4,888
Factored receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual loans	0	0
Factored receivables greater than 90 days past due	8,638	4,226
Nonperforming Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Nonaccrual loans	38,321	36,054
Troubled debt restructurings accruing interest	3	333
Total loans	56,991	40,613
Nonperforming Loans | Factored receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Factored receivables greater than 90 days past due	8,638	4,226
Other nonperforming factored receivables	$ 10,029	$ 0

Loans and Allowance for Cred_14

Loans and Allowance for Credit Losses - Summary of Analysis Performed Risk category Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	$ 2,465,365
2019	291,855
2018	240,124
2017	181,503
2016	72,651
Prior	116,021
Revolving Loans	1,466,782
Revolving Loans Converted To Term Loans	18,610
Total	4,852,911	$ 4,194,512
Purchased Credit Impaired Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total		12,675
Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	2,420,288
2019	282,712
2018	233,522
2017	179,183
2016	70,547
Prior	112,614
Revolving Loans	1,453,456
Revolving Loans Converted To Term Loans	18,610
Total	4,770,932	4,115,695
Classified
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	45,077
2019	9,143
2018	6,602
2017	2,320
2016	2,104
Prior	3,407
Revolving Loans	13,326
Revolving Loans Converted To Term Loans	0
Total	81,979	66,142
Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	388,911
2019	85,895
2018	96,000
2017	92,748
2016	36,428
Prior	54,517
Revolving Loans	7,124
Revolving Loans Converted To Term Loans	908
Total	762,531	1,046,961
Commercial real estate | Purchased Credit Impaired Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total		9,067
Commercial real estate | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	374,993
2019	85,458
2018	95,818
2017	92,112
2016	35,576
Prior	53,189
Revolving Loans	7,124
Revolving Loans Converted To Term Loans	908
Total	745,178	1,030,358
Commercial real estate | Classified
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	13,918
2019	437
2018	182
2017	636
2016	852
Prior	1,328
Revolving Loans	0
Revolving Loans Converted To Term Loans	0
Total	17,353	7,536
Construction, land development, land
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	142,845
2019	30,492
2018	55,887
2017	12,362
2016	268
Prior	2,145
Revolving Loans	13
Revolving Loans Converted To Term Loans	500
Total	244,512	160,569
Construction, land development, land | Purchased Credit Impaired Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total		2,446
Construction, land development, land | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	141,940
2019	29,654
2018	55,887
2017	12,362
2016	268
Prior	1,776
Revolving Loans	13
Revolving Loans Converted To Term Loans	500
Total	242,400	155,985
Construction, land development, land | Classified
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	905
2019	838
2018	0
2017	0
2016	0
Prior	369
Revolving Loans	0
Revolving Loans Converted To Term Loans	0
Total	2,112	2,138
1-4 family residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	36,529
2019	12,690
2018	15,188
2017	13,316
2016	12,132
Prior	30,834
Revolving Loans	38,776
Revolving Loans Converted To Term Loans	5,320
Total	164,785	179,425
1-4 family residential | Purchased Credit Impaired Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total		508
1-4 family residential | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	35,959
2019	12,614
2018	15,172
2017	13,316
2016	11,773
Prior	30,076
Revolving Loans	38,669
Revolving Loans Converted To Term Loans	5,320
Total	162,899	177,177
1-4 family residential | Classified
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	570
2019	76
2018	16
2017	0
2016	359
Prior	758
Revolving Loans	107
Revolving Loans Converted To Term Loans	0
Total	1,886	1,740
Farmland
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	21,077
2019	17,517
2018	18,130
2017	15,313
2016	13,829
Prior	21,710
Revolving Loans	2,904
Revolving Loans Converted To Term Loans	486
Total	110,966	154,975
Farmland | Purchased Credit Impaired Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total		104
Farmland | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	19,870
2019	17,100
2018	16,458
2017	15,168
2016	13,829
Prior	21,150
Revolving Loans	2,130
Revolving Loans Converted To Term Loans	486
Total	106,191	144,777
Farmland | Classified
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	1,207
2019	417
2018	1,672
2017	145
2016	0
Prior	560
Revolving Loans	774
Revolving Loans Converted To Term Loans	0
Total	4,775	10,094
Commercial
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	855,846
2019	142,626
2018	53,298
2017	42,976
2016	6,744
Prior	5,896
Revolving Loans	418,121
Revolving Loans Converted To Term Loans	11,396
Total	1,536,903	1,342,683
Commercial | Purchased Credit Impaired Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total		550
Commercial | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	848,660
2019	135,269
2018	48,573
2017	41,531
2016	6,013
Prior	5,548
Revolving Loans	405,676
Revolving Loans Converted To Term Loans	11,396
Total	1,502,666	1,313,042
Commercial | Classified
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	7,186
2019	7,357
2018	4,725
2017	1,445
2016	731
Prior	348
Revolving Loans	12,445
Revolving Loans Converted To Term Loans	0
Total	34,237	29,091
Factored receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	1,016,337
2019	0
2018	0
2017	0
2016	0
Prior	0
Revolving Loans	0
Revolving Loans Converted To Term Loans	0
Total	1,016,337	619,986
Factored receivables | Purchased Credit Impaired Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total		0
Factored receivables | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	995,046
2019	0
2018	0
2017	0
2016	0
Prior	0
Revolving Loans	0
Revolving Loans Converted To Term Loans	0
Total	995,046	604,774
Factored receivables | Classified
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	21,291
2019	0
2018	0
2017	0
2016	0
Prior	0
Revolving Loans	0
Revolving Loans Converted To Term Loans	0
Total	21,291	15,212
Consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	3,820
2019	2,635
2018	1,621
2017	4,788
2016	3,250
Prior	919
Revolving Loans	73
Revolving Loans Converted To Term Loans	0
Total	17,106	21,925
Consumer | Purchased Credit Impaired Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total		0
Consumer | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	3,820
2019	2,617
2018	1,614
2017	4,694
2016	3,088
Prior	875
Revolving Loans	73
Revolving Loans Converted To Term Loans	0
Total	16,781	21,594
Consumer | Classified
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	0
2019	18
2018	7
2017	94
2016	162
Prior	44
Revolving Loans	0
Revolving Loans Converted To Term Loans	0
Total	325	331
Mortgage warehouse
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	0
2019	0
2018	0
2017	0
2016	0
Prior	0
Revolving Loans	999,771
Revolving Loans Converted To Term Loans	0
Total	999,771	667,988
Mortgage warehouse | Purchased Credit Impaired Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total		0
Mortgage warehouse | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	0
2019	0
2018	0
2017	0
2016	0
Prior	0
Revolving Loans	999,771
Revolving Loans Converted To Term Loans	0
Total	999,771	667,988
Mortgage warehouse | Classified
Accounts, Notes, Loans and Financing Receivable [Line Items]
2020	0
2019	0
2018	0
2017	0
2016	0
Prior	0
Revolving Loans	0
Revolving Loans Converted To Term Loans	0
Total	$ 0	$ 0

Loans and Allowance for Cred_15

Loans and Allowance for Credit Losses - Schedule of Loans Modified as Troubled Debt Restructurings (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020USD ($)loan	Sep. 30, 2019USD ($)loan	Sep. 30, 2020USD ($)loan	Sep. 30, 2019USD ($)loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications	$ 3,626	$ 554	$ 17,750	$ 6,923
Number of Loans | loan	14	1	23	7
Extended Amortization Period
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications	$ 123	$ 554	$ 8,208	$ 1,649
Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications	3,503	0	9,542	84
AB Note Restructure
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications	0	0	0	4,597
Interest Rate Reduction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications	0	0	0	593
Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications		$ 0	$ 246	$ 4,597
Number of Loans | loan		0	2	1
Commercial real estate | Extended Amortization Period
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications		$ 0	$ 0	$ 0
Commercial real estate | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications		0	246	0
Commercial real estate | AB Note Restructure
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications		0	0	4,597
Commercial real estate | Interest Rate Reduction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications		0	0	0
Construction, land development, land
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications			$ 8
Number of Loans | loan			1
Construction, land development, land | Extended Amortization Period
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications			$ 8
Construction, land development, land | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications			0
Construction, land development, land | AB Note Restructure
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications			0
Construction, land development, land | Interest Rate Reduction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications			0
Farmland
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications			$ 3,486
Number of Loans | loan			1
Farmland | Extended Amortization Period
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications			$ 3,486
Farmland | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications			0
Farmland | AB Note Restructure
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications			0
Farmland | Interest Rate Reduction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications			0
Commercial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications	$ 3,626	$ 554	$ 14,010	$ 2,326
Number of Loans | loan	14	1	19	6
Commercial | Extended Amortization Period
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications	$ 123	$ 554	$ 4,714	$ 1,649
Commercial | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications	3,503	0	9,296	84
Commercial | AB Note Restructure
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications	0	0	0	0
Commercial | Interest Rate Reduction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Modifications	$ 0	$ 0	$ 0	$ 593

Loans and Allowance for Cred_16

Loans and Allowance for Credit Losses - Summary of Amortized Cost of Loans Currently in Deferral (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans	$ 4,852,911	$ 4,194,512
Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Balance of Loans Currently in Deferral	$ 102,987
Percentage of Portfolio	2.10%
Accrued Interest Receivable	$ 695
Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans	762,531	1,046,961
Commercial real estate | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Balance of Loans Currently in Deferral	$ 77,419
Percentage of Portfolio	10.20%
Accrued Interest Receivable	$ 464
Construction, land development, land
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans	244,512	160,569
Construction, land development, land | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Balance of Loans Currently in Deferral	$ 116
Percentage of Portfolio	0.00%
Accrued Interest Receivable	$ 1
1-4 family residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans	164,785	179,425
1-4 family residential | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Balance of Loans Currently in Deferral	$ 8,560
Percentage of Portfolio	5.20%
Accrued Interest Receivable	$ 127
Farmland
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans	110,966	154,975
Farmland | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Balance of Loans Currently in Deferral	$ 0
Percentage of Portfolio	0.00%
Accrued Interest Receivable	$ 0
Commercial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans	1,536,903	1,342,683
Commercial | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Balance of Loans Currently in Deferral	$ 16,787
Percentage of Portfolio	1.10%
Accrued Interest Receivable	$ 99
Factored receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans	1,016,337	619,986
Factored receivables | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Balance of Loans Currently in Deferral	$ 0
Percentage of Portfolio	0.00%
Accrued Interest Receivable	$ 0
Consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans	17,106	21,925
Consumer | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Balance of Loans Currently in Deferral	$ 105
Percentage of Portfolio	0.60%
Accrued Interest Receivable	$ 4
Mortgage warehouse
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans	999,771	$ 667,988
Mortgage warehouse | Payment Deferrals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Balance of Loans Currently in Deferral	$ 0
Percentage of Portfolio	0.00%
Accrued Interest Receivable	$ 0

Loans and Allowance for Cred_17

Loans and Allowance for Credit Losses - Schedule of Outstanding Contractually Required Principal and Interest and Carrying Amount of PCI Loans Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding contractually required principal and interest		$ 14,692
Gross loans	$ 4,852,911	4,194,512
Real Estate Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding contractually required principal and interest		14,015
Commercial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding contractually required principal and interest		677
Gross loans	$ 1,536,903	1,342,683
Purchased Credit Impaired Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans		12,675
Purchased Credit Impaired Loans | Commercial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross loans		$ 550

Loans and Allowance for Cred_18

Loans and Allowance for Credit Losses - Schedule of Changes in Accretable Yield for the PCI Loans (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Accretable Yield Movement Schedule [Roll Forward]
Accretable yield, beginning balance	$ 4,793	$ 5,711
Additions	0	0
Accretion	(460)	(1,228)
Reclassification from nonaccretable to accretable yield	50	64
Disposals	(54)	(218)
Accretable yield, ending balance	$ 4,329	$ 4,329

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Intangible Assets and Goodwill (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Goodwill And Intangible Assets [Line Items]
Goodwill	$ 163,263	$ 158,743
Gross Carrying Amount	62,778	59,278
Accumulated Amortization	(34,000)	(27,735)
Net Carrying Amount	28,778	31,543
Core deposit intangibles
Goodwill And Intangible Assets [Line Items]
Gross Carrying Amount	43,578	43,578
Accumulated Amortization	(26,217)	(22,258)
Net Carrying Amount	17,361	21,320
Other intangible assets
Goodwill And Intangible Assets [Line Items]
Gross Carrying Amount	19,200	15,700
Accumulated Amortization	(7,783)	(5,477)
Net Carrying Amount	$ 11,417	$ 10,223

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Changes in Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Goodwill [Roll Forward]
Goodwill and intangible assets, beginning	$ 186,162	$ 194,668	$ 190,286	$ 199,417
Acquired goodwill	4,520	0	4,520	0
Acquired intangibles	3,500	0	3,500	0
Amortization of intangibles	(2,141)	(2,228)	(6,265)	(6,977)
Goodwill and intangible assets, ending	$ 192,041	$ 192,440	$ 192,041	$ 192,440

Derivative Financial Instrume_3

Derivative Financial Instruments - Additional Information (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)
Derivative Instruments, Gain (Loss) [Line Items]
Fair value of derivatives in a net liability position	$ 0
Terminal value of agreements	0
Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of estimate additional reclassified as an increase in interest expense	$ 132

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Fair Value of Derivative Financial Instruments Classification on Balance Sheet (Details) - Derivatives Designated as Hedging Instruments - Interest rate swaps - Other Liabilities $ in Thousands	Sep. 30, 2020USD ($)
Derivatives, Fair Value [Line Items]
Derivative Liabilities Notional Amount	$ 200,000
Derivative Liabilities Fair Value Total	$ 16

Derivative Financial Instrume_5

Derivative Financial Instruments - Schedule of Effect of Fair Value and Cash Flow Hedge on Accumulated Other Comprehensive Income, Net of Tax (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Recognized in OCI on Derivative	$ 257	$ 0	$ 11	$ 0
Amount of Gain or (Loss) Reclassified from AOCI into Income	12	$ 0	12	$ 0
Derivatives in Cash Flow Hedging Relationships | Interest rate swaps
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Recognized in OCI on Derivative	257		11
Amount of Gain or (Loss) Recognized in OCI Included Component	257		11
Derivatives in Cash Flow Hedging Relationships | Interest rate swaps | Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Income	(16)		(16)
Amount of Gain or (Loss) Reclassified from AOCI into Income Included Component	$ (16)		$ (16)

Variable Interest Entities - Su

Variable Interest Entities - Summary of Closed Collateralized Loan Obligation ("CLO") Funds (Details) - Collateralized Loan Obligation Funds - USD ($) $ in Thousands	Jun. 20, 2017	Sep. 22, 2016	Jun. 02, 2016
Trinitas IV
Variable Interest Entity [Line Items]
Offering Amount			$ 406,650
Trinitas V
Variable Interest Entity [Line Items]
Offering Amount		$ 409,000
Trinitas VI
Variable Interest Entity [Line Items]
Offering Amount	$ 717,100

Variable Interest Entities - Ad

Variable Interest Entities - Additional Information - (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Variable Interest Entity [Line Items]
Securities - held to maturity, net carrying amount	$ 6,096	$ 8,417
Collateralized Loan Obligation Funds
Variable Interest Entity [Line Items]
Securities - held to maturity, net carrying amount	$ 6,096	$ 8,417

Borrowings and Borrowing Capa_3

Borrowings and Borrowing Capacity - Summary of Customer Repurchase Agreements (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Amount outstanding at end of period	$ 14,192	$ 2,033
Weighted average interest rate at end of period	0.03%	0.03%
Average daily balance during the period	$ 6,520	$ 7,823
Weighted average interest rate during the period	0.03%	0.02%
Maximum month-end balance during the period	$ 14,192	$ 14,463

Borrowings and Borrowing Capa_4

Borrowings and Borrowing Capacity - Additional Information (Details) - USD ($)	Nov. 27, 2019	Sep. 30, 2016	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Pledged debt securities, at carrying value			$ 83,013,000	$ 48,237,000
Amount outstanding at end of period			223,713,000	0
Federal funds purchased			0	0
Unsecured federal funds line of credit			227,500,000
Subordinated notes			87,455,000	87,327,000
Junior subordinated debentures			39,944,000	39,566,000
Fixed-to-Floating Rate Subordinated Notes due 2026
Debt Instrument [Line Items]
Subordinated notes issued		$ 50,000,000
Initial interest rate		6.50%
Issuance costs of notes		$ 1,324,000
Subordinated notes			$ 87,455,000
Fixed-to-Floating Rate Subordinated Notes due 2026 | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Description of floating rate basis			three-month LIBOR
Basis spread on variable rate		5.345%
Fixed-to-Floating Rate Subordinated Notes due 2029
Debt Instrument [Line Items]
Subordinated notes issued	$ 39,500,000
Initial interest rate	4.875%
Issuance costs of notes	$ 1,218,000
Subordinated notes				87,327,000
Fixed-to-Floating Rate Subordinated Notes due 2029 | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Description of floating rate basis			three-month LIBOR
Basis spread on variable rate	3.33%
Junior Subordinated Debentures | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Debt weighted average interest rate			2.24%
Federal Reserve Bank Discount Window
Debt Instrument [Line Items]
Amount outstanding at end of period			$ 0
Unused borrowing capacity			467,256,000
Loans pledged outstanding			636,992,000
Paycheck Protection Program Liquidity Facility
Debt Instrument [Line Items]
Amount outstanding at end of period			$ 223,713,000	0
Debt weighted average interest rate			0.35%
Pledged Securities | Customer Repurchase Agreements
Debt Instrument [Line Items]
Pledged debt securities, at carrying value			$ 14,544,000	$ 2,997,000

Borrowings and Borrowing Capa_5

Borrowings and Borrowing Capacity - Summary of FHLB Advances and Weighted Average Interest Rates by Contractual Maturity (Details) $ in Thousands	Sep. 30, 2020USD ($)
Debt Disclosure [Abstract]
2020, Balance Outstanding, Fixed Rate	$ 405,000
2027, Balance Outstanding, Fixed Rate	0
Total Balance Outstanding, Fixed Rate	$ 405,000
2020, Fixed Weighted Average Interest Rate	0.13%
2027, Fixed Weighted Average Interest Rate	0.00%
Total Fixed Weighted Average Interest Rate	0.13%
2020, Balance Outstanding, Variable Rate	$ 0
2027, Balance Outstanding, Variable Rate	30,000
Total Balance Outstanding, Variable Rate	$ 30,000
2020, Variable Weighted Average Interest Rate	0.00%
2027, Variable Weighted Average Interest Rate	0.33%
Total Variable Weighted Average Interest Rate	0.33%

Borrowings and Borrowing Capa_6

Borrowings and Borrowing Capacity - Summary of Information Concerning FHLB Advances (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Federal home loan bank advances, amount outstanding at end of period	$ 435,000,000	$ 430,000,000
Weighted average interest rate at end of period	0.15%	1.58%
Average amount outstanding during the period	$ 430,250,000	$ 369,548,000
Weighted average interest rate during the period	0.61%	2.32%
Highest month end balance during the period	$ 850,000,000	$ 530,000,000

Borrowings and Borrowing Capa_7

Borrowings and Borrowing Capacity - Schedule of FHLB Advances (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Borrowing capacity	$ 1,323,927	$ 1,300,985
Borrowings outstanding	435,000	430,000
Unused borrowing capacity	$ 888,927	$ 870,985

Borrowings and Borrowing Capa_8

Borrowings and Borrowing Capacity - Summary of Information Concerning Borrowings under PPPLF (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Amount outstanding at end of period	$ 223,713,000	$ 0
Paycheck Protection Program Liquidity Facility
Debt Instrument [Line Items]
Amount outstanding at end of period	$ 223,713,000	$ 0
Weighted average interest rate at end of period	0.35%
Average amount outstanding during the period	$ 119,236,000
Weighted average interest rate during the period	0.35%
Highest month end balance during the period	$ 223,809,000

Borrowings and Borrowing Capa_9

Borrowings and Borrowing Capacity - Summary of Scheduled Maturities of PPPLF Borrowings (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Total	$ 223,713,000	$ 0
Paycheck Protection Program Liquidity Facility
Debt Instrument [Line Items]
Within one year	0
After one but within two years	223,713,000
Total	$ 223,713,000	$ 0

Borrowings and Borrowing Cap_10

Borrowings and Borrowing Capacity - Summary of Junior Subordinated Debentures (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Face Value	$ 51,031
Carrying Value	39,944	$ 39,566
National Bancshares Capital Trust II
Debt Instrument [Line Items]
Face Value	15,464
Carrying Value	$ 13,187
National Bancshares Capital Trust II | London Interbank Offered Rate (LIBOR) | Junior Subordinated Debentures
Debt Instrument [Line Items]
Basis spread on variable rate	3.00%
National Bancshares Capital Trust III
Debt Instrument [Line Items]
Face Value	$ 17,526
Carrying Value	$ 12,924
National Bancshares Capital Trust III | London Interbank Offered Rate (LIBOR) | Junior Subordinated Debentures
Debt Instrument [Line Items]
Basis spread on variable rate	1.64%
ColoEast Capital Trust I
Debt Instrument [Line Items]
Face Value	$ 5,155
Carrying Value	$ 3,594
ColoEast Capital Trust I | London Interbank Offered Rate (LIBOR) | Junior Subordinated Debentures
Debt Instrument [Line Items]
Basis spread on variable rate	1.60%
ColoEast Capital Trust II
Debt Instrument [Line Items]
Face Value	$ 6,700
Carrying Value	$ 4,684
ColoEast Capital Trust II | London Interbank Offered Rate (LIBOR) | Junior Subordinated Debentures
Debt Instrument [Line Items]
Basis spread on variable rate	1.79%
Valley Bancorp Statutory Trust I
Debt Instrument [Line Items]
Face Value	$ 3,093
Carrying Value	$ 2,876
Valley Bancorp Statutory Trust I | London Interbank Offered Rate (LIBOR) | Junior Subordinated Debentures
Debt Instrument [Line Items]
Basis spread on variable rate	3.40%
Valley Bancorp Statutory Trust II
Debt Instrument [Line Items]
Face Value	$ 3,093
Carrying Value	$ 2,679
Valley Bancorp Statutory Trust II | London Interbank Offered Rate (LIBOR) | Junior Subordinated Debentures
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%

Off-Balance Sheet Loan Commit_3

Off-Balance Sheet Loan Commitments - Summary of Financial Instruments with Off-Balance Sheet Risk - (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Unused lines of credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial instruments, off balance sheet risk, Fixed Rate	$ 35,764	$ 49,057
Financial instruments, off balance sheet risk, Variable Rate	594,305	444,028
Financial instruments, off balance sheet risk	630,069	493,085
Standby letters of credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial instruments, off balance sheet risk, Fixed Rate	5,382	3,017
Financial instruments, off balance sheet risk, Variable Rate	3,259	3,781
Financial instruments, off balance sheet risk	8,641	6,798
Commitments to purchase loans
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial instruments, off balance sheet risk, Fixed Rate	0
Financial instruments, off balance sheet risk, Variable Rate	51,747	22,004
Financial instruments, off balance sheet risk	51,747	22,004
Mortgage warehouse commitments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial instruments, off balance sheet risk, Fixed Rate	0	0
Financial instruments, off balance sheet risk, Variable Rate	318,972	340,502
Financial instruments, off balance sheet risk	$ 318,972	$ 340,502

Off-Balance Sheet Loan Commit_4

Off-Balance Sheet Loan Commitments - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Other Noninterest Expense
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Credit loss expense (reversal) for off-balance sheet credit exposure	$ (8,000)	$ 150,000	$ 3,840,000	$ 116,000
Other Liabilities
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Allowance for credit losses on off-balance sheet credit exposure	$ 6,395,000		$ 6,395,000		$ 638,000

Fair Value Disclosures - Additi

Fair Value Disclosures - Additional Information (Details)	Jun. 02, 2018USD ($)	Sep. 30, 2020USD ($)	Dec. 31, 2019USD ($)
Fair Value, Measurements, Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value disclosure		$ 0	$ 0
Minimum | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Selling and closing costs for loans as a percentage of appraised value		5.00%
Maximum | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Selling and closing costs for loans as a percentage of appraised value		8.00%
Interstate Capital Corporation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration earnout period	30 months
Final contingent consideration payout		$ 22,000,000	$ 22,000,000
Interstate Capital Corporation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Final contingent consideration payout	$ 0
Interstate Capital Corporation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Final contingent consideration payout	$ 22,000,000
Measurement Input Discount Rate | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Indemnification asset, discount rate		0.04
Measurement Input Discount Rate | Interstate Capital Corporation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration fair value, discount rate		0.002	0.017
Measurement Input, Appraised Value | Minimum | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Real estate selling and closing costs, percentage of appraised value		0.05
Measurement Input, Appraised Value | Maximum | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Real estate selling and closing costs, percentage of appraised value		0.08

Fair Value Disclosures - Assets

Fair Value Disclosures - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Assets measured at fair value on a recurring basis
Securities - available for sale	$ 242,802	$ 248,820
Securities - equity investments	6,040	5,437
Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	242,802	248,820
Loans held for sale	36,716	2,735
Fair Value, Measurements, Recurring | Interest rate swaps
Assets measured at fair value on a recurring basis
Derivative financial instruments (cash flow hedges)	16
Mutual fund
Assets measured at fair value on a recurring basis
Securities - equity investments	6,040	5,437
Mutual fund | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - equity investments	6,040	5,437
U.S. Government agency obligations
Assets measured at fair value on a recurring basis
Securities - available for sale	18,448	39,760
U.S. Government agency obligations | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	18,448	39,760
Mortgage-backed securities, residential
Assets measured at fair value on a recurring basis
Securities - available for sale	29,790	38,016
Mortgage-backed securities, residential | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	29,790	38,016
Asset-backed securities
Assets measured at fair value on a recurring basis
Securities - available for sale	7,091	7,959
Asset-backed securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	7,091	7,959
State and municipal
Assets measured at fair value on a recurring basis
Securities - available for sale	43,362	32,065
State and municipal | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	43,362	32,065
CLO securities
Assets measured at fair value on a recurring basis
Securities - available for sale	117,491	75,273
CLO securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	117,491	75,273
Corporate bonds
Assets measured at fair value on a recurring basis
Securities - available for sale	22,927	51,583
Corporate bonds | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	22,927	51,583
SBA pooled securities
Assets measured at fair value on a recurring basis
Securities - available for sale	3,693	4,164
SBA pooled securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	3,693	4,164
ICC Contingent consideration | Fair Value, Measurements, Recurring
Liabilities measured at fair value on a recurring basis
Fair value of consideration paid included contingent consideration	21,991	21,622
Level 1 | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Loans held for sale	0	0
Level 1 | Fair Value, Measurements, Recurring | Interest rate swaps
Assets measured at fair value on a recurring basis
Derivative financial instruments (cash flow hedges)	0
Level 1 | Mutual fund | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - equity investments	6,040	5,437
Level 1 | U.S. Government agency obligations | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 1 | Mortgage-backed securities, residential | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 1 | Asset-backed securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 1 | State and municipal | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 1 | CLO securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 1 | Corporate bonds | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 1 | SBA pooled securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 1 | ICC Contingent consideration | Fair Value, Measurements, Recurring
Liabilities measured at fair value on a recurring basis
Fair value of consideration paid included contingent consideration	0	0
Level 2 | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	242,802	248,820
Loans held for sale	36,716	2,735
Level 2 | Fair Value, Measurements, Recurring | Interest rate swaps
Assets measured at fair value on a recurring basis
Derivative financial instruments (cash flow hedges)	16
Level 2 | Mutual fund | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - equity investments	0	0
Level 2 | U.S. Government agency obligations | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	18,448	39,760
Level 2 | Mortgage-backed securities, residential | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	29,790	38,016
Level 2 | Asset-backed securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	7,091	7,959
Level 2 | State and municipal | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	43,362	32,065
Level 2 | CLO securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	117,491	75,273
Level 2 | Corporate bonds | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	22,927	51,583
Level 2 | SBA pooled securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	3,693	4,164
Level 2 | ICC Contingent consideration | Fair Value, Measurements, Recurring
Liabilities measured at fair value on a recurring basis
Fair value of consideration paid included contingent consideration	0	0
Level 3 | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Loans held for sale	0	0
Level 3 | Fair Value, Measurements, Recurring | Interest rate swaps
Assets measured at fair value on a recurring basis
Derivative financial instruments (cash flow hedges)	0
Level 3 | Mutual fund | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - equity investments	0	0
Level 3 | U.S. Government agency obligations | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 3 | Mortgage-backed securities, residential | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 3 | Asset-backed securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 3 | State and municipal | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 3 | CLO securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 3 | Corporate bonds | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 3 | SBA pooled securities | Fair Value, Measurements, Recurring
Assets measured at fair value on a recurring basis
Securities - available for sale	0	0
Level 3 | ICC Contingent consideration | Fair Value, Measurements, Recurring
Liabilities measured at fair value on a recurring basis
Fair value of consideration paid included contingent consideration	$ 21,991	$ 21,622

Fair Value Disclosures - Reconc

Fair Value Disclosures - Reconciliation of Opening Balance to Closing Balance of Fair Value of Contingent Consideration (Details) - Level 3 - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 21,963	$ 21,302	$ 21,622	$ 20,745
Contingent consideration recognized in business combination	0	0	0	0
Change in fair value of contingent consideration recognized in earnings	28	124	369	681
Consideration settlement payments	0	0	0	0
Ending balance	$ 21,991	$ 21,426	$ 21,991	$ 21,426

Fair Value Disclosures - Fair V

Fair Value Disclosures - Fair Value of Assets Measured on Non-recurring Basis (Details) - Fair Value, Measurements, Nonrecurring - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	$ 43,566	$ 19,268
Collateral dependent loans | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	5,302
Collateral dependent loans | Construction, land development, land
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	637
Collateral dependent loans | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	5
Collateral dependent loans | Commercial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	3,584
Collateral dependent loans | Factored receivables
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	33,803
Collateral dependent loans | Consumer
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	46
Other real estate owned | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		388
Other real estate owned | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	189	89
Impaired loans | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		534
Impaired loans | Construction, land development, land
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		664
Impaired loans | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		2
Impaired loans | Commercial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		4,754
Impaired loans | Factored receivables
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		12,762
Impaired loans | Consumer
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		8
Impaired loans | PCI
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		67
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0	0
Level 1 | Collateral dependent loans | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 1 | Collateral dependent loans | Construction, land development, land
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 1 | Collateral dependent loans | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 1 | Collateral dependent loans | Commercial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 1 | Collateral dependent loans | Factored receivables
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 1 | Collateral dependent loans | Consumer
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 1 | Other real estate owned | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 1 | Other real estate owned | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0	0
Level 1 | Impaired loans | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 1 | Impaired loans | Construction, land development, land
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 1 | Impaired loans | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 1 | Impaired loans | Commercial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 1 | Impaired loans | Factored receivables
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 1 | Impaired loans | Consumer
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 1 | Impaired loans | PCI
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0	0
Level 2 | Collateral dependent loans | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 2 | Collateral dependent loans | Construction, land development, land
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 2 | Collateral dependent loans | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 2 | Collateral dependent loans | Commercial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 2 | Collateral dependent loans | Factored receivables
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 2 | Collateral dependent loans | Consumer
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0
Level 2 | Other real estate owned | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 2 | Other real estate owned | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	0	0
Level 2 | Impaired loans | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 2 | Impaired loans | Construction, land development, land
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 2 | Impaired loans | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 2 | Impaired loans | Commercial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 2 | Impaired loans | Factored receivables
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 2 | Impaired loans | Consumer
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 2 | Impaired loans | PCI
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	43,566	19,268
Level 3 | Collateral dependent loans | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	5,302
Level 3 | Collateral dependent loans | Construction, land development, land
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	637
Level 3 | Collateral dependent loans | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	5
Level 3 | Collateral dependent loans | Commercial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	3,584
Level 3 | Collateral dependent loans | Factored receivables
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	33,803
Level 3 | Collateral dependent loans | Consumer
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	46
Level 3 | Other real estate owned | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		388
Level 3 | Other real estate owned | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring	$ 189	89
Level 3 | Impaired loans | Commercial real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		534
Level 3 | Impaired loans | Construction, land development, land
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		664
Level 3 | Impaired loans | 1-4 family residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		2
Level 3 | Impaired loans | Commercial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		4,754
Level 3 | Impaired loans | Factored receivables
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		12,762
Level 3 | Impaired loans | Consumer
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		8
Level 3 | Impaired loans | PCI
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure, nonrecurring		$ 67

Fair Value Disclosures - Estima

Fair Value Disclosures - Estimated Fair Value of Company's Financial Assets and Financial Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Financial assets:
Cash and cash equivalents, Carrying Amount	$ 288,278	$ 197,880
Securities - held to maturity, Carrying Amount	6,096	8,417
Loans not previously presented Carrying Amount	4,810,731	4,170,604
FHLB and other restricted stock, Carrying Amount	18,464	19,860
Accrued interest receivable, Carrying Amount	20,254	20,322
Cash and cash equivalents, Fair Value	288,278	197,880
Securities - Held to maturity, Fair value	5,473	6,907
Loans not previously presented Fair Value	4,791,092	4,170,051
Accrued interest receivable, Fair Value	20,254	20,322
Financial liabilities:
Deposits, Carrying Amount	4,248,101	3,789,906
Customer repurchase agreements, Carrying Amount	14,192	2,033
Federal Home Loan Bank advances, Carrying Amount	435,000	430,000
Paycheck Protection Program Liquidity Facility	223,713	0
Subordinated notes, Carrying Amount	87,455	87,327
Junior subordinated debentures	39,944	39,566
Accrued interest payable, Carrying Amount	6,006	9,367
Deposits, Fair Value	4,254,371	3,793,603
Customer repurchase agreements, Fair Value	14,192	2,033
Federal Home Loan Bank advances, Fair Value	435,000	430,000
Paycheck Protection Program Liquidity Facility, Fair Value	223,713
Subordinated notes, Fair Value	89,806	93,877
Junior subordinated debentures, Fair Value	40,135	40,700
Accrued interest payable, Fair Value	6,006	9,367
Level 1
Financial assets:
Cash and cash equivalents, Fair Value	288,278	197,880
Securities - Held to maturity, Fair value	0	0
Loans not previously presented Fair Value	197,859	83,454
Accrued interest receivable, Fair Value	20,254	20,322
Financial liabilities:
Deposits, Fair Value	0	0
Customer repurchase agreements, Fair Value	0	0
Federal Home Loan Bank advances, Fair Value	0	0
Paycheck Protection Program Liquidity Facility, Fair Value	0
Subordinated notes, Fair Value	0	0
Junior subordinated debentures, Fair Value	0	0
Accrued interest payable, Fair Value	6,006	9,367
Level 2
Financial assets:
Cash and cash equivalents, Fair Value	0	0
Securities - Held to maturity, Fair value	0	0
Loans not previously presented Fair Value	0	0
Accrued interest receivable, Fair Value	0	0
Financial liabilities:
Deposits, Fair Value	4,254,371	3,793,603
Customer repurchase agreements, Fair Value	14,192	2,033
Federal Home Loan Bank advances, Fair Value	435,000	430,000
Paycheck Protection Program Liquidity Facility, Fair Value	223,713
Subordinated notes, Fair Value	89,806	93,877
Junior subordinated debentures, Fair Value	40,135	40,700
Accrued interest payable, Fair Value	0	0
Level 3
Financial assets:
Cash and cash equivalents, Fair Value	0	0
Securities - Held to maturity, Fair value	5,473	6,907
Loans not previously presented Fair Value	4,593,233	4,086,597
Accrued interest receivable, Fair Value	0	0
Financial liabilities:
Deposits, Fair Value	0	0
Customer repurchase agreements, Fair Value	0	0
Federal Home Loan Bank advances, Fair Value	0	0
Paycheck Protection Program Liquidity Facility, Fair Value	0
Subordinated notes, Fair Value	0	0
Junior subordinated debentures, Fair Value	0	0
Accrued interest payable, Fair Value	$ 0	$ 0

Regulatory Matters - Schedule o

Regulatory Matters - Schedule of Actual Capital Amounts and Ratios (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Triumph Bancorp Inc
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Total Capital (to Risk Weighted Assets) Actual Amount	$ 689,050	$ 604,832
Total Capital (to Risk Weighted Assets) Actual Ratio	12.90%	12.80%
Total Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Amount	$ 427,318	$ 378,020
Total Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Ratio	8.00%	8.00%
Tier 1 Capital (to Risk Weighted Assets) Actual Amount	$ 549,445	$ 487,775
Tier 1 Capital (to Risk Weighted Assets) Actual Ratio	10.30%	10.30%
Tier 1 Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Amount	$ 320,065	$ 284,141
Tier 1 Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Ratio	6.00%	6.00%
Common Equity Tier 1 Capital (to Risk Weighted Assets) Actual Amount	$ 464,501	$ 448,209
Common Equity Tier 1 Capital (to Risk Weighted Assets) Actual Ratio	8.70%	9.50%
Common Equity Tier 1 Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Amount	$ 240,259	$ 212,310
Common Equity Tier 1 Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Ratio	4.50%	4.50%
Tier 1 Capital (to Average Assets) Actual Amount	$ 549,445	$ 487,775
Tier 1 Capital (to Average Assets) Actual Ratio	10.80%	10.00%
Tier 1 Capital (to Average Assets) Minimum for Capital Adequacy Purposes Amount	$ 203,498	$ 195,110
Tier 1 Capital (to Average Assets) Minimum for Capital Adequacy Purposes Ratio	4.00%	4.00%
TBK Bank SSB
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Total Capital (to Risk Weighted Assets) Actual Amount	$ 624,406	$ 555,213
Total Capital (to Risk Weighted Assets) Actual Ratio	11.90%	12.00%
Total Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Amount	$ 419,769	$ 370,142
Total Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Ratio	8.00%	8.00%
Total Capital (to Risk Weighted Assets) To Be Well Capitalized Under Prompt Corrective Action Provisions Amount	$ 524,711	$ 462,678
Total Capital (to Risk Weighted Assets) To Be Well Capitalized Under Prompt Corrective Action Provisions Ratio	10.00%	10.00%
Tier 1 Capital (to Risk Weighted Assets) Actual Amount	$ 573,637	$ 525,490
Tier 1 Capital (to Risk Weighted Assets) Actual Ratio	10.90%	11.40%
Tier 1 Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Amount	$ 315,763	$ 276,574
Tier 1 Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Ratio	6.00%	6.00%
Tier 1 Capital (to Risk Weighted Assets) To Be Well Capitalized Under Prompt Corrective Action Provisions Amount	$ 421,018	$ 368,765
Tier 1 Capital (to Risk Weighted Assets) To Be Well Capitalized Under Prompt Corrective Action Provisions Ratio	8.00%	8.00%
Common Equity Tier 1 Capital (to Risk Weighted Assets) Actual Amount	$ 573,637	$ 525,490
Common Equity Tier 1 Capital (to Risk Weighted Assets) Actual Ratio	10.90%	11.40%
Common Equity Tier 1 Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Amount	$ 236,823	$ 207,430
Common Equity Tier 1 Capital (to Risk Weighted Assets) Minimum for Capital Adequacy Purposes Ratio	4.50%	4.50%
Common Equity Tier 1 Capital (to Risk Weighted Assets) To Be Well Capitalized Under Prompt Corrective Action Provisions Amount	$ 342,077	$ 299,621
Common Equity Tier 1 Capital (to Risk Weighted Assets) To Be Well Capitalized Under Prompt Corrective Action Provisions Ratio	6.50%	6.50%
Tier 1 Capital (to Average Assets) Actual Amount	$ 573,637	$ 525,490
Tier 1 Capital (to Average Assets) Actual Ratio	11.30%	10.90%
Tier 1 Capital (to Average Assets) Minimum for Capital Adequacy Purposes Amount	$ 203,057	$ 192,840
Tier 1 Capital (to Average Assets) Minimum for Capital Adequacy Purposes Ratio	4.00%	4.00%
Tier 1 Capital (to Average Assets) To Be Well Capitalized Under Prompt Corrective Action Provisions Amount	$ 253,822	$ 241,050
Tier 1 Capital (to Average Assets) To Be Well Capitalized Under Prompt Corrective Action Provisions Ratio	5.00%	5.00%

Regulatory Matters - Additional

Regulatory Matters - Additional Information (Details)	3 Months Ended	9 Months Ended
	Mar. 31, 2020	Sep. 30, 2020
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Capital conservation buffer rate	2.50%	2.50%
ASU 2016-13
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Regulatory capital calculation CECL transition adjustment		25.00%
Regulatory capital calculation CECL transition relief period		2 years
Percentage of fixed transition adjustment phased out of regulatory capital calculations over three year		75.00%
Percentage of fixed transition adjustment phased out of regulatory capital calculations in year four		50.00%
Percentage of fixed transition adjustment phased out of regulatory capital calculations in year five		25.00%

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Capital Structure (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2020	Jun. 19, 2020	Sep. 30, 2020	Dec. 31, 2019
Class of Stock [Line Items]
Shares issued (in shares)				0
Shares authorized (in shares)	50,000,000		50,000,000	50,000,000
Shares issued (in shares)	27,932,671		27,932,671	27,163,642
Treasury shares (in shares)	(3,081,070)		(3,081,070)	(2,198,681)
Shares outstanding (in shares)	24,851,601		24,851,601	24,964,961
Par value per share (in dollars per share)	$ 0.01		$ 0.01	$ 0.01
Preferred Stock Series C
Class of Stock [Line Items]
Shares authorized (in shares)	51,750		51,750
Shares issued (in shares)	45,000	45,000	45,000
Shares outstanding (in shares)	45,000		45,000
Par value per share (in dollars per shares)	$ 0.01	$ 0.01	$ 0.01
Liquidation preference per share (in dollars per shares)	$ 1,000	$ 1,000	$ 1,000
Liquidation preference amount	$ 45,000		$ 45,000
Dividend rate	7.125%	7.125%	7.125%

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) - USD ($)	Sep. 30, 2020	Jun. 19, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)											0
Issuance of preferred stock, net of issuance costs									$ 42,364,000	$ 0
Shares repurchased value and held into treasury stock				$ 186,000	$ 35,586,000	$ 24,998,000	$ 17,559,000	$ 7,553,000
Share repurchase program
Class of Stock [Line Items]
Shares repurchased and held into treasury stock (in shares)			0		871,319	850,093				1,688,234
Shares repurchased, average price per share (in dollars per share)					$ 40.81	$ 29.38				$ 29.56
Shares repurchased value and held into treasury stock					$ 35,600,000	$ 24,972,000				$ 49,902,000
Maximum | Share repurchase program
Class of Stock [Line Items]
Amount authorized under stock repurchase program					$ 50,000,000
Series C Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)	45,000	45,000	45,000						45,000
Preferred stock, dividend rate	7.125%	7.125%							7.125%
Preferred stock, par value per share (in dollars per shares)	$ 0.01	$ 0.01	$ 0.01						$ 0.01
Preferred stock, liquidation preference per share (in dollars per shares)	$ 1,000	$ 1,000	$ 1,000						$ 1,000
Stock issued during period shares (in shares)		1,800,000
Gross proceeds from preferred stock offering		$ 45,000,000
Issuance of preferred stock, net of issuance costs		$ 42,364,000

Stock Based Compensation - Addi

Stock Based Compensation - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation	$ 1,309,000	$ 1,058,000	$ 3,443,000	$ 2,794,000
2014 Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares approved for issuance (in shares)					2,000,000
2014 Omnibus Incentive Plan | Restricted Stock Awards (RSAs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost	3,597,000		$ 3,597,000
Remaining period to recognize cost			3 years 1 month 20 days
2014 Omnibus Incentive Plan | Restricted Stock Awards (RSAs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation, award vesting period			3 years
2014 Omnibus Incentive Plan | Restricted Stock Awards (RSAs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation, award vesting period			4 years
2014 Omnibus Incentive Plan | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation, award vesting period			5 years
Total unrecognized compensation cost	1,872,000		$ 1,872,000
Remaining period to recognize cost			2 years 6 months 29 days
2014 Omnibus Incentive Plan | Performance stock units - market based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost	$ 1,786,000		$ 1,786,000
Remaining period to recognize cost			2 years 5 months 15 days
2014 Omnibus Incentive Plan | Performance stock units - market based | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation, award vesting period			3 years
Stock based compensation, award vesting percentage			0.00%
2014 Omnibus Incentive Plan | Performance stock units - market based | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation, award vesting period			5 years
Stock based compensation, award vesting percentage			175.00%
2014 Omnibus Incentive Plan | Performance Based Performance Stock Units (Performance Based PSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation			$ 0
Stock based compensation, award vesting period			3 years
Remaining period to recognize cost	2 years 3 months
2014 Omnibus Incentive Plan | Performance Based Performance Stock Units (Performance Based PSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation, award vesting percentage			0.00%
2014 Omnibus Incentive Plan | Performance Based Performance Stock Units (Performance Based PSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation, award vesting percentage			200.00%
Total unrecognized compensation cost	$ 19,618,000		$ 19,618,000
2014 Omnibus Incentive Plan | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation, award vesting period			4 years
Remaining period to recognize cost			2 years 10 months 9 days
Total unrecognized compensation cost	$ 401,000		$ 401,000
Employees stock options contractual terms			10 years
2019 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)	2,500,000		2,500,000
Purchase price of common stock, percentage			85.00%

Stock Based Compensation - Summ

Stock Based Compensation - Summary of Changes in Company's Nonvested Restricted Stock Awards (Details) - Restricted Stock Awards (RSAs)	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Shares
Nonvested Shares, Beginning balance (in shares) | shares	148,349
Nonvested Shares, Granted (in shares) | shares	138,417
Nonvested Shares, Vested (in shares) | shares	(75,103)
Nonvested Shares, Forfeited (in shares) | shares	(3,634)
Nonvested Shares, Ending balance (in shares) | shares	208,029
Weighted-Average Grant-Date Fair Value
Weighted-Average Grant-Date Fair Value, Nonvested, Beginning balance (in dollars per share) | $ / shares	$ 31.86
Weighted-Average Grant-Date Fair Value, Nonvested, Granted (in dollars per share) | $ / shares	26.54
Weighted-Average Grant-Date Fair Value, Nonvested, Vested (in dollars per share) | $ / shares	29.64
Weighted-Average Grant-Date Fair Value, Nonvested, Forfeited (in dollars per share) | $ / shares	31.07
Weighted-Average Grant-Date Fair Value, Nonvested, Ending balance (in dollars per share) | $ / shares	$ 29.14

Stock Based Compensation - Su_2

Stock Based Compensation - Summary of Changes in Company's Nonvested Restricted Stock Units (Details) - Restricted stock units	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Shares
Nonvested Shares, Beginning balance (in shares) | shares	55,228
Nonvested Shares, Granted (in shares) | shares	38,801
Nonvested Shares, Vested (in shares) | shares	0
Nonvested Shares, Forfeited (in shares) | shares	(4,316)
Nonvested Shares, Ending balance (in shares) | shares	89,713
Weighted-Average Grant-Date Fair Value
Weighted-Average Grant-Date Fair Value, Nonvested, Beginning balance (in dollars per share) | $ / shares	$ 38.75
Weighted-Average Grant-Date Fair Value, Nonvested, Granted (in dollars per share) | $ / shares	26.25
Weighted-Average Grant-Date Fair Value, Nonvested, Vested (in dollars per share) | $ / shares	0
Weighted-Average Grant-Date Fair Value, Nonvested, Forfeited (in dollars per share) | $ / shares	38.75
Weighted-Average Grant-Date Fair Value, Nonvested, Ending balance (in dollars per share) | $ / shares	$ 33.34

Stock Based Compensation - Su_3

Stock Based Compensation - Summary of Changes in Company's Nonvested Market Based Performance Stock Units (Details) - Performance stock units - market based	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Shares
Nonvested Shares, Beginning balance (in shares) | shares	67,707
Nonvested Shares, Granted (in shares) | shares	22,220
Nonvested Shares, Vested (in shares) | shares	0
Nonvested Shares, Forfeited (in shares) | shares	(4,316)
Nonvested Shares, Ending balance (in shares) | shares	85,611
Weighted-Average Grant-Date Fair Value
Weighted-Average Grant-Date Fair Value, Nonvested, Beginning balance (in dollars per share) | $ / shares	$ 37.71
Weighted-Average Grant-Date Fair Value, Nonvested, Granted (in dollars per share) | $ / shares	29.93
Weighted-Average Grant-Date Fair Value, Nonvested, Vested (in dollars per share) | $ / shares	0
Weighted-Average Grant-Date Fair Value, Nonvested, Forfeited (in dollars per share) | $ / shares	38.57
Weighted-Average Grant-Date Fair Value, Nonvested, Ending balance (in dollars per share) | $ / shares	$ 35.65

Stock Based Compensation - Sche

Stock Based Compensation - Schedule of Performance Stock Units, Valuation Assumptions (Details) - Performance stock units - market based - $ / shares	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date	May 1, 2020	May 1, 2019
Performance period	3 years	3 years
Stock price (in dollars per share)	$ 26.25	$ 30.82
Triumph stock price volatility	43.02%	28.29%
Risk-free rate	0.25%	2.25%

Stock Based Compensation - Su_4

Stock Based Compensation - Summary of Changes in Company's Nonvested Performance Based Performance Stock Units (Details) - Performance Based Performance Stock Units (Performance Based PSUs)	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Shares
Nonvested Shares, Beginning balance (in shares) | shares	254,000
Nonvested Shares, Granted (in shares) | shares	10,125
Nonvested Shares, Vested (in shares) | shares	0
Nonvested Shares, Forfeited (in shares) | shares	(3,000)
Nonvested Shares, Ending balance (in shares) | shares	261,125
Weighted-Average Grant-Date Fair Value
Weighted-Average Grant-Date Fair Value, Nonvested, Beginning balance (in dollars per share) | $ / shares	$ 38.02
Weighted-Average Grant-Date Fair Value, Nonvested, Granted (in dollars per share) | $ / shares	26.25
Weighted-Average Grant-Date Fair Value, Nonvested, Vested (in dollars per share) | $ / shares	0
Weighted-Average Grant-Date Fair Value, Nonvested, Forfeited (in dollars per share) | $ / shares	38.02
Weighted-Average Grant-Date Fair Value, Nonvested, Ending balance (in dollars per share) | $ / shares	$ 37.56

Stock Based Compensation - Su_5

Stock Based Compensation - Summary of Changes in Company's Stock Options (Details) - Stock Options - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2020
Shares
Stock Options, Beginning Balance (in shares)	225,055
Stock Options, Granted (in shares)	32,937
Stock Options, Exercised (in shares)	(743)
Stock Options, Forfeited or expired (in shares)	(443)
Stock Options, Ending Balance (in shares)	256,806
Stock Options, Fully vested shares and shares expected (in shares)	256,806
Stock Options, Shares exercisable (in shares)	174,073
Weighted-Average Exercise Price
Weighted-Average Exercise Price, Beginning Balance (in dollars per share)	$ 24.10
Weighted-Average Exercise Price, Granted (in dollars per share)	24.66
Weighted-Average Exercise Price, Exercised (in dollars per share)	15.87
Weighted-Average Exercise Price, Forfeited or expired (in dollars per share)	38.75
Weighted-Average Exercise Price, Ending Balance (in dollars per share)	24.18
Weighted-Average Exercise Price, Fully vested shares and shares expected to vest (in dollars per share)	24.18
Weighted-Average Exercise Price, Shares exercisable (in dollars per share)	$ 21.48
Weighted-Average Remaining Contractual Term (In Years)
Weighted-Average Remaining Contractual Term, Outstanding	6 years 9 months 25 days
Weighted-Average Remaining Contractual Term, Fully vested shares and shares expected to vest	6 years 9 months 25 days
Weighted-Average Remaining Contractual Term, Shares exercisable	6 years 21 days
Aggregate Intrinsic Value (In Thousands)
Aggregate Intrinsic Value, Outstanding	$ 2,141
Aggregate Intrinsic Value, Fully vested shares and shares expected to vest	2,141
Aggregate Intrinsic Value, Shares exercisable	$ 1,859

Stock Based Compensation - Sc_2

Stock Based Compensation - Schedule of Information Related to Stock Options (Details) - Stock Options - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value of options exercised	$ 10	$ 148
Cash received from option exercises	0	0
Tax benefit realized from option exercises	$ 2	$ 31
Weighted average fair value per share of options granted	$ 8.85	$ 10.03

Stock Based Compensation - Fair

Stock Based Compensation - Fair Value of Stock Options Granted Using Weighted-Average Assumptions (Details) - Stock Options	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.46%	2.33%
Expected term	6 years 3 months	6 years 3 months
Expected stock price volatility	33.83%	27.46%
Dividend yield	0.00%	0.00%

Earnings Per Share - Factors Us

Earnings Per Share - Factors Used in Computation of Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Basic
Net income to common stockholders	$ 22,005	$ 14,317	$ 30,995	$ 41,835
Weighted average common shares outstanding (in shares)	24,592,092	25,621,054	24,298,897	26,228,499
Basic earnings per common share (in dollars per share)	$ 0.89	$ 0.56	$ 1.28	$ 1.60
Diluted
Net income to common stockholders	$ 22,005	$ 14,317	$ 30,995	$ 41,835
Weighted average common shares outstanding (in shares)	24,592,092	25,621,054	24,298,897	26,228,499
Dilutive effects of:
Average shares and dilutive potential common shares (in shares)	24,802,388	25,734,471	24,464,215	26,331,740
Diluted earnings per common share (in dollars per share)	$ 0.89	$ 0.56	$ 1.27	$ 1.59
Stock Options
Dilutive effects of:
Stock based compensation (in shares)	48,102	60,068	53,232	61,054
Restricted stock awards
Dilutive effects of:
Stock based compensation (in shares)	67,907	45,631	65,893	40,572
Restricted stock units
Dilutive effects of:
Stock based compensation (in shares)	18,192	3,045	15,198	57
Performance stock units - market based
Dilutive effects of:
Stock based compensation (in shares)	76,095	4,673	30,995	1,558
Performance stock units - performance based
Dilutive effects of:
Stock based compensation (in shares)	0	0	0	0

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Shares not Considered in Computing Diluted Earnings per Common Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	98,513	67,023	98,513	67,023
Restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	0	3,209	0	3,209
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	0	0	0	54,077
Performance stock units - market based
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	0	55,228	0	55,228
Performance stock units - performance based
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	261,125	0	261,125	0

Business Segment Information -

Business Segment Information - Banking Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Segment Reporting Information [Line Items]
Total interest income	$ 82,364	$ 79,415	$ 232,176	$ 229,982
Total interest expense	7,985	14,650	31,046	40,487
Net interest income (expense)	74,379	64,765	201,130	189,495
Credit loss expense (benefit)	(258)	2,865	33,649	7,560
Net interest income after credit loss expense	74,637	61,900	167,481	181,935
Gain on sale of subsidiary or division	0	0	9,758	0
Other noninterest income	10,493		28,241
Noninterest income	10,493	7,742	37,999	22,903
Noninterest expense	55,297	52,153	162,776	151,423
Net income before income tax expense	29,833	17,489	42,704	53,415
Total assets	5,836,787		5,836,787		$ 5,060,297
Gross loans	4,852,911		4,852,911		4,194,512
Operating Segments | Banking
Segment Reporting Information [Line Items]
Total interest income	52,288	54,266	157,957	155,645
Total interest expense	6,176	13,091	25,368	35,746
Net interest income (expense)	49,424	44,093	141,462	128,087
Credit loss expense (benefit)	(3,417)	2,019	27,378	5,847
Net interest income after credit loss expense	52,841	42,074	114,084	122,240
Gain on sale of subsidiary or division			9,758
Other noninterest income	7,490		22,586
Noninterest income		6,401		19,150
Noninterest expense	40,584	38,371	122,001	109,406
Net income before income tax expense	19,747	10,104	24,427	31,984
Total assets	5,767,857		5,767,857		4,976,009
Gross loans	4,759,135		4,759,135		4,108,735
Operating Segments | Factoring
Segment Reporting Information [Line Items]
Total interest income	30,068	24,869	73,952	73,435
Total interest expense	0	0	0	0
Net interest income (expense)	26,756	21,951	65,079	65,247
Credit loss expense (benefit)	3,053	846	4,437	1,789
Net interest income after credit loss expense	23,703	21,105	60,642	63,458
Gain on sale of subsidiary or division			0
Other noninterest income	3,157		5,524
Noninterest income		1,291		3,572
Noninterest expense	13,665	12,792	37,695	39,340
Net income before income tax expense	13,195	9,604	28,471	27,690
Total assets	1,042,571		1,042,571		662,002
Gross loans	948,987		948,987		573,372
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Total interest income	8	280	267	902
Total interest expense	1,809	1,559	5,678	4,741
Net interest income (expense)	(1,801)	(1,279)	(5,411)	(3,839)
Credit loss expense (benefit)	106	0	1,834	(76)
Net interest income after credit loss expense	(1,907)	(1,279)	(7,245)	(3,763)
Gain on sale of subsidiary or division			0
Other noninterest income	(154)		131
Noninterest income		50		181
Noninterest expense	1,048	990	3,080	2,677
Net income before income tax expense	(3,109)	(2,219)	(10,194)	(6,259)
Total assets	828,065		828,065		771,048
Gross loans	800		800		1,519
Eliminations
Segment Reporting Information [Line Items]
Total assets	(1,801,706)		(1,801,706)		(1,348,762)
Gross loans	(856,011)		(856,011)		$ (489,114)
Eliminations | Banking
Segment Reporting Information [Line Items]
Intersegment interest allocations	3,312	2,918	8,873	8,188
Eliminations | Factoring
Segment Reporting Information [Line Items]
Intersegment interest allocations	(3,312)	(2,918)	(8,873)	(8,188)
Eliminations | Corporate
Segment Reporting Information [Line Items]
Intersegment interest allocations	$ 0	$ 0	$ 0	$ 0